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PELVIC ORGAN PROLAPSE 
 
Female pelvic organ prolapse (POP) is the herniation of pelvic organs into or through the 
vagina. (figure 1.1) The anterior compartment, with descent of the urinary bladder 
(cystocele), is most commonly affected.1 POP of the posterior compartment concerns the 
rectum (rectocele) or small bowel (enterocele) and POP of the apical compartment includes 
uterine descent or vaginal vault prolapse (in case of hysterectomy). Most affected women 
have POP in more than one compartment.  
 
 
Figure 1.1 Female pelvic organ prolapse 
 
a. normal anatomy   b. cystocele   c. rectocele   d. uterine descent 
Source: http://www.bardmedical.com Pelvic Organ Prolapse: An Interactive Guide 
 
 
Many women with POP are asymptomatic. Symptomatic women complain of symptoms such 
as feeling or seeing a bulge or experiencing vaginal pressure. Associated symptoms such as 
urinary, defecatory or sexual dysfunction are frequently reported.2 The severity of symptoms 
a. b. 
c. d. 
uterus 
bladder rectum 
vagina 
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does not correlate well with the severity of POP.3 Symptoms may vary during the day and 
are related to position and physical activity. The complaints are often less noticeable in the 
morning or while supine and worsen when the day progresses and in standing position. 
Women with symptomatic disorders suffer physical and emotional distress.4 It has a great 
negative impact on women’s social, physical and psychological well-being.5 In case of 
symptomatic POP, options include expectant management (including physical therapy), 
pessary treatment and surgery.2 
 
 
EPIDEMIOLOGY 
 
It has been reported that in a general population 40% of women aged between 45 and 85 
years have an objective POP on examination, but only 12% of these women is symptomatic.6 
Two thirds of parous women have anatomical evidence of POP.7 As the general population 
ages, pelvic floor dysfunction will become increasingly burdensome in terms of reduced 
quality of life, workforce productivity, and cost to both the individual and the health care 
system as a whole.8 
The lifetime risk of surgery for POP in the general female population is 13-20%.9-11 POP 
surgery is known to have high reoperation rates.12 Cystocele is the most common affected 
compartment in POP and is also the most prone for recurrence after surgery.13  
 
 
ETIOLOGY AND RISK FACTORS 
 
The etiology of POP is multifactorial.14 It is likely that combinations of anatomical, 
physiological, genetic, lifestyle, and reproductive factors interact throughout a woman’s 
lifespan to contribute to pelvic floor dysfunction.15 The factors causing POP development 
vary from patient to patient.16 
Frequently described risk factors for POP are aging, vaginal childbirth, obesity, family 
history of POP and collagen weakness.17-19 Vaginal childbirth gives a 4 to 11 fold increase in 
risk for developing POP among parous women compared to women without a history of 
vaginal delivery.20 The most inferior and medial parts of the levator ani muscle must increase 
in length by a factor of 3.5 during crowning of the fetal head during vaginal delivery, which 
can cause injury to the muscle. (figure 1.2) It has been postulated that damage of the levator 
ani muscle is the intermediary between vaginal childbirth and POP.14 
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Figure 1.2 Crowning of the fetal head during vaginal childbirth causing levator ani 
muscle damage 
 
 
Source: http://www.uptodate.com Urinary incontinence and pelvic organ prolapse associated   
with pregnancy and childbirth 
 
 
LEVATOR ANI MUSCLE 
 
The levator ani muscle is a U-shaped sling around the pelvic organs, which consists of the 
pubococcygeus (also called pubovisceral), the puborectalis, and iliococcygeus muscles. 
(figure 1.3) The levator ani muscle is critical to pelvic floor function because it provides 
support to the pelvic organs, keeps them in place during increased intra-abdominal pressure 
and plays an essential role in urinary, defecatory, and sexual function. 
Trauma to the levator ani muscle generally seems to manifest as a detachment of the 
inferomedial parts of the muscle from its insertion on the pelvic sidewall.21, 22 A levator defect 
can be partial, with residual connection of the levator muscle to the pubic bone, or total.  
The levator ani hiatus is defined as the area within the levator ani muscle, bordered by the 
levator ani muscle, the symphysis pubis and the inferior pubic ramus, through which the 
urethra, vagina and rectum pass.23 The size of the levator hiatal area varies with pubovisceral 
muscle activity. 
 
Tear of pubococcygeus 
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Figure 1.3 Levator ani muscle  
 
 
Levator ani muscle within the continuous white lines 
Source: http://www.youtube.com Levator Ani Muscles - Innervation, Function & Anatomy - Human Anatomy 
 
 
PELVIC FLOOR IMAGING 
     Figure 1.4: Translabial 3D ultrasound  
The levator ani muscle and the levator hiatal 
area can be visualized by Magnetic 
Resonance Imaging (MRI) and translabial 
three-dimensional (3D) ultrasound. MRI has 
superior resolution capability, but until 
recently could not be used for dynamic 
scanning of the pelvic floor. Translabial 3D 
ultrasound has the advantage of being more 
accessible, less expensive and can offer real-
time imaging in different positions and 
during pubovisceral muscle activity such as 
contractions or Valsalva manoeuvres.23, 24 
The transducer is placed against the perineum.    Source: http://www.bkultrasound.com - Guide 
(figure 1.4)            to Pelvic Floor Multicompartment Scanning 
 
First, a two-dimensional (2D) image in the midsagittal plane is visualized. (figure 1.5) From 
this view, a 3D image in the axial plane is visualized, in which the levator ani muscle and the 
Pubococcygeus 
Iliococcygeus 
P uborectalis 
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Urethra Vagina 
levator hiatal area can be examined. (figure 1.6) With MRI, the levator ani muscle and the 
levator hiatal area can directly be visualized in an axial plane. (figure 1.7) 
 
 
Figure 1.5 Translabial 2D ultrasound in the midsagittal plane 
 
     
Left: ultrasound image   Right: schematic representation 
Source: http://www.ics.org 
 
 
Figure 1.6 Translabial 3D ultrasound in the axial plane 
 
 
3D ultrasound in the axial plane 
Source: http://www.researchgate.net 
Urethra 
Vagina 
P uborectalis 
Anal canal 
Anal canal 
Symphysis 
Bladder 
Uterus 
Rectum 
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Figure 1.7 MRI in the axial plane 
 
   
Left: overview   Right: enlarged image, levator hiatal area marked with white lines 
Source: Trudil study 
 
 
Studies with MRI and translabial 3D ultrasound have demonstrated the occurrence of levator 
ani damage after vaginal childbirth. In 20–23% of women who have delivered vaginally, 
trauma of the levator ani was identified.21, 25 No defects were seen in nulliparous women. 
POP was seen in 83% of women with levator defects and in 44% of women without levator 
defects. The association was strongest for cystocele and uterine descent.  
 
 
PREDICTION OF POP RECURRENCE AFTER SURGERY 
 
Little is known about the factors associated with surgical failure. It is thought that factors that 
play a role in the origin of POP may also be risk factors for POP recurrence after surgery. 
Nonetheless, in studies concerning risk factors for POP recurrence, a selected group of 
women is investigated, because all women already have primary POP with higher prevalence 
of associated risk factors. Evidence regarding prediction of POP recurrence after surgery is 
limited. Identifying patients at high risk of POP recurrence after surgery could be useful for 
individualized counselling and making treatment choices. 
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OUTLINE OF THIS THESIS 
 
This thesis will give an insight in the risk factors for POP recurrence after native tissue repair 
and explores the role of translabial 3D ultrasound in predicting POP recurrence. The research 
topics are the following: 
• What are the risk factors for POP and POP recurrence? 
• What is the role of translabial 3D ultrasound in diagnosing levator defects and 
measuring levator ani biometry? 
• Is a levator defect a risk factor for cystocele recurrence after native tissue repair? 
And what are other risk factors? 
• Can the classification system used to describe levator defects on ultrasound be 
compared to the classification system used on MRI? 
• Is the size of the levator hiatal area a risk factor for cystocele recurrence after native 
tissue repair? And what are other risk factors? 
• Can measurements of levator hiatal biometry on ultrasound be compared with 
measurements on MRI? 
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ABSTRACT 
 
Introduction and hypothesis 
Pelvic organ prolapse (POP) is a common condition with multifactorial etiology. The purpose 
of this systematic review was to provide an overview of literature on risk factors for POP and 
POP recurrence. 
 
Methods 
PubMed and Embase were searched with “pelvic organ prolapse” combined with 
“recurrence” and combined with “risk factors”, with Medical Subject Headings and 
Thesaurus terms and text words variations until August 4th 2014, without language or 
publication date restrictions. Only cohort or cross-sectional studies situated in western 
developed countries containing multivariate analyses and with a definition of POP based on 
anatomical references were included. POP recurrence had to be defined as anatomical 
recurrence after native tissue repair without mesh. Follow-up after surgery should have been 
at least one year. Articles were excluded if POP was not a separate entity or if it was unclear 
whether the outcome was primary POP or recurrence. 
 
Results 
PubMed and Embase revealed 2,988 and 4,449 articles, respectively. After preselection, 534 
articles were independently evaluated by two researchers, of which 15 met the selection 
criteria.  
In 10 articles on primary POP, 30 risk factors were investigated. Parity, vaginal delivery, age 
and body mass index (BMI) were significantly associated in at least two articles.  
In 5 articles on POP recurrence, 29 risk factors were investigated. Only preoperative stage 
was significantly associated in at least two articles.  
 
Conclusion  
Parity, vaginal delivery, age and BMI are risk factors for POP and preoperative stage is a risk 
factor for POP recurrence. 
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INTRODUCTION 
 
Female pelvic organ prolapse (POP) is a common condition that is multifactorial in etiology.1 
It is likely that combinations of anatomical, physiological, genetic, lifestyle, and reproductive 
factors interact throughout a woman’s lifespan to contribute to pelvic floor dysfunction.2 The 
factors causing POP development vary from patient to patient.3 Unraveling the complex 
causal network of genetic factors, birth-induced injury, connective tissue aging, lifestyle and 
co-morbid factors is challenging.2 
While two thirds of parous women have anatomical evidence of POP 4, the majority of these 
women are asymptomatic.5 It has been reported that in a general population 40% of women 
aged between 45 and 85 years have an objective POP on examination, but only 12% of these 
women is symptomatic.6 Women with symptomatic disorders suffer physical and emotional 
distress.7 It has a great negative impact on women’s social, physical and psychological well-
being.8 As the general population ages, pelvic floor dysfunction will become increasingly 
burdensome in terms of reduced quality of life, workforce productivity, and cost to both the 
individual and the health care system as a whole.9 
The lifetime risk of surgery for POP in the general female population is 11.1%.10 Surgery for 
POP is known to have a high reoperation rate.10 The identification of risk factors for POP 
development and its recurrence appears therefore crucial for the best management of women 
with this condition in order to provide a proper preoperative counseling or modulate patients’ 
expectations and tailor surgical treatment.11 
An overview on the literature on risk factors for POP and its recurrence after native tissue 
repair would help to build a risk model in order to identify low and high risk women. The 
purpose of this systematic review was to provide an overview of the published literature on 
risk factors for the development of POP and its recurrence after native tissue repair.  
 
 
MATERIALS AND METHODS 
 
The primary investigator (TFMV) and a clinical librarian searched the electronic databases 
PubMed and Embase with the search terms “pelvic organ prolapse” in combination with 
“recurrence”, and “pelvic organ prolapse” in combination with “risk factors” from inception 
until August 4th 2014. To capture all relevant articles on this subject, Medical Subject 
Headings (MeSH) and Thesaurus terms and text words with different word variations were 
used. Restrictions on publication date or language were not applied. The searches are 
depicted in Appendices A1 and A2.  
At first, all studies were evaluated by title. Of the papers available, those titles were selected 
that could contain information about risk factors for primary POP or POP recurrence.  
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After this preselection, two researchers (TFMV and MW) independently evaluated all studies 
by abstract. In case of disagreement, full text articles were evaluated. If full text was 
unavailable, authors were contacted to obtain the article. Abstracts were included in case they 
reported on clinical studies on the etiology or risk factors for primary POP or POP recurrence. 
Letters, commentaries and editorial notes were excluded. The full text of included articles 
was assessed using an in- and exclusion form. Cohort studies or cross-sectional studies 
situated in western developed countries were included. The definition of POP had to be based 
on anatomical references such as the hymenal remnants or the Pelvic Organ Prolapse 
Quantification (POPQ) system stage 2. POP recurrence had to be defined as anatomical 
recurrence after native tissue repair (i.e. without the use of mesh-materials and follow-up 
after surgery should at least be one year. Furthermore articles had to contain a multivariate 
analysis. Articles were excluded in case they did not study POP as a separate entity (but 
investigated pelvic floor dysfunction in general), in case it was unclear whether the outcome 
was a primary POP or a POP recurrence (e.g. after hysterectomy) and in case POP recurrence 
was studied after mesh augmentation. In case there were more publications using the same 
study population, only the most recent study was included. In case of disagreement on the in- 
or exclusion of an article after discussion between the two observers, the decision was made 
by asking the opinion of one of the other researchers in the research-group (KBK). 
A manual search of the references of each selected article was performed in order to further 
identify studies not captured by the online search but potentially relevant for this review.  
After the final selection, data were extracted on study design, aim of the study, sample size, 
study population, definition of outcome, investigated risks factors, and results of the 
multivariate analysis. In case multiple analyses were performed with different definitions of 
POP, data regarding the definition ‘POPQ stage 2 or more’ or closest to this definition, were 
extracted.  
P-values <0.05 were considered statistically significant. Only risk factors that were 
significantly associated with POP or POP recurrence in the multivariate analysis in at least 
two studies, were defined as confirmed risk factors. 
 
 
RESULTS 
 
The PubMed search and the Embase search revealed 2,988 and 4,449 articles, respectively. 
After elimination of duplicates, 5,093 articles were evaluated by title and/or abstract. Full 
texts of 130 articles were assessed using the in- and exclusion form, of which 15 articles met 
the selection criteria. No additional studies were identified by cross-checking reference lists. 
Of the 15 articles included in this systematic review, 10 investigated risk factors for primary 
POP and 5 articles investigated risk factors for POP recurrence after surgery. Figure 2.1 
shows the flow diagram of the selection process.  
Risk factors for pelvic organ prolapse and its recurrence: a systematic review 
21 
 
Figure 2.1 Flow diagram of the selection process  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Search Pubmed: 
2,988 
Selection of abstracts by two 
independent reviewers:     
130 
Assessment with inclusion 
and exclusion form:            
15 
Articles on risk 
factors for primary 
prolapse: 10 
Articles on risk 
factors for prolapse 
recurrence: 5 
Removal of duplicates: 
5,093 
Search Embase: 
4,449 
Selection on title:      
534 
Reference check: 0 
Exclusion because:  
- no multivariable analysis or insufficient data: 48 
- insufficient definition of prolapse: 21 
- no cohort or cross-sectional study: 19 
- pelvic floor dysfunction in general: 6 
- unclear if prolapse was primary or recurrence: 5 
- review with primary studies already included: 5 
- prolapse after non-conventional surgery: 3 
- not about risk factors for prolapse: 3 
- non-Western population: 2 
- conference paper: 2 
- follow-up less than one year: 1 
Eligible for inclusion: 
15 
Exclusion because: 
- not about risk factors for prolapse: 143 
- no clinical research: 89 
- pelvic floor dysfunction in general: 59 
- conference paper, editors comments etc.: 56  
- prolapse after non-conventional surgery: 45  
- non-Western population: 7  
- animal study: 3 
- duplicates (missed in the first removal): 2 
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Risk factors for primary POP 
The articles investigating potential risk factors for primary POP are listed in table 2.1. Of the 
10 articles included, 7 were cross-sectional studies and 3 were prospective cohort studies. 
Overall, the quality of the included studies was assessed as adequate: all studies had clear 
participant recruitment and selection criteria; the outcome and covariables were clearly 
defined; results were well presented; sample sizes were sufficient for the number of predictor 
variables examined (i.e. more than 10 events per candidate variable).12 In 3 studies it was 
explicitly described that the examining physician was blinded against other data, such as a 
questionnaire or ultrasound findings.6,13,14  
The 10 included articles enrolled a total of 41,501 women. POP was defined as POPQ stage 
2 or more in 4 studies 6,14-16, as the most dependent point of the vaginal wall to or beyond the 
hymenal remnants in 3 studies 17-19, as degree 2 or 3 of the Baden-Walker classification 
system in one study 20, as the most dependent point of the vaginal wall to the introitus or 
outside of the vagina (according to the Women’s Health Initiative classification system) in 
one study 21, and as the most dependent point of the vaginal wall -0.5cm above the hymenal 
remnants in one study.13 
In the 10 articles, 30 potential risk factors were investigated, of which 17 risk factors were at 
least once significantly associated with primary POP in the multivariate analysis. Obstetric 
factors are represented in table 2.2. Other potential risk factors are shown in table 2.3. 
 
Risk factors for POP recurrence 
The articles investigating potential risk factors for prolapse recurrence are listed in table 2.4. 
Out of the 5 articles included, 3 were prospective cohort studies and 2 were retrospective 
cohort studies. Overall, the quality of the included studies was assessed as adequate: all 
studies had clear participant recruitment and selection criteria; the outcome and covariables 
were clearly defined; results were well presented; median follow-up after surgery was 
between 1 and 12 years. However, selective loss to follow-up could not be excluded in 1 
study, in which less than half of the included women attended the follow-up visit and no 
comparisons were reported between women attending the follow-up visit and women not 
attending the follow-up visit.22 In 4 out of 5 studies the number of evaluated risk factors was 
higher than generally advised (i.e. 10 events per candidate variable).12,23-26 For example, 1 
study had 36 events (i.e. prolapse recurrence) and assessed 10 candidate variables 23, and 
another study had 42 events and assessed 12 candidate variables.24 In 1 study it was explicitly 
described that the examining physician was blinded against other data, such as a 
questionnaire or ultrasound findings.25 
The 5 included articles enrolled a total of 954 women of which 316 with POP recurrence. 
POP recurrence was defined as POPQ stage 2 or more in all studies.  
In the 5 articles, 29 potential risk factors were investigated of which 8 risk factors were at 
least once significantly associated with POP recurrence after surgery in the multivariate 
analysis (table 2.5). 
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Risk factors discussed by topic 
Obstetric factors 
Parity and vaginal delivery were frequently investigated and showed to be risk factors for 
primary POP 15,16,18-21, except in 2 studies.6,13 The association with cesarean delivery was less 
clear. While in 2 studies no association between caesarean delivery and primary POP was 
found 19,20, 1 study showed that cesarean delivery was a risk factor when compared to 
nulliparous women 16, and 2 studies found that it was protective when compared to 
spontaneous or operative vaginal delivery.17,18 There was a trend towards an association 
between larger birth weight and primary POP, but only in 1 out of 3 studies this was 
statistically significant.13,15,20 Higher age at first delivery was a risk factor in 1 study 18, but 
in another study no significant association was found.15 Operative vaginal delivery, age at 
last delivery and gravidity were investigated only once and no significant associations were 
found, except for forceps delivery which was protective against primary POP when compared 
to spontaneous vaginal delivery only.13,15,18 
For POP recurrence, parity and complicated delivery were not significant risk factors.23-25 
This was in contrast with primary POP, for which parity was a risk factor. This phenomenon 
might be due to the fact that in studies concerning POP recurrence, only women with a 
primary POP are included, so this is a selected group of women. Birth weight and age at last 
delivery were only investigated once and no significant association was found.23,24 
 
Lifestyle factors 
Higher body mass index (BMI) as a categorical variable was a significant risk factor for 
primary POP 13,16,20,21, except in the 2 studies with the smallest sample sizes.15,18 Two studies 
investigated BMI as a continuous variable, of which 1 found no association 6 and in contrast 
with the other studies, 1 found that a higher BMI was slightly protective.19 Waist 
circumference and use of hormone replacement therapy were each only once significantly 
associated with primary POP, so no conclusion can be drawn.13,15,21 The results for the 
relation between smoking and primary POP were inconsistent. One study showed a trend 
towards a positive association 20, while in 3 studies smoking was protective 6,19,21, and in 2 
studies no association was found.13,15 One study argued that there might be an association 
between cigarette smoking and POP because smoking causes chronic respiratory diseases 
and higher abdominal pressure, but a negative association was found because smoking 
seemed to be linked to factors such as age and menopausal status.19 This hypothesis was 
supported by the fact that in another study the seemingly protective effect disappeared in the 
multivariate analysis.13 Physical activity was not a significant risk factor for primary 
POP.6,15,21 
Although higher BMI was a risk factor for primary POP, it was not a significant risk factor 
for POP recurrence.23-26 Weight, intense physical exercise, heavy lifting and smoking were 
examined only once and only weight was significantly associated with POP recurrence, but 
no firm conclusions can be drawn due to a lack of confirmation.24,26 
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Unmodifiable factors 
Age was a risk factor for primary POP 13,16,20,21, except in the 2 smallest studies.6,15 The role 
of ethnicity remained unclear in relation to primary POP. In 1 study a higher risk in Hispanic 
women compared to white women was found, while in another study this showed no 
significant association.13,21 Another study found a higher risk in white women compared to 
black women, while 2 other studies found no association.13,16,21 Menopausal status showed a 
trend towards a positive association with primary POP, but in only 1 of the 3 studies it was a 
significant risk factor.6,13,19 Family history was not a significant risk factor.6,15 Age at 
menopause and age at menarche were only examined once and showed no association.20 
Age as a risk factor for POP recurrence showed inconsistent results. In 2 studies, in which 
age was categorized as below 60 years compared to 60 years or older, younger age was a 
significant risk factor for POP recurrence after surgery.22,24 In 2 studies in which age was a 
continuous variable and in 1 study in which age was categorized as older than 70 years 
compared to 70 years or younger, no significant associations were found.23,25,26 For family 
history, 1 study found a significant association while another found no significant 
association.24,25 Menopausal status was not significantly associated with POP recurrence.22,23 
  
Comorbidity 
Constipation and pulmonary disease were not significantly associated with primary 
POP.13,15,21 Urge and mixed urinary incontinence showed a significant association, while 
urinary incontinence surgery, stress urinary incontinence and other forms of urinary 
incontinence were not significantly associated with primary POP.6,21 Diabetes mellitus, 
chronic illness, hysterectomy status, prior hernia surgery and POP in pregnancy were 
examined once and only diabetes mellitus was significantly associated with primary 
POP.13,15,16,21 Due to a lack of confirmation, no firm conclusions can be drawn. 
For POP recurrence, previous pelvic floor surgery and any urinary incontinence 
preoperatively showed inconsistent results.22,25,26 Constipation, pulmonary disease and 
previous hysterectomy were not significant risk factors.22-26 Incomplete bladder emptying, 
fecal incontinence, diabetes mellitus and abdominal hernias were only investigated once and 
no significant associations were found.22,24,26 Due to a lack of confirmation, no firm 
conclusions can be drawn. 
Social factors 
Having less education was a significant risk factor for primary POP in 2 out of 4 studies, 
while occupation was not significantly related.6,13,15,16,20 Income was only investigated once.13 
Women with a medium income were less likely to have POP when compared to women with 
a high income, while the amount of women with POP in the low income group was not 
significantly different from the women in the high income group. 
The relation between social factors and POP recurrence was not evaluated in the 5 selected 
articles. 
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Pelvic floor factors 
For primary POP, levator defects and the genital hiatus on transperineal ultrasound were 
investigated as risk factors once.14 Both a unilateral and a bilateral avulsion compared to no 
avulsion were significant risk factors for primary POP. An increased hiatal area on Valsalva 
was also associated with primary POP. For POP recurrence, levator defects, the site of most 
advanced prolapse, the genital hiatus on pelvic floor examination and levator muscle 
contraction on pelvic floor examination were examined once and only levator defects were 
significantly associated with POP recurrence.22-25 Due to a lack of confirmative studies, no 
clear conclusion can be drawn.   
 
Surgical factors 
In 4 studies, preoperative stage 3 or 4 was a significant risk factor for POP recurrence after 
surgery.22-25 Only the study in which preoperative stage 4 was compared with a preoperative 
stage of less than 4 found no significant association.26 The number of sites involved 
preoperatively and the surgeon’s experience were not significant risk factors for POP 
recurrence.22,24-26 Concomitant surgery was examined once and a sacrospinous fixation was 
a significant risk factor for POP recurrence.25 
  
  
 
Table 2.1 Included articles on primary prolapse 
 
Reference Study type N / n Inclusion criteria Risk factors 
Progetto 
Menopausa Italia 
Study Group, 
2000 20 
Cross-sectional 
study 
21449 / 410 Non-hysterectomized women around 
menopause attending an outpatient 
menopause clinic for general counselling 
about menopause 
BMI, delivery mode, age, parity, smoking, education, 
birth weight, age at menarche, age at menopause 
Nygaard, 2004 15 Cross-sectional 
study 
270 / 173 Non-hysterectomized women enrolled in 
the WHI Hormone Replacement Therapy 
clinical randomized trial 
BMI, delivery mode, age, smoking, hormone 
replacement therapy, education, birth weight, waist 
circumference, occupation, physical activity, family 
history, age at first and last delivery, pulmonary disease, 
prior hernia surgery 
Swift, 2005 13 Cross-sectional 
study 
1004 / 218 Women older than 18 years of age 
presenting for routine gynaecologic health 
care 
BMI, delivery mode, age, parity, smoking, ethnicity, 
hormone replacement therapy, birth weight, 
constipation, occupation, hysterectomy status, 
menopausal status, chronic illness, income, gravidity 
Whitcomb,   
2009 16 
Cross-sectional 
study 
1137 / 762 Women between 40 and 69 years of age 
who, since age 18 years, had been 
members of the Kaiser Permanente 
Medical Care Program of Northern 
California 
BMI, age, parity, ethnicity, education, diabetes 
Slieker-Ten 
Hove, 2009 6 
Cross-sectional 
study 
649 / 227 A general population of women aged 45 
to 85 years 
BMI, age, parity, smoking, menopausal status, 
education, physical activity, family history, urinary 
incontinence, prolapse during pregnancy 
Handa, 2011 17 Prospective 
cohort study 
1011 / 75 Women between 15 and 50 years of age 
giving birth to their first child 5 to 10 
years before enrolment 
Delivery mode 
  
 
Kudish, 2011 21 Prospective 
cohort study 
12650 / 2266 Non-hysterectomized  postmenopausal 
women enrolled in the WHI Estrogen plus 
Progestin Clinical Trial 
BMI, age, parity, smoking, ethnicity, hormone 
replacement therapy, waist circumference, constipation, 
physical activity, pulmonary disease, urinary 
incontinence 
Dietz, 2012 14 Cross-sectional 
study 
605 / NAa Women without prior incontinence or 
prolapse surgery with symptoms of pelvic 
floor dysfunction, with data of four-
dimensional ultrasound 
Levator avulsion, hiatal area on Valsalva 
Glazener, 2013 18 Prospective 
cohort study 
762 / 182 Women who delivered over a 12-month 
period in three maternity units 
BMI, delivery mode, parity, age at first birth 
Yeniel, 2013 19 Cross-sectional 
study 
1964 / 155 Women without prior prolapse surgery 
with benign gynaecological disorders 
BMI, delivery mode, smoking, menopausal status 
N / n = number of women included in the study who underwent physical examination / number of women with pelvic organ prolapse, BMI = Body Mass Index, WHI 
= Women’s Health Initiative, NA = not available 
a Number of women categorized by type of prolapse: 222 women with cystocele, 159 women with rectocele, 40 women with apical prolapse
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Table 2.2 Obstetric risk factors for primary prolapse  
 
Risk factor Inv. Sign. N Definition Adjusted ORa 
(95% CI) 
Ref. 
Delivery mode 7 5 21449 ≥1 cesarean vs no cesarean OR 0.6 (0.4-1.0) 20 
270 Per 1 vaginal delivery 
No vaginal deliveries vs 1 or 2 
No vaginal deliveries vs 3 or 4 
No vaginal deliveries vs ≥5 
3 or 4 vaginal deliveries vs 1 or 2 
≥5 vaginal deliveries vs 1 or 2 
OR 1.6 (1.0-2.5)* 
OR 0.0 (0.0-0.4)* 
OR 0.1 (0.0-0.5)* 
OR 0.1 (0.0-0.6)* 
OR 0.7 (0.3-1.7) 
OR 1.2 (0.4-3.4) 
15 
1004 Per 1 vaginal delivery OR 1.1 (0.9-1.4) 13 
1137 Cesarean only vs nulliparous 
≥1 vaginal delivery vs nulliparous 
PR 1.1 (1.0-1.2)* 
PR 1.1 (1.1-1.2)* 
16 
1011 All cesarean before full dilation vs 
    all cesarean before labor 
≥1 cesarean after full dilation vs all  
    cesarean before labor 
Spontaneous vaginal births vs all  
    cesarean before labor 
≥1 operative vaginal birth vs all  
    cesarean before labor 
 
RR 0.5 (0.1-2.3) 
 
RR 0.7 (0.2-3.1) 
 
RR 5.6 (2.2-14.7)* 
 
RR 7.5 (2.7-20.9)* 
17 
726 Cesarean only vs spontaneous  
    vaginal delivery only 
≥1 forceps delivery vs spontaneous  
    vaginal delivery only 
≥1 vacuum extraction, no forceps 
    vs spontaneous vaginal delivery 
    only 
Vaginal and caesarean deliveries vs  
    spontaneous vaginal delivery  
    only 
 
OR 0.1 (0.0-0.4)* 
 
OR 0.6 (0.4-1.0)* 
 
 
OR 0.7 (0.4-1.4) 
 
 
OR 0.5 (0.2-1.0)* 
18 
1964 Vaginal delivery vs nulliparous 
Cesarean vs nulliparous 
OR 2.9 (1.2-7.2)* 
OR 0.3 (0.0-2.5) 
19 
Parity 6 4 21449 1 vs 0 
2 vs 0 
≥3 vs 0 
OR 3.1 (1.5-6.4)* 
OR 3.4 (1.7-6.7)* 
OR 4.6 (2.3-9.1)* 
20 
1004 Per 1 OR 1.1 (0.7-1.7) 13 
649 1 vs 0 
2 vs 0 
≥3 vs 0 
OR 0.4 (0.2-1.2) 
OR 1.6 (0.9-2.7) 
OR 1.5 (0.9-2.8) 
6 
12650 1 vs 0 
2 vs 0  
HR 2.4 (1.7-3.6)* 
HR 3.5 (2.5-4.9)* 
21 
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3 vs 0 
4 vs 0 
≥5 vs 0 
HR 3.9 (2.8-5.4)* 
HR 5.1 (3.7-7.1)* 
HR 5.9 (4.2-8.1)* 
726 2 vs 1 
3 vs 1 
≥4 vs 1 
OR 3.3 (1.5-7.3)* 
OR 3.9 (1.7-9.2)* 
OR 5.2 (2.0-13.4)* 
18 
1964 Per 1 OR 1.2 (1.1-1.4)* 19 
Birth weight 3 1 21449 >4500g vs ≤4500g OR 1.3 (0.9-1.7) 20 
270 >3690g vs ≤3690g NSb 15 
1004 Per 10 ounce OR 1.1 (1.0-1.2)* 13 
Age at first delivery 2 1 270 <20 vs 20-24 vs ≥25 NSb 15 
726 25-29 vs ≤24 
30-34 vs ≤24 
≥35 vs ≤24 
OR 1.5 (0.9-2.3) 
OR 2.5 (1.5-4.2)* 
OR 3.1 (1.4-6.6)* 
18 
Age at last delivery 1 0 270 ≤29 vs 30-34 vs ≥35 NSb 15 
Gravidity 1 0 1004 Per 1 OR 0.9 (0.7-1.2) 13 
Inv. = times investigated, Sign. = times statistically significant, N = number of participants, OR = odds ratio, 95% 
CI = 95% confidence interval, Ref. = reference, vs = versus, PR = prevalence ratio, RR = risk ratio, HR = hazard 
ratio, NS = not statistically significant 
* Statistically significant association (p<0.05); a In some studies prevalence ratio, relative risk or hazard ratio was 
used; b No other data in article 
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Table 2.3 Non-obstetric risk factors for primary prolapse  
 
Risk factor Inv. Sign. N Definition Adjusted ORa  
(95% CI) 
Ref. 
Lifestyle factors 
BMI 8 5 21449 23.8-27.2 vs <23.8  
>27.2 vs <23.8 
OR 1.6 (1.2-2.2)* 
OR 1.8 (1.3-2.4)* 
20 
270 <27 vs ≥27 NSb 15 
1004 25-30 vs <25 
>30 vs <25 
OR 2.5 (1.2-5.4)* 
OR 2.6 (1.2-5.4)* 
13 
1137 25-30 vs <25 
≥30 vs <20 
PR 1.1 (1.0-1.1)* 
PR 1.1 (1.0-1.1)* 
16 
649 Per kg/m2 NSb,c 6 
12650 25-30 vs <25 
≥30 vs <25 
HR 1.3 (1.1-1.4)* 
HR 1.3 (1.1-1.5)* 
21 
726 <18.5 vs 18.5-24.9 
25-29.9 vs 18.5-24.9 
≥30 vs 18.5-24.9 
OR 1.2 (0.3-5.0) 
OR 1.3 (0.9-2.0) 
OR 1.5 (0.9-2.4) 
18 
1964 Per kg/m2 OR 1.0 (0.9-1.0)* 19 
Smoking 6 3 21449 <10 vs no 
10-20 vs no 
>20 vs no 
OR 1.6 (1.0-2.6) 
OR 1.1 (0.6-2.1) 
OR 1.3 (0.7-2.4) 
20 
270 Unknown NSb,c 15 
1004 Ever vs never 
Current vs never 
OR 1.2 (0.6-2.4) 
OR 0.9 (0.3-2.5) 
13 
649 Current vs no OR 0.5 (0.3-0.8)* 6 
12650 Past vs never 
Current vs never 
HR 0.8 (0.7-0.8)* 
HR 0.5 (0.4-0.7)* 
21 
1964 Yes vs no OR 0.6 (0.3-0.9)* 19 
HRT 3 1 270 Unknown NSb,c 15 
1004 Ever vs never OR 1.0 (0.6-1.7) 13 
12650 E + P treatment vs placebo 
Past hormone use vs never 
Current hormone use vs never 
HR 1.1 (1.0-1.3)* 
HR 1.1 (1.0-1.2) 
HR 1.2 (1.0-1.5) 
21 
Physical activity 3 0 270 Mild vs moderate vs strenuous NSb,c 15 
649 Current heavy work vs no 
Past heavy work vs no 
OR 1.3 (0.9-2.0) 
NSb,c 
6 
12650 Unknown HR 1.0 (1.0-1.0) 21 
Waist circumference 2 1 270 <88cm vs ≥88cm NSb 15 
12650 >88cm vs <88cm HR 1.2 (1.0-1.4)* 21 
Unmodifiable factors 
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Age 6 4 21449 52-55 vs ≤51 
≥56 vs ≤51 
OR 1.5 (1.1-2.0)* 
OR 2.6 (2.0-3.4)* 
20 
270 ≥68 vs <68 NSb,c 15 
1004 Per 10 years OR 1.4 (1.1-1.8)* 13 
1137 Per 10 years PR 1.0 (1.0-1.1)* 16 
649 Per 1 year NSb,c 6 
12650 Per 1 year HR 1.0 (1.0-1.0)* 21 
Ethnicity 3 2 1004 Black vs White 
Hispanic vs White 
Other vs White 
OR 1.2 (0.4-3.3) 
OR 4.3 (1.8-10.2)* 
OR 2.4 (0.5-12.1) 
13 
1137 White vs Afr.-Am. 
Asian vs Afr.-Am. 
Latina/other vs Afr.-Am. 
PR 1.0 (1.0-1.1) 
PR 1.0 (1.0-1.1) 
PR 1.0 (1.0-1.1) 
16 
12650 Black vs White 
Hispanic vs White 
HR 0.5 (0.4-0.7)* 
HR 0.9 (0.7-1.1) 
21 
Menopausal status 3 1 1004 No vs yes OR 0.6 (0.4-1.1)c 13 
649 Yes vs no OR 1.3 (0.9-1.9) 6 
1964 Yes vs no OR 5.2 (3.4-8.0)* 19 
Family history 2 0 270 Family with prolapse/UI surgery NSb,c 15 
649 Mother with prolapse vs no OR 1.6 (1.0-2.4) 6 
Age at menopause 1 0 21449 49-51 vs <48 
≥52 vs <48 
OR 0.9 (0.7-1.3) 
OR 1.1 (0.8-1.5) 
20 
Age at menarche 1 0 21449 12-13 vs <11 
≥14 vs <11 
OR 0.8 (0.6-1.0) 
OR 1.0 (0.8-1.3) 
20 
Comorbidity 
Urinary incontinence 2 1 649 UI surgery vs no OR 2.2 (0.9-5.4) 6 
12650 Stress UI vs never 
Urge UI vs never 
Mixed UI vs never 
Other UI vs never 
HR 1.1 (1.0-1.3) 
HR 1.3 (1.1-1.5)* 
HR 1.2 (1.0-1.5)* 
HR 1.0 (0.8-1.4) 
21 
Pulmonary disease 2 0 270 Asthma yes vs no NSb,c 15 
12650 Asthma 
Emphysema 
HR 1.0 (0.8-1.2) 
HR 1.2 (0.9-1.6) 
21 
Constipation 2 0 1004 Yes vs no NSc,d 13 
12650 Moderate/severe vs no HR 1.0 (0.8-1.2) 21 
Diabetes 1 1 1137 Yes vs no PR 1.1 (1.1-1.1)* 16 
Chronic illness 1 0 1004 Any vs none OR 1.1 (0.5-2.1)c 13 
Hysterectomy status 1 0 1004 Yes vs no OR 1.1 (0.7-1.6)c 13 
Prior hernia surgery 1 0 270 Yes vs no NSb,c 15 
POP in pregnancy 1 0 649 Yes vs no OR 1.4 (1.0-2.1) 6 
Social factors 
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Education 4 2 21449 Intermediate school vs elem. 
High school/university vs elem. 
OR 0.6 (0.5-0.8)* 
OR 0.6 (0.4-0.8)* 
20 
270 ≤High school vs >high school OR 2.2 (1.1-4.2)* 15 
1137 ≥College vs <college PR 1.0 (1.0-1.1) 16 
649 Intermediate school vs unknown OR 0.7 (0.4-1.1) 6 
Occupation 2 0 270 Previous employment history NSb,c 15 
1004 Labor vs nonlabor OR 1.2 (0.6-2.3)c 13 
Income 1 1 1004 Medium vs high 
Low vs high 
OR 0.3 (0.1-0.8)* 
OR 1.4 (0.5-3.9) 
13 
Pelvic floor factors 
Levator defect 1 1 605 Unilateral vs no avulsion 
Bilateral vs no avulsion 
OR 2.8 (1.4-5.4)* 
OR 4.0 (1.8-9.1)* 
14 
Hiatus genitalis 1 1 605 Hiatal area on Valsalva per cm2 OR 1.1 (1.1-1.1)* 14 
Inv. = times investigated, Sign. = times statistically significant, N = number of participants, OR = odds ratio, CI = 
confidence interval, Ref. = reference, BMI = body mass index, vs = versus, NS = not statistically significant, PR = 
prevalence ratio, HR = hazard ratio, HRT = hormone replacement therapy, E + P = estrogen plus progesterone, Afr.-
Am. = African American, UI = Urinary incontinence, POP = pelvic organ prolapse, elem. = elementary 
* Statistically significant association (p<0.05); a In some studies hazard ratio or prevalence ratio was used; b No 
other data in article; c Data of univariable analysis, not in multivariable analysis; d Described in article twice with 
different results, both not significant  
  
 
Table 2.4 Included articles on prolapse recurrence 
N / n = number of women included in the study who underwent physical examination / number of women with pelvic organ prolapse recurrence, BMI = Body Mass 
Index   
Reference Study type N / n Inclusion criteria Follow-up Risk factors 
Tegerstedt, 
2004 26 
Retrospective 
cohort study 
128 / 56 Women who had prolapse surgery 
(Manchester procedure, anterior 
colporrhaphy, posterior colporrhaphy, 
cervix amputation, vaginal hysterectomy, 
enterocele repair, abdominal 
vaginosacropexi or combinations) 
10-12 years Age, preoperative stage, BMI, pulmonary disease, 
smoking, urinary incontinence, complicated 
delivery, previous pelvic floor surgery, heavy 
lifting, incomplete emptying of bladder, 
constipation, fecal incontinence, surgeon’s 
experience 
Whiteside, 
2004 22 
Prospective 
cohort study 
176 / 102 Women who underwent  anterior 
colporrhaphy, with or without 
hysterectomy, posterior colporrhaphy, 
bladder neck plication, vaginal vault 
suspension, enterocele repair, culdoplasty, 
bladder neck suspension or retropubic 
paravaginal defect repair 
1 year Age, preoperative stage, hysterectomy status, 
number of sites involved, urinary incontinence, 
previous prolapse surgery, menopausal status, 
diabetes, site of most advanced preoperative 
prolapse, previous incontinence surgery 
Diez-Itza, 
2007 24 
Retrospective 
cohort study 
134 / 42 Women who had vaginal hysterectomy, 
anterior colporrhaphy or posterior 
colporrhaphy for prolapse 
5 years Age, preoperative stage, BMI, constipation, 
pulmonary disease, parity, family history, surgeon’s 
experience, weight, abdominal hernias, intense 
physical exercise, levator muscle contraction 
Salvatore, 
2009 23 
Prospective 
cohort study 
360 / 36  Women who underwent prolapse surgery 
without using grafts (vaginal hysterectomy, 
and/or anterior  colporrhaphy and/or 
posterior  colporrhaphy) 
26 months Age, preoperative stage, BMI, constipation, 
hysterectomy status, pulmonary disease, parity, 
genital hiatus, menopausal status, birth weight 
Weemhoff, 
2011 25 
Prospective 
cohort study 
156 / 80 Women who underwent anterior 
colporrhaphy, with or without 
hysterectomy, posterior colporrhaphy or 
sacrospinous fixation 
2 years Age, preoperative stage, BMI, constipation, parity, 
number of sites involved, family history, 
concomitant surgery, previous prolapse surgery, 
complicated delivery, levator defect 
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Table 2.5 Risk factors for prolapse recurrence  
 
Risk factor Inv. Sign. N Definition Adjusted OR  
(95% CI) 
Ref. 
Obstetric factors 
Parity 3 0 134 0 vs ≥1 NSa 24 
360 Per 1 NSa 23 
156 Per 1 OR 0.9 (0.7-1.2)b 25 
Complicated delivery 2 0 128 Yes vs no OR 1.4 (0.9-1.9)b 26 
156 Assisted vs no OR 0.8 (0.3-2.1)b 25 
Birth weight 1 0 360 >4000g vs ≤4000g OR 1.8 (0.9-3.6)b 23 
Age at last delivery 1 0 134 Per 1 NSa 24 
Lifestyle factors 
BMI 4 0 128 >25 vs ≤25 OR 1.2 (0.9-1.8)b 26 
134 Per kg/m2 NSa 24 
360 >30 vs ≤30 OR 1.2 (0.5-2.8)b 23 
156 Per kg/m2 OR 1.0 (0.9-1.1)b 25 
Weight 1 1 134 >65 vs ≤65 OR 4.0 (1.6-9.6)* 24 
Intense physical 
exercise 
1 0 134 Yes vs no NSa 24 
Heavy lifting 1 0 128 Yes vs no OR 1.1 (0.7-1.6)b 26 
Smoking 1 0 128 Yes vs no OR 1.4 (0.8-2.5)b 26 
Unmodifiable factors 
Age 5 2 128 >70 vs ≤70 NSa 26 
176 <50 vs 50-59 vs 60-69 vs ≥70 
<60 vs ≥60 
NSa 
OR 3.2 (1.6-6.4)* 
22 
134 <60 vs ≥60 OR 4.1 (1.6-10.4)* 24 
360 Age per year NSa 23 
156 Age per year NSa 25 
Family history 2 1 134 Yes vs no NSa 24 
156 Yes vs no OR 2.4 (1.2-4.9)* 25 
Menopausal status 2 0 176 Yes vs no NSa 22 
360 Yes vs no NSa 23 
Comorbidity 
Constipation 4 0 128 Yes vs no OR 1.1 (0.7-1.7)b 26 
134 Yes vs no NSa 24 
360 Yes vs no OR 0.6 (0.3-1.4)b 23 
156 Yes vs no OR 1.0 (0.4-2.3)b 25 
Previous pelvic floor  
surgery 
3 1 128 Yes vs no OR 1.8 (1.1-2.8)b* 26 
176 Yes vs no NSa 22 
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156 Yes vs no OR 1.4 (0.5-4.0)b 25 
Pulmonary disease 3 0 128 Yes vs no OR 1.3 (0.7-2.4)b 26 
134 Yes vs no NSa 24 
360 Yes vs no OR 1.6 (0.7-3.8)b 23 
Any incontinence  
preoperative 
2 1 128 Yes vs no OR 1.4 (1.0-2.1)b* 26 
176 Yes vs no NSa 22 
Previous  
hysterectomy 
2 0 176 Yes vs no NSa 22 
360 Yes vs no OR 0.6 (0.3-1.2)b 23 
Incomplete emptying 
of bladder 
1 0 128 Yes vs no OR 1.3 (0.9-1.9)b 26 
Fecal incontinence 1 0 128 Yes vs no NSa 26 
Diabetes 1 0 176 Yes vs no NSa 22 
Abdominal hernias 1 0 134 Yes vs no NSa 24 
Surgical factors 
Preoperative stage 5 4 128 Stage IV vs <stage IV OR 1.5 (0.9-2.4) 26 
176 Stage III or IV vs stage II OR 2.7 (1.3-5.3)* 22 
134 Stage III or IV vs stage I or II OR 3.9 (1.2-13.0)* 24 
360 Stage III or IV vs stage I or II OR 2.4 (1.1-5.1)* 23 
156 Stage III or IV vs stage I or II OR 2.0 (1.0–4.1)* 25 
Surgeon’s experience 2 0 128 Senior vs no senior surgeon OR 0.8 (0.5-1.3)b 26 
134 Junior vs no junior surgeon NSa 24 
No. of sites involved  
preoperative 
2 0 176 1 vs 2 vs 3 NSa 22 
156 2 vs 1 
3 vs 1 
OR 1.1 (0.5-2.5)b 
OR 0.7 (0.3-1.8)b 
25 
Concomitant surgery 1 1 156 Sacrosp. fix. vs no OR 6.5 (2.0-21.2)* 25 
Pelvic floor factors 
Levator defect 1 1 156 Yes vs no OR 2.3 (1.1-4.8)* 25 
Hiatus genitalis 1 0 360 Unknown OR 1.4 (0.5-2.3)b 23 
Levator muscle 
contraction 
1 0 134 Oxford scale <3 vs ≥3 NSa 24 
Site of most 
advanced prolapse 
1 0 176 Ant. vs apex vs pos. NSa 22 
Inv. = times investigated, Sign. = times statistically significant, N = number of participants, OR = odds ratio, 95% 
CI = 95% confidence interval, Ref. = reference, vs = versus, NS = not statistically significant, BMI = Body Mass 
Index, No. = number, Sacrosp. fix. = sacrospinous fixation, Ant. = anterior, pos. = posterior 
* Statistically significant association (p<0.05); a No other data in article; b Data of univariable analysis, not in 
multivariable analysis  
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DISCUSSION 
 
This systematic review provides an overview of the risk factors for the development of POP 
and POP recurrence after native tissue repair, investigated in cohort studies and cross-
sectional studies. For primary POP, parity, vaginal delivery, age and BMI were the most 
important risk factors. For POP recurrence, only preoperative stage was a confirmed risk 
factor.  
The differences between risk factors for primary POP and POP recurrence might be explained 
by the differences in population. In studies concerning POP recurrence, only women with a 
primary POP are included, so this is a selected group of women. For instance, higher age was 
a risk factor for primary POP. If a woman obtained POP at a younger age, she might be more 
prone to POP recurrence after surgery than an older woman with POP, because of hereditary 
factors or connective tissue weakness. Indeed, the studies investigating the association 
between age and POP recurrence showed conflicting results. Perhaps the association between 
age and POP recurrence is not linear but parabolic with both younger age and higher age as 
risk factors for POP recurrence. This is difficult to prove, but could explain the conflicting 
results. Other causes for the differences in confirmed risk factors for primary POP and POP 
recurrence might have been the smaller number of studies and the smaller sample sizes in the 
evaluation of risk factors for POP recurrence.  
In the prevention of primary POP, BMI was the only modifiable risk factor. Theoretically, 
also parity and vaginal delivery are modifiable, but in obstetric care future POP seldom plays 
a role in considerations. With regard to preoperative counselling only preoperative stage was 
a confirmed risk factor in the estimation of the chance of POP recurrence. The role of other 
patients' or surgeons’ characteristics was not confirmed. 
There were several strengths and limitations of this review. The search was thorough and 
systematic. Two reviewers independently did the study selection and data extraction to 
minimize errors. Potential risk factors for both primary POP and POP recurrence were 
studied. We extracted the results of the multivariate analyses, so that the reported effects were 
adjusted for potentially confounding variables. Studies with follow-up after surgery of less 
than 1 year were excluded to avoid bias due to surgical failures which represents a different 
phenomenon than POP recurrence.  
Only studies situated in western developed countries were included, because the population 
in developing countries may differ from the population in developed countries. It has been 
stated that the prevalence of symptomatic POP among women in developing countries is 
higher than among women in developed countries, due to early childbearing, high parity, low 
birth spacing, early return to work after delivery, poor birthing practices, frequent heavy 
lifting, and malnutrition.27 Many women do not seek medical attention because of 
embarrassment, social taboos, fear of abandonment, knowledge deficit, lack of resources, and 
lack of access to trained personnel.28,29  
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POP recurrence was defined as anatomical recurrence after native tissue repair, so without 
the use of mesh-materials. Native tissue repair is the standard method of POP surgery, while 
the use of mesh in POP surgery has become controversial.30 It is stated that the use of mesh 
should be reserved for high-risk individuals in whom the benefit of the use of mesh may 
justify the risks, such as individuals with recurrent POP.31 The population in studies on POP 
recurrence after mesh-surgery often consists of a selected, high-risk, group of women, which 
can not be compared to the population in studies on POP recurrence after native tissue repair. 
Systematic reviews of prognostic studies are complicated by several issues, which have been 
well described by Altman.32 Two major concerns are the quality of the primary studies and 
the possibility of publication bias. Although there is abundant literature to help researchers 
perform this type of research, there are still no widely agreed guidelines for assessing the 
quality of prognostic studies and there is no standard approach to build a multivariate 
prediction model.33 Clear guidelines on the assessment of quality of this type of studies would 
be helpful. 
Because of the enormous amount of available articles and variables studied on this subject, 
we were forced to make a selection of the papers providing the strongest evidence. We 
decided to exclude case-control studies because they are more prone to selection bias and 
often contain a smaller sample size than cohort or cross-sectional studies. Risk factors that 
have only been examined in case-control studies, such as collagen and matrix 
metalloproteinase polymorphisms have been missed due to this strategy.  
Even after exclusion of case-control studies there was heterogeneity in the available studies. 
For example, the definitions of primary POP and the definitions of risk factors varied widely 
between studies, diverse covariables were used in multivariate analyses, and in the studies on 
POP recurrence there was diversity in the performed surgeries. Due to this heterogeneity, it 
was not possible to perform a meta-analysis in order to pool the available results into reliable 
risk ratios. For uniformity, only articles were included with a definition of POP based on 
anatomical references such as the hymenal remnants or POPQ stage 2. POP recurrence was 
defined as anatomical recurrence after surgery, but this does not equate to recurrence or 
persistence of symptoms which would have been a more patient-centered outcome.34 Many 
women who may be categorized as ‘anatomic failures’ are, in fact, satisfied with their 
postsurgical results.35 The problem with studies using only subjective findings for the 
definition of POP recurrence is, that it is not possible to differentiate between the re-
occurrence of POP in the same operated vaginal compartment and in a different one.11 That 
is why only studies in which pelvic floor examination was performed were included in this 
review. Uniformly accepted criteria for the definition of a successful POP operation are still 
lacking.36 
Furthermore, there are inconsistencies between studies whether a potential risk factor was 
indeed significantly associated with the primary outcome. Some potential risk factors were 
even protective against the primary outcome in one study while they were a risk factor for 
that same outcome in another study. This made it difficult to come to conclusions. That is 
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why we only defined risk factors that were significantly associated with POP or POP 
recurrence in at least two studies, as confirmed risk factors. Consequently, risk factors that 
have only been studied once and were significantly associated with POP or POP recurrence, 
were not described as confirmed risk factors. 
In conclusion, this systematic review showed that parity, vaginal delivery, age and BMI were 
confirmed risk factors for the development of POP and preoperative stage was a confirmed 
risk factor for POP recurrence after native tissue repair in western developed countries.   
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Appendix A1: full PubMed literature search terms 
 
((((pelvic prolapse[tiab] OR pelvic prolapses[tiab] OR ((((prolapse[tiab] OR prolapses[tiab]) 
AND (urogenital[tiab] OR genital[tiab] OR vaginal[tiab] OR pelvic organ[tiab]) OR 
cystocele[tiab] OR cystoceles[tiab] OR urinary bladder prolapse[tiab] OR urinary bladder 
prolapses[tiab])) OR rectocele OR rectoceles OR ("Pelvic Organ Prolapse"[Mesh])))) AND 
((((("Recurrence"[Mesh])) OR (recurrence[tiab] OR recurrences[tiab] OR recurrent[tiab] OR 
relapse[tiab] OR relapses[tiab]))) OR (relapsing[tiab])))) OR ((("Risk Factors"[Mesh] OR 
risk[tiab] OR risks[tiab] OR "risk factor"[tiab] OR "risk factors"[tiab] OR “predict”[tiab] OR 
“predicts”[tiab] OR “prediction”[tiab] OR “predictions”[tiab] OR “predictive”[tiab] OR 
“predicting”[tiab])) AND (("Pelvic Organ Prolapse"[Mesh]) OR ((prolapse[tiab] OR 
prolapses[tiab]) AND (urogenital[tiab] OR genital[tiab] OR vaginal[tiab] OR pelvic 
organ[tiab] OR pelvic[tiab]) OR cystocele[tiab] OR cystoceles[tiab] OR urinary bladder 
prolapse[tiab] OR urinary bladder prolapses[tiab]))) 
 
  
Appendix A2: full Embase literature search terms 
 
((((pelvic prolapse[tiab] OR pelvic prolapses[tiab] OR ((((prolapse[tiab] OR prolapses[tiab]) 
AND (urogenital[tiab] OR genital[tiab] OR vaginal[tiab] OR pelvic organ[tiab]) OR 
cystocele[tiab] OR cystoceles[tiab] OR urinary bladder prolapse[tiab] OR urinary bladder 
prolapses[tiab])) OR rectocele OR rectoceles OR ("Pelvic Organ Prolapse"[Mesh])))) AND 
((((("Recurrence"[Mesh])) OR (recurrence[tiab] OR recurrences[tiab] OR recurrent[tiab] OR 
relapse[tiab] OR relapses[tiab]))) OR (relapsing[tiab])))) OR ((("Risk Factors"[Mesh] OR 
risk[tiab] OR risks[tiab] OR "risk factor"[tiab] OR "risk factors"[tiab] OR “predict”[tiab] OR 
“predicts”[tiab] OR “prediction”[tiab] OR “predictions”[tiab] OR “predictive”[tiab] OR 
“predicting”[tiab])) AND (("Pelvic Organ Prolapse"[Mesh]) OR ((prolapse[tiab] OR 
prolapses[tiab]) AND (urogenital[tiab] OR genital[tiab] OR vaginal[tiab] OR pelvic 
organ[tiab] OR pelvic[tiab]) OR cystocele[tiab] OR cystoceles[tiab] OR urinary bladder 
prolapse[tiab] OR urinary bladder prolapses[tiab]))) 
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LETTER TO THE EDITOR 
 
 
Comment on Vergeldt et al.: Risk factors for pelvic organ prolapse and its recurrence: a 
systematic review 
 
Shek K.L., Dietz H.P. 
 
 
Dear Editor, 
We would like to comment on the review article entitled ‘Risk factors for pelvic organ 
prolapse and its recurrence: a systematic review’. 1 In this article the authors reviewed cohort 
or cross-sectional studies carried out in western developed countries containing multivariate 
analyses and with a definition of pelvic organ prolapse (POP) based on anatomical references. 
They have exclusively included studies after native tissue repair and with a follow up of at 
least 1 year for their review of risk factors for POP recurrence. We would like to take this 
opportunity to make a few comments. 
Due to strict selection criteria the authors have excluded a substantial number of studies on 
this topic. The authors have reviewed only one study on ‘pelvic floor’ risk factors for primary 
POP and one for POP recurrence. There are in fact multiple publications in the literature that 
have studied the above issues and have shown levator defects/avulsion and abnormal hiatal 
area to be risk factors for both primary POP 2-5 and POP recurrence (Table 3.1). In our opinion 
there is now quite substantial evidence to show that levator avulsion and hiatal area are of 
importance in the pathogenesis of POP and for recurrence after treatment. The authors’ 
concluding statement about pelvic floor factors (‘Because of a lack of confirmative studies, 
no clear conclusion can be drawn’) is, in our opinion, not supported by the current literature. 
We feel that the authors have come to this erroneous conclusion by excluding at least eight 
studies by setting arbitrary inclusion criteria, and by ignoring some studies altogether. This 
is a pity and a major shortcoming of this review, given the paramount clinical relevance of 
this question. 
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Table 3.1 Studies showing levator avulsion to be a risk factor for prolapse recurrence  
 
Author Year N Follow-
up 
Woman-
years 
Odds ratio / 
Relative risk* 
Omitted in the 
review because 
Dietz et al 2010 83 4.5 
years 
374 2.8-2.9*  
(CI 1.7-4.5) 
No multivariate 
analysis 
Model et al 2010 106 >5 years >500 3.37  
(CI 1.32-8.54) 
No multivariate 
analysis 
Morgan et 
al 
2011 83 6 weeks 10 3.08 Short follow-up 
Wong et al 2013 209 2.2 
years 
460 2.24  
(CI 1.13-4.43) 
Mesh repair 
Rodrigo et 
al 
2014 334 2.5 
years 
835 2.19  
(CI 1.39-3.43) 
Part of the study 
population had 
mesh repair 
Abdul Jalil 
et al 
2014 207 1.25 
years 
259 2.5  
(CI 1.3-4.5) 
Conference abstract; 
some patients had 
follow-up <1 year 
Notten et al 2014 137 1 year 137 1.4-2.4  
(CI 0.62-9.46) 
Conference abstract 
Crosby et al 2014 42 6.6 277 6.6  
(CI 1.6-27.4) 
Conference abstract; 
case-control study 
ORs all significant except for Notten et al. References available from authors. 
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RESPONSE TO LETTER TO THE EDITOR 
 
 
Response to the letter to the editor by Shek et al. on Vergeldt et al: Risk factors for pelvic 
organ prolapse and its recurrence: a systematic review 
 
Vergeldt T.F.M., Weemhoff M., IntHout J., Kluivers K.B. 
 
 
Dear Editor, 
We thank Ka Lai Shek and Hans Peter Dietz for their interest in our systematic review. 1 
They state in their comment that we have come to an erroneous conclusion by setting 
arbitrary inclusion criteria and by ignoring some studies all together. We disagree with this 
statement and would like to explain this further. 
Because of the enormous amount of articles published on risk factors for pelvic organ 
prolapse (POP) and POP recurrence, we were able to apply strict inclusion criteria in our 
systematic review, to select only the strongest available evidence. Because of this strategy, 
risk factors with a low prevalence that can only be examined in case–control studies, such as 
collagen and matrix metalloproteinase polymorphisms, have been missed in our systematic 
review. In our discussion we have described this as a limitation of our study. 
Nonetheless, pelvic floor factors such as levator ani muscle defects and the size of the levator 
ani hiatus, are not rare. 2,3 Thus, they can easily be investigated as risk factors for POP or 
POP recurrence in cohort studies or cross-sectional studies. To prevent bias in these types of 
studies, it is important to control for potential confounders, for example, by stratification or 
multivariate analysis. To select only strong evidence, we included only articles in which 
confounders were taken into account, i.e., in which a multivariate analysis was performed. In 
addition, we have only defined a variable as a confirmed risk factor in case it was significantly 
associated with POP or POP recurrence in at least two studies. 
Shek et al. state that there is “quite substantial evidence” that levator defects and the levator 
hiatal area are risk factors for POP and POP recurrence. Nonetheless, among the articles with 
the strongest available evidence selected for our systematic review only one study showed a 
significant association between levator defects and POP and the levator hiatal area and POP, 
and only one study showed a significant association between levator defects and POP 
recurrence. There were no other studies that met the inclusion criteria to confirm these results. 
In addition, Shek et al. state that we “ignored some studies all together”. As they showed in 
the table they have provided, none of these articles met our inclusion criteria. This supports 
our claim that our search was thorough and complete. 
Finally, the statement that our conclusion concerning pelvic floor factors is erroneous is not 
supported by the articles with the strongest available evidence on this subject. We have 
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provided the highest level of evidence possible, to prevent bias and to provide undisputable 
evidence. More high level evidence that would expand the results of our systematic review 
would be appreciated. 
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ABSTRACT 
 
Aims 
To review the diagnostic accuracy and clinical implications of translabial three-dimensional 
(3D) ultrasound for the assessment of levator ani defects and biometry in women with pelvic 
organ prolapse (POP). 
 
Methods 
An electronic literature search was performed through computerized databases. Articles that 
reported on women with POP, diagnostic accuracy of translabial 3D ultrasound for the 
detection of levator ani defects or for pelvic floor biometry, or clinical relevance of levator 
ani defects in women with POP, were included. 
 
Results 
Thirty-one articles were selected. Detecting levator ani defects on translabial 3D ultrasound 
compared to magnetic resonance (MR) imaging showed a moderate to good agreement, 
whereas measuring hiatal biometry on translabial 3D ultrasound compared to MR imaging 
showed a moderate to very good agreement. The inter-observer agreement for diagnosing 
levator ani defects with translabial 3D ultrasound and measuring the levator hiatal area 
showed a moderate to very good agreement. Furthermore, levator ani defects increases the 
risk of cystocele and uterine prolapse and levator ani defects are associated with recurrent 
POP. Finally a larger hiatus was associated with POP and recurrent POP after pelvic floor  
surgery. 
 
Conclusion 
Translabial 3D ultrasound is reproducible for diagnosing levator ani defects and ballooning 
hiatus. Both levator ani defects and a larger hiatal area are, in a selected population of patients 
with pelvic floor dysfunction, associated with POP and recurrent POP after surgery.  
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INTRODUCTION 
 
Pelvic organ prolapse (POP) is a bothersome condition that occurs in 40% of adult women.1-
3 The lifetime prevalence of surgery for POP is 13-20% and the risk of recurrence is high.4-6 
To optimize treatment selection and counselling it is important to identify patients with 
increased risk of recurrence. One of the factors that has been related to recurrent POP is 
trauma of the levator ani muscle. Such trauma is a complication of vaginal delivery and 
generally seems to manifest as a partial or complete detachment of the levator ani from the 
inferior ramus of the symphysis.7 Magnetic resonance imaging (MRI) has been shown to 
visualize levator ani defects effectively, but in recent years translabial three- and four-
dimensional (3D/4D) ultrasound has shown to provide valuable information on biometrical 
properties of the pelvic floor and morphology of the levator ani muscle.8 
Ultrasound imaging currently plays a limited role in the diagnostic work-up of POP or post-
treatment follow-up. Most hospitals , while awaiting evidence of beneficial effects, have not 
yet incorporated translabial ultrasound findings in their treatment decision, while others 
claim that there is sufficient evidence to base treatment decisions on these ultrasound 
findings. In this review we aim to provide an overview of peer-reviewed studies on the use 
of translabial 3D ultrasound for the diagnosis of levator ani defects and measuring the levator 
ani biometry. 
 
The following key questions were answered: 
 
1a.  How is the diagnostic accuracy of translabial 3D ultrasound for diagnosing levator 
ani defects? 
1b.  Is diagnosing levator ani defects with translabial 3D ultrasound reproducible? 
1c.  Are levator ani defects, diagnosed with translabial 3D ultrasound, associated with 
primary POP? 
1d.  Is it possible to predict the risk of POP recurrence after surgery based on the 
presence of a levator ani defect on translabial 3D ultrasound? 
 
2a.  How is the diagnostic accuracy of translabial 3D ultrasound for measuring levator 
ani biometry? 
2b.  Is measuring levator ani biometry with translabial 3D ultrasound reproducible? 
2c.  Is a ballooning hiatus, diagnosed with translabial 3D ultrasound, associated with 
primary POP? 
2d.  Is it possible to predict the risk of POP recurrence after surgery based on the 
presence of a ballooning hiatus measured with 3D translabial ultrasound? 
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METHODS 
 
Selection of studies 
We selected original studies evaluating the diagnostic accuracy of translabial 3D ultrasound 
for the detection of levator ani defects and studies which evaluated pelvic floor biometry in 
women. Peer-reviewed articles that evaluated diagnostic accuracy and/or inter- and intra-
rater agreement of translabial 3D ultrasound were considered eligible for this review.  
 
Information sources and search strategy 
We performed a systematic literature search through computerized databases including 
Medline (via Pubmed), Embase (via OvidSP), and the Cochrane Library using both medical 
subject headings (MeSH) and text terms from January the 1st 2003 to October the 25th 2015. 
We restricted the search to studies that were published in English. The structured search was 
designed to be sensitive and included the following search terms pelvic floor, levator ani, 
pubovisceral, pelvic organ, prolapse, sensitivity, specificity, diagnostic accuracy, intraclass 
correlation coefficient, bland-altman, kappa, diagnosis, ultrasonography, ultrasound, and 
translabial. 
 
Study selection 
Three authors (KN, TV, SvK) independently assessed the title and abstract of each of the 
studies for eligibility. In case of disagreement on the suitability of a study a fourth reviewer 
(MW) repeated the assessment. References cited in the selected studies were screened for 
other relevant publications and, if applicable, included in the assessment. We included 
articles identified by the literature search that reported on POP status, diagnostic accuracy 
measures of using translabial 3D ultrasound for the detection of levator ani defect or for 
measuring pelvic floor biometry i.e. levator ani hiatus, or reported on the clinical relevance 
of using translabial 3D ultrasound for levator ani defects or measuring pelvic floor biometry 
in women with POP. We evaluated the full articles to describe the number of patients in the 
study, the inclusion criteria, the study design, patient characteristics (i.e. age and body mass 
index (BMI)) and outcome measures that were reported. 
 
Quality assessment 
The present study was undertaken in accordance with parts of the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines that can be applied to 
studies of diagnostic accuracy.9 However, in the absence of a validated checklist specifically 
designed to determine the quality of diagnostic accuracy studies to be included in meta-
analyses, we assessed study quality on expert opinion guided by a list of domains we deemed 
crucial. We included items on the article’s study population, prevention of selection bias, test 
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reader blinding, reproducibility of study methods, statistical analysis, and presentation of the 
main results. No studies were excluded based on quality assessment. 
 
Diagnostic accuracy and reproducibility 
To review measures of diagnostic accuracy we reported agreement (i.e. Cohen’s Kappa or  
measures of (intra-class) correlation) and classification performance (sensitivity, specificity, 
area under the receiver operating characteristic (ROC) curve). Reproducibility was reported 
as measures of inter- and intra-observer agreement (i.e. intra-class correlation coefficient 
(ICC)). 
 
 
RESULTS 
 
Study selection 
The results of the search are shown in Figure 4.1. The search identified 1815 publications , 
of which 31 were selected after reading the abstracts. No additional studies were identified 
by crosschecking the reference lists of each article which is included. Of the 31 selected 
articles, 17 reported on levator ani defects and 18 reported on hiatal biometry. Four of the 31 
selected articles reported both on levator ani defects and hiatal biometry. 
The 17 included articles reporting on levator ani defects included a total of 5823 women 
(range from 69-781). Of the 17 articles included, 6 were prospective observational studies 10-
15, 2 were cross-sectional studies 16-17, and 9 were retrospective observational studies.8,18-25 
Overall, the quality of the included studies was assessed as adequate: all studies clearly 
defined the study population; the methods were clearly described and reproducible; the 
methods used for the analyses were correct; the main results were well presented and yielded 
answers to the study aims; timeframes of recruiting were not mentioned in 4 studies 10,17-19; 
the test readers were not blinded to other test results and patients complaints in 3 studies 18-
20; in 12 studies it was unclear if selection bias was prevented.8,12,14,16-23,25 
The 18 included articles related to measuring hiatal biometry reported on 3572 women (range 
17-605). Of the 18 studies included, 3 were a prospective observational study 26-28, 9 were 
cross-sectional studies 16,29-36, and 6 were retrospective observational studies.21,24,25,37-39 
Overall, the quality of the included studies was assessed as adequate: all studies clearly 
defined the study population; the methods were clearly described and reproducible; the 
methods used for the analyses were correct; the main results were well presented and yielded 
answers to the study aims; timeframes of recruiting were not mentioned in 5 studies 7,29,30,32,37; 
the test readers were not blinded to other test results and patients complaints in 2 studies 36,39; 
in 11 studies it was unclear if selection bias was prevented.7,16,21,25,32,33,35-39  
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Figure 4.1 Flowchart inclusion articles about levator ani defects  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study characteristics 
Details of the studies are summarised in Table 4.1 and Table 4.2. All studies summarized in 
Table 4.1 report on detection of levator ani defects using translabial 3D ultrasound. All 
studies summarized in Table 4.2 report on ballooning hiatus diagnosed with translabial 3D 
ultrasound. 
 
Studies identified from the search 
 
 
N= 1815 
Evaluation of full text articles 
 
 
N= 31 
Studies excluded after reading 
title and abstract 
 
N= 1784 
Studies concerning 
 levator ani defects 
 
N= 17 
Studies concerning  
hiatal measurements 
 
N= 18 
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Results studies reporting on levator ani defects 
1a. How is the diagnostic performance of translabial 3D ultrasound for diagnosing levator 
ani defects? 
We identified 2 prospective observational studies which answered our research question. 
Zhuang et al. (2011) assessed 69 Chinese women with POP prospectively by translabial 3D 
ultrasound and magnetic resonance (MR) imaging.14 Using tomographic ultrasound imaging 
(TUI), levator ani defects were found in 27 (39%) women. Agreement between tomographic 
3D scans and the MR imaging 3D model was 92%, with a kappa of 0.79 (95% CI, 0.62–
0.96), which was defined as substantial agreement. 
Notten et al. (2014) assessed 139 women undergoing anterior colporraphy in a multicentre 
prospective cohort study. Sensitivity was 0.78 (32/41) (95% CI, 0.65-0.91), specificity was 
0.86 (81/94) (95% CI, 0.79-0.93) in detecting major levator ani defects with translabial 3D 
ultrasound compared to MR imaging.15 There was a good agreement scoring levator ani 
defects on translabial 3D ultrasound, with a kappa of 0.67 (95% CI, 0.58–0.76). However, 
agreement in recognizing major levator ani defects was moderate, with a kappa of 0.53 
(95% CI, 0.37–0.69). 
 
1b. Is diagnosing levator ani defects with translabial 3D ultrasound reproducible? 
Eight articles were selected, of which 4 prospective observational studies 10,11,14,15, 2 cross-
sectional studies 16,17, and 2 retrospective observational study 22,25, for answering this research 
question. All studies but 2 were single centre studies in which the inter-observer agreement 
was tested for diagnosing levator ani defects. The study by Dietz et al. (2007) recruited 
women from 2 different centres 11, and the study of Notten et al. recruited women from 9 
different centres.15 All studies measured a Cohen’s Kappa and were interpreted in terms of 
‘poor’ (0-0.20), ‘fair’ (0.21-0.40), ‘moderate’ (0.41-0.60), ‘good’ (0.61-0.80) and ‘very 
good’ (0.81-1.00) agreement, as described by Altman et al.40 The 8 selected studies found a 
Kappa ranging from 0.57 to 0.89, depicted in Table 4.3. In 2 studies the inter-observer 
agreement for diagnosing levator ani defects with translabial 3D ultrasound was indicated as 
moderate agreement 17,22, in 3 studies the inter-observer agreement was good 11,15,25, and in 3 
studies the inter-observer agreement was very good.10,14,16 
 
1c. Are levator ani defects, diagnosed with translabial 3D ultrasound, associated with 
primary POP? 
Six observational studies were selected for answering this question of which 2 studies were 
prospective 10,11 and 4 studies were retrospective.8,18,19,21 All studies reported on the 
association between findings on translabial 3D ultrasound and different aspects of pelvic 
floor dysfunction. In one study odds ratios (OR) were reported 21 and in one study relative 
risks 10, while in the other 4 studies the outcome measurements were defined differently.  
  
 
Table 4.1 Included studies on levator ani defects 
Article N Inclusion criteria Study design Outcome measure(s) 
Dietz et al (2006) 10 338 Women referred for urodynamic 
assessment with complaints of pelvic 
floor and/or bladder dysfunctions 
Prospective 
observational study 
Levator ani defects in relation to POP 
Dietz et al (2007) 11 262 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Prospective 
observational study 
Levator ani defects in relation to POP 
Dietz et al (2010) 12 83 Women who underwent anterior 
colporrhaphy procedure without mesh 
augmentation 
Prospective 
observational study 
Levator ani defects in relation to POP recurrence 
Weemhoff et al (2011) 13 156 Women undergoing anterior 
colporrhaphy 
Prospective 
observational study 
Levator ani defects and other risk factors in relation 
to POP recurrence 
Zhuang et al (2011) 14 69 Women who were to undergo surgery 
for POP repair 
Prospective 
observational study 
Interobserver repeatability between translabial 3D 
ultrasound and MR imaging in the assessment of 
levator ani defects 
Notten et al (2014) 15 139 Women undergoing anterior 
colporrhaphy 
Prospective 
observational study 
Diagnosing levator ani defects with ultrasound 
compared to MRI 
Volloyhaug et al (2013) 16 
 
295 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Cross sectional study Levator ani defects in relation to measurements of 
the genital hiatus and the perineal body 
Kruger et al (2013) 17 72 Women over 60 years, urinary 
incontinence, and pelvic floor 
dysfunction, attended or going to 
attend physiotherapy for treatment 
Cross sectional study Levator ani defects on ultrasound in relation to 
digital assessment parameters to detect levator ani 
defects 
  
 
N = number of patients, POP = pelvic organ prolapse, 3D = three-dimensional, MR = magnetic resonance  
Dietz et al (2008) 18 781 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Retrospective 
observational study 
Levator ani defects in relation to POP 
Abdool et al (2009) 19 414 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Retrospective 
observational study 
Levator ani defects in relation to POP recurrence 
Model et al (2010) 20 737 Women who had presented for the 
investigation pelvic organ prolapse and 
lower urinary tract dysfunction 
Retrospective 
observational study 
Levator ani defects in relation to POP recurrence 
Dietz et al (2011) 8 764 Women with symptoms of lower 
urinary tract and pelvic floor 
dysfunctions 
Retrospective 
observational study 
Levator ani defects in relation to POP 
Dietz et al (2012) 21 605 Women presenting with POP Retrospective 
observational study 
Levator ani defects and biometry of the levator 
hiatus in relation to POP  
Dietz et al (2012) 22 266 Women presented for urodynamic 
testing and pelvic floor dysfunction 
Retrospective 
observational study 
Diagnosing levator ani defects with digital 
palpation and two ultrasound methods 
 
Wong et al (2013) 23 209 Women who previously received 
anterior transobturator mesh procedure 
Retrospective 
observational study 
Levator ani defects in relation to POP recurrence 
Rodrigo et al (2014) 24 334 Women who underwent anterior 
colporrhaphy procedure with or 
without mesh augmentation 
Retrospective 
observational study 
Levator ani defects in relation to POP recurrence 
Tan et al (2015) 25 106 Women with symptoms of lower 
urinary tract and pelvic floor 
dysfunctions 
Retrospective 
observational study 
Interobserver repeatability in the assessment of 
levator ani defects with translabial 3D ultrasound 
  
 
Table 4.2 Included studies on measuring levator ani biometry 
Article N Inclusion criteria Study design Outcome measure(s) 
Dietz et al (2005) 26 52 Nulliparous women Prospective 
observational study 
Biometry of the levator hiatus in relation to POP 
 
Vergeldt et al (2015) 27 139 Women undergoing anterior 
colporrhaphy 
Prospective 
observational study 
Biometry of the levator hiatus with ultrasound 
compared to MRI 
Vergeldt et al (2015) 28 139 Women undergoing anterior 
colporrhaphy 
Prospective 
observational study 
Biometry of the levator hiatus in relation to POP 
recurrence 
Brækken et al (2008) 29 17 Female volunteers Cross sectional study 
 
Intra-observer agreement of measuring levator ani 
biometry 
 
Majida et al (2009) 30  17 Female volunteers Cross sectional study Inter-observer agreement of measuring levator ani 
biometry 
 
 
Majida et al (2010) 31 18 Female volunteers Cross sectional study Biometry of the levator hiatus with ultrasound 
compared to MRI 
Chen et al (2011) 32  103 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Cross sectional study 
 
Biometry of the levator hiatus in relation to POP 
and urinary incontinence 
Majida et al (2011) 33 157 Women who were at least one year 
beyond childbirth, with or without 
symptoms of POP 
Cross sectional study 
 
Biometry of the levator hiatus in relation to POP 
  
 
N = number of patients, POP = pelvic organ prolapse, 3D = three-dimensional, MR = magnetic resonance 
Dietz et al (2011) 34  100 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Cross sectional study Biometry of the levator hiatus, measured with two 
differenent ultrasound methods, in relation to POP 
Khunda et al (2012) 35 188 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Cross sectional study Biometry of the levator hiatus in relation to 
measurements of the genital hiatus and the perineal 
body 
Ying et al (2012) 36 100 Nulliparous women and women 
presenting with POP 
Cross sectional study Biometry of the levator hiatus in relation to POP 
Volloyhaug et al (2012) 16 
 
295 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Cross sectional study Biometry of the levator hiatus in relation to 
measurements of the genital hiatus and the perineal 
body 
Dietz et al (2008) 37 544 Women presenting with POP Retrospective 
observational study 
Biometry of the levator hiatus in relation to POP 
Dietz et al (2012) 21  605 Women presenting with POP Retrospective 
observational study 
Levator ani defects and biometry of the levator 
hiatus in relation to POP 
Pineda et al (2013) 38 
 
577 Women presenting with symptoms of 
lower urinary tract and pelvic floor 
dysfunction 
Retrospective 
observational study 
Biometry of the levator hiatus in relation to POP 
Andrew et al (2013) 39 81 Women who underwent surgery for 
prolapse repair 
Retrospective 
observational study 
Biometry of the levator hiatus in relation to POP 
surgery 
Rodrigo et al (2014) 24 334 Women who underwent anterior 
colporrhaphy procedure with or 
without mesh augmentation 
Retrospective 
observational study 
Biometry of the levator hiatus in relation to POP 
recurrence 
Tan et al (2015) 25 106 Women with symptoms of lower 
urinary tract and pelvic floor 
dysfunctions 
Retrospective 
observational study 
Inter-observer agreement of measuring levator ani 
biometry 
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Table 4.3 Overview of Kappa’s with regard to the inter-observer agreement for 
diagnosing levator ani defects with translabial 3D ultrasound
 
Study N Cohen’s Kappa (95% CI) 
Dietz et al (2006) 10 50 0.83 (0.59–1.0) 
Dietz et al (2007) 11 20 0.61 (NA) 
Zhuang et al (2011) 14 69 0.86 (0.75–0.96) 
Dietz et al (2012) 22 43 0.57 (0.32–0.76) 
Volloyhaug et al (2013) 16 20 0.89 (0.73–0.96) 
Kruger et al (2013) 17 68 0.57 (0.32–0.82) 
Notten et al (2014) 15 139 0.67 (0.58–0.76) 
Tan et al (2015) 25 20 0.77 (0.47–1.0) 
N = number of patients, CI = confidence interval, NA = not applicable 
 
 
Prospective observational studies 
In a prospective observational study in 2006 with 338 women with lower urinary tract 
symptoms and pelvic floor dysfunction, Dietz et al. found defects of the pubovisceral muscle 
using translabial 3D ultrasound, in 15.4% of parous compared to 0% in non-parous women.10 
These defects were associated with anterior and central compartment prolapse (all p < 0.01). 
In another prospective observational study from Dietz et al (2007), 262 women with 
complaints of lower urinary tract dysfunction and POP underwent an interview, clinical 
assessment and translabial 3D ultrasound imaging.11 Levator ani defects were diagnosed in 
50 (19%) women. Of these 50 women, 42 (84%) were diagnosed with anterior vaginal wall 
prolapse. The percentage of women with POP in the group of women without levator ani 
defects was not described. They found a significant linear association between the degree of 
a defect as seen on translabial 3D ultrasound and higher POP stage.  
 
Retrospective observational studies 
In 2008, Dietz et al. investigated in a population of 781 women the association between POP 
stage 2 and higher and the presence of levator ani defects.18 Prolapse was seen in 150/181 
(83%) women with levator ani defects and in 265/600 (44%) women without levator ani 
defects, yielding a RR of 1.9 (95% CI, 1.7–2.1). The association was strongest for cystocele 
(RR 2.3, 95% CI, 2.0–2.7) and uterine prolapse (RR 4.0, 95% CI, 2.5–6.5). 
Abdool et al. (2009) investigated the association between levator ani defects and different 
types of POP in a population of 414 women with complaints of POP, incontinence or both.19 
They found a strong positive association between a unilateral and a bilateral levator ani defect 
and anterior vaginal wall prolapse (both p < 0.01) and with a rectocele (p = 0.01 and p < 0.01 
respectively). Only a bilateral defect was associated with uterine prolapse (p = 0.04). 
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In 2011, Dietz et al. found a significant association between a complete levator ani defect, 
diagnosed with TUI, and POP (p < 0.01) in a retrospective cohort study among 764 women 
with complaints of lower urinary tract dysfunction and POP complaints.8 This association 
was not found between partial levator ani defects and POP. 
In 2012, Dietz et al. compared the results of the Pelvic Organ Quantification system (POP-
Q) with levator ani defects diagnosed with translabial 3D ultrasound in 605 women with 
urinary tract and POP symptoms.21 They found an independent association between unilateral 
levator ani defects and symptoms of POP with an OR of 1.88 (95% CI, 1.06-3.35) and 
between bilateral levator ani defects and symptoms of POP with an OR of 2.22 (95% CI, 
1.15-4.27). Unilateral levator ani defects were significantly association with cystocele (OR 
2.66, 95% CI, 1.46-4.85), with uterine prolapse (OR 2.87, 95% CI, 1.11-7.41) and with POP 
in general (OR 2.76, 95% CI 1.42-5.37), measured with POP-Q. Bilateral levator ani defects 
were also significantly associated with cystocele, uterine prolapse and POP in general 
(respectively OR 5.31, 95% CI, 2.49-11.32, OR 5.3, 95% CI, 2.17-12.92 and OR 4.01, 95% 
CI, 1.77-9.10). A rectocele was not associated with an unilateral of bilateral levator ani 
defect. 
 
1d. Is it possible to predict the risk of POP recurrence after surgery based on the presence 
of a levator ani defect on translabial 3D ultrasound? 
We have selected 2 prospective observational studies 12,13 and 3 retrospective observational 
studies 20,23,24, that identified associations or risk factors. No multivariable tools for predictive 
purposes were found.  
 
Prospective observational studies 
Dietz et al. (2010) investigated the association between levator ani defects and cystocele 
recurrence after anterior colporraphy.12 Of 83 women, 24 (29%) reported symptoms of 
recurrent POP and 33 (40%) had recurrent cystocele on clinical examination using the POP-
Q assessment. On translabial 3D ultrasound examination, a levator ani defect was detected 
in 29 patients (35%). The RR of recurrence in women with levator ani defect was 2.9 (95% 
CI, 1.7–4.5). 
Weemhoff et al. (2012) conducted a prospective observational cohort study in which women 
underwent an interview, physical examination and translabial 3D ultrasound 2 years after 
anterior colporraphy to identify risk factors for recurrent cystocele.13 Complete defects of the 
puborectalis muscle were found to be risk factors for anatomical recurrence with an OR of 
2.4 (95%, CI 1.3- 4.7). 
 
Retrospective observational studies 
Model et al., Wong et al. and Rodrigo et al. found a significant association between a levator 
ani defect and recurrent POP after POP surgery.20,23,24 
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Model et al. (2010) evaluated 737 datasets of patients with symptoms of pelvic floor 
dysfunction.20 The prevalence of POP was calculated for patients with previous 
hysterectomy, for patients with previous anterior colporraphy, for patients with 
colposuspenion and for patients with previous anti-incontinence or other POP surgery, with 
and without confirmed levator ani defects. In all groups levator ani defects were significantly 
associated with objective POP (RR between 2.3 and 3.3, OR between 3.4 and 6). 
Wong et al (2013) concluded in 209 patients that a levator ani defect doubles the risk of 
cystocele recurrence after anterior colporraphy with transobturator mesh.23 
Rodrigo et al (2014) found that levator avulsion was a significant predictor of objective POP 
recurrence on clinical examination and ultrasound in a population of 334 women who had 
undergone anterior colporraphy with or without mesh, with an OR of 1.93 (95% CI, 1.19–
3.12).24 
 
Results studies reporting on measurements pelvic floor i.e hiatal biometry 
2a. How is the diagnostic performance of translabial 3D ultrasound for measuring levator 
ani biometry? 
There was one cross-sectional study and one prospective observational study concerning 
validation of translabial ultrasound.27,31 In 2010, Majida et al. compared the measurements 
of the pubovisceral muscle using translabial 3D ultrasound with MR imaging as the reference 
test in 18 female volunteers.31 The area and anteroposterior and transverse diameters of the 
levator ani hiatus in the axial plane in which hiatal dimensions were minimal, were measured 
both with translabial 3D ultrasound and MR imaging. One single investigator previewed the 
ultrasound and MR images. The ones with the best image quality (visible symphysis pubis 
and inner and posterior margins of pubovisceral muscle) were selected. The images with the 
minimal hiatus dimensions were searched and measured three times from the same volume 
recording and the mean of these three values was used for statistical analysis. They found a 
good to very good agreement with ICC’s between 0.80 and 0.97. 
In 2015, Vergeldt et al. found that the agreement between translabial 3D ultrasound and MR 
imaging for the measurement of the levator hiatus biometry at rest in women with POP was 
only moderate with an ICC of 0.52 (95% CI, 0.32-0.66) for levator hiatal area, an ICC of 
0.44 (95% CI ,0.21-0.60) for the anteroposterior diameter and an ICC of 0.44 (95% CI, 0.22-
0.60) for the transversal diameter.27 
 
2b. Is measuring levator ani biometry with translabial 3D ultrasound reproducible? 
We found 10 articles that studied the reproducibility of translabial 3D ultrasound for the 
measurement of the levator ani hiatus, of which one prospective cohort study 27, 6 cross-
sectional studies 16,29,30,32,34,35, and 3 retrospective cohort studies.25,38,39 All studies were single 
centre studies, except for the study of Vergeldt et al. in which women from 9 different centres 
were recruited.27 Two studies investigated the intra-observer agreement 29,32, while the rest 
tested the inter-observer agreement between 2 observers. 
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Brækken et al. (2008) and Majida et al. (2009) assessed 17 female volunteers.29,30 They found 
a moderate to good intra-observer agreement for measuring hiatal area (ICC 0.56, 95% CI, 
0.13–0.81), the anterior-posterior dimension (ICC 0.61, 95%, CI 0.21–0.84) and the 
transverse dimension of the levator ani hiatus (ICC 0.72, 95% CI, 0.39–0.88), and a good to 
very good inter-observer agreement between 2 observers for measuring hiatal area (ICC 0.92 
at rest, ICC 0.92 during contraction and ICC 0.98 during Valsalva), the anterior-posterior 
dimension (ICC 0.96 at rest, ICC 0.82 during contraction and ICC 0.90 during Valsalva) and 
the transverse dimension of the levator ani hiatus (ICC 0.96 at rest), with no description of 
95% CI.  
Chen et al. (2011) recruited 103 patients, of which 36 women with POP, 36 women with 
stress urinary incontinence and 31 normal controls.32 They estimated the displacement of the 
bladder neck, sagittal hiatal diameter, levator ani hiatal angle and levator ani hiatus area on 
translabial 3D ultrasound. Twenty datasets were randomly retrieved for analysis of intra-
observer reproducibility, that were assessed twice by the same observer on 2 occasions 1 
week apart. They found a good intra-observer agreement for all different parameters with 
ICC’s between 0.77 and 0.90. Measuring the hiatal area at rest and during Valsalva showed 
an ICC of 0.87 (95% CI, 0.71–0.95) and 0.81 (95% CI, 0.58–0.92) respectively.  
Dietz et al. (2011) performed an offline analysis of 100 translabial 4D volume datasets of 
women seen in a tertiary urogynaecological clinic.34 They compared hiatal measurements 
obtained in sectional planes and rendered volumes. A test–retest series in 20 women showed 
a good inter-observer agreement between 2 observers for the measurement of hiatal 
dimensions with an ICC of 0.85 (95% CI, 0.81–0.88) in sectional planes and an ICC of 0.88 
(95% CI, 0.85–0.90) in rendered volumes. 
Khunda et al. (2012) demonstrated a good inter-observer agreement between 2 observers for 
measuring hiatal area during Valsalva (ICC 0.89, 95% CI, 0.73–0.95) and for measuring 
anterior-posterior diameter during Valsalva (ICC 0.85, 95% CI, 0.62–0.94).35 The study 
included datasets of 188 urogynaecology patients assessed in a cross-sectional study. For the 
inter-observer reliability datasets of 20 women were used. These findings were confirmed by 
Volloyhaug et al. in 2013 in another sample of 20 women using an extended database of the 
same population.16 They found an ICC of  0.90 (95% CI, 0.70–0.96) for measuring hiatal 
area during Valsalva. 
Pineda et al. (2013) showed a good inter-observer agreement (ICC 0.71, 95% CI not 
described) between 2 observers for measuring the anterior-posterior diameter of the hiatal 
area during Valsalva in a sample of 20 women seen at a tertiary urogynaecological unit.38 
Andrew et al. (2013) showed a good inter-observer agreement for measuring hiatal biometry 
in women who were seen at a tertiary urogynaecological unit and who had undergone POP 
surgery in the past.39 A test–retest series of 10 volumes for each measurement was conducted 
by 2 observers. They yielded ICC’s of 0.81 (95% CI, 0.35–0.95) for area at rest, of 0.74 (95% 
CI, 0.29–0.93) for area during Valsalva and of 0.75 (95% CI, 0.26–0.93) for area during 
pelvic floor contraction. 
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Tan et al. (2015) showed a good inter-observer and intra-observer agreement for measuring 
hiatal area on Valsalva with an ICC of 0.92 (95% CI, 0.80–0.97) and 0.93 (95% CI, 0.90-
0.95) respectively.25 
Vergeldt et al. (2015) found that the inter-observer reliability between the assessments on 
ultrasound at rest, during Valsalva and during contraction at rest by two independent 
observers out of a pool of 4 observers was good with ICC’s ranging from 0.55 to 0.81.27 
 
2c. Is a larger hiatus (ballooning hiatus), diagnosed with translabial 3D ultrasound, 
associated with primary POP? 
The relationship between hiatal biometry, diagnosed with translabial 3D ultrasound, and 
signs and symptoms of POP has been described in 8 articles, of which 1 prospective 
observational study 26, 4 cross-sectional studies 32,33,35,36 and 3 retrospective observational 
studies.21,37,38 The first publication concerning hiatal biometry of the levator ani 
measurements with translabial 3D ultrasound was published in 2005. 
 
Prospective observational study 
In a prospective observational study, Dietz et al. (2005) assessed 52 nulligravid female 
Caucasian volunteers with translabial 3D ultrasound at rest and during Valsalva.26 Biometric 
parameters of the pubovisceral muscle and levator ani hiatus were determined in the axial 
and coronal planes. They found significant correlations between the size of the hiatus and 
pelvic organ descent. With respect to the hiatal area at rest, they found a significant negative 
correlation with a cystocele (Pearson’s r -0.34, p = 0.02), with uterine descent (Pearson’s r -
0.50, p < 0.01) and with a rectocele (Pearson’s r -0.41, p < 0.01). During Valsalva they also 
found a significant negative correlation between size of the hiatus and cystocele (Pearson’s r 
-0.63, p < 0.01), uterine descent (Pearson’s r -0.66, p < 0.01) and rectocele (Pearson’s r -0.60, 
p < 0.01). This means that, the larger the hiatal area, the lower the position of pelvic organs 
on Valsalva, i.e. the more descent. In all cases, more marked pelvic organ descent was 
associated with a larger hiatal area on Valsalva. 
 
Cross-sectional studies 
In a population of 103 women with and without POP, Chen et al. (2011) found that women 
with POP had a significantly larger levator ani hiatus than women without POP complaints 
measured at rest and during contraction.32 At rest they found a hiatal area of 20.06 cm2 (± 
3.77) in women with POP (n= 33) compared to 15.20 cm2 (± 2.54) in controls (n=29) 
(Spearman’s r 0.56, p < 0.01). During contraction they found a hiatal area of 16.10 cm2 (± 
2.88) in women with POP and 12.21 cm2 (± 2.13) in women without POP (Spearman’s r 0.55, 
p < 0.01). 
Khunda et al. (2012) assessed 188 urogynaecology patients who underwent an interview, 
clinical examination and translabial 3D ultrasound.35 They demonstrated significantly larger 
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hiatal measurements in the patients with signs and symptoms of POP compared with those 
without such signs and symptoms.  
Majida et al. (2011) found a positive association with a clinically significant POP in the 
anterior but not in the posterior compartment and the area of the levator ani hiatus (p < 0.01), 
in a population of 157 women with and without symptoms.33 They did not find an 
independent association between area of the levator ani hiatus and symptoms of pelvic floor 
dysfunction (Pearson’s r 0.62, not significant). 
Ying et al. (2012) included 50 women with POP and 50 nulliparous women in their 
prospective study.36 Both groups underwent translabial 3D ultrasound. The results showed 
that the size of the levator ani hiatus of POP women was larger than that in nulliparous women 
at rest, during Valsalva and during contraction (p < 0.01). 
 
Retrospective studies 
In 2008, in a population of 544 women who were seen in a tertiary urogynaecological unit, 
Dietz et al. found that levator ani hiatal area as measured by translabial 3D ultrasound 
examination was strongly associated with symptoms and clinical signs of POP (p < 0.01).37 
ROC analysis showed an area under the curve (AUC) of 0.65 (95% CI, 0.60–0.70) for hiatal 
area at rest and 0.71 (95% CI, 0.66–0.76) for hiatal area during Valsalva. 
In 2012, Dietz et al. evaluated 605 women with symptoms of lower urinary tract and pelvic 
floor dysfunction in a retrospective cohort study.21 They found a strong association between 
a ballooning hiatus and signs and symptoms of POP. Hiatal area during Valsalva was 
associated with symptoms of POP with an OR of 1.06 (95% CI, 1.03-1.08). The presence of 
a cystocele, uterine prolapse, rectocele, or POP in general was also associated with hiatal area 
with OR’s of respectively 1.09 (95% CI, 1.06-1.12), 1.09 (95% CI, 1.04-1.13), 1.09 (95% 
CI, 1.07-1.13) and 1.11 (95% CI, 1.08-1.14). 
In a retrospective analysis of 577 women seen at a tertiary urogynaecological unit, Pineda et 
al. (2013) found a strong association between POP and hiatal anterior-posterior diameter 
during Valsalva (p < 0.01).38 ROC curve analyses confirmed the relationship with an AUC 
of 0.64 (95% CI, 0.59–0.68) for anterior-posterior diameter during Valsalva. They also found 
a relationship with midsagittal anterior-posterior diameter and clinical findings of significant 
POP (AUC 0.71, 95% CI, 0.67–0.76]), as well as with significant POP diagnosed on 
translabial 3D ultrasound (AUC 0.75, 95% CI, 0.71–0.79). 
 
2d. Is it possible to predict the risk of POP recurrence after surgery based on the presence 
of a ballooning hiatus measured with translabial 3D ultrasound? 
We did not find any multivariable models aimed at predicting the risk of POP. Rodrigo et al. 
(2014) found that hiatal area on Valsalva was a significant predictor of objective POP 
recurrence on clinical examination and ultrasound, with an OR of 1.04 (95% CI, 1.01–1.06).24 
In this population of 334 women who had undergone anterior colporraphy, 74% was operated 
on with mesh materials. 
Chapter 4 
66 
 
Vergeldt et al. (2015) compared women with and without anatomical cystocele recurrence to 
assess the association with levator hiatal area on 3D ultrasound.28 Increased levator hiatal 
area during Valsalva on ultrasound was significantly associated with cystocele recurrence, 
with an OR of 1.06 (95% CI, 1.01–1.11). 
 
 
DISCUSSION 
 
Main findings 
Detecting levator ani defects and measuring hiatal biometry show moderate to good 
agreement between findings on translabial 3D ultrasound compared to MR imaging 14,15,27,31  
and the inter-observer agreement is good.10,11,14-17,22,25,27,29,30,32,34,35,38,39 Furthermore, evidence 
shows that both levator ani defects and a larger hiatal biometry increases the risk of cystocele 
and uterine prolapse but the relationship to rectocele seems less clear.8,10,11,18,19,21,26,32,33,35-38 
All included studies regarding the possibility to predict the risk of POP recurrence after 
surgery based on the presence of a levator ani defect found an association between recurrent 
POP and levator ani defects.12,13,20,23,24 Two studies showed that a larger hiatal biometry is a 
risk factor for cystocele recurrence.24,28 
 
Strengths and limitations 
Strengths of this systematic review were the thorough and systematic search and the 
independent selection of articles and data extraction by multiple authors. 
We can conclude that our reviews’ generalizability has some limitations. Even though the 
aims of the studies were very similar, there were many differences in the methods used and 
primary outcomes that were reported. As a result of this heterogeneity it is difficult to assess 
study quality and compare the different articles, and more importantly, perform a meta-
analysis on relevant primary outcomes such as sensitivity and specificity, and odds ratios. 
 
Interpretation of the evidence 
To interpret this overview of the literature objectively, some limitations of the selected 
studies need to be addressed.  
Concerning the reproducibility of detecting levator ani muscle defects with translabial 3D 
ultrasound, 6 of the 8 included studies were derived from an expert in the field with different 
co-authors, in which reproducibility was tested between 2 observers (trainer and 
trainee).10,11,16,17,22,25 Studies on external validation and reproducibility between observers in 
a multicentre setting are scarce.  
The 6 studies that were selected to answer the question whether levator ani muscle defects 
are associated with primary POP, were all published by the same expert in the field with 
different co-authors.8,10,11,18,19,21 The population in this tertiary centre consists of women with 
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symptoms of urinary tract dysfunction and pelvic floor dysfunction. None of these studies 
compared women with POP to women without POP. It is possible that levator ani defects are 
more often present in a selected patient group who visit a tertiary centre because of symptoms 
of pelvic floor dysfunction. The available studies show, within a selected population with 
POP, that levator defects are associated with primary POP. 
To answer the question whether it is possible to predict the risk of POP recurrence after 
surgery based on the presence of a levator ani defect on translabial 3D ultrasound, we selected 
2 prospective and 3 retrospective studies. Four of the 5 studies 12,20,23,24 were derived from 
the same expert in the field with different co-authors. In all studies the translabial ultrasound 
was performed after surgery at the time the incidence of recurrent POP was studied and not 
prior to the first surgery.  
Of the 10 studies that investigated the reproducibility of measuring levator ani biometry with 
translabial 3D ultrasound, 6 were published by the same expert in the field with different co-
authors.16,25,34,35,38,39 Two other studies used the same population of which one assessed the 
intra-observer agreement, and one assessed the inter-observer agreement.29,30 Of these 
studies, 9 tested a sample of 20 women or less, while only one study tested 139 women and 
used multiple observers.27 
Of the 8 studies that assessed the association between a larger hiatus diagnosed with 
translabial 3D ultrasound and primary POP, 3 studies compared women with POP or POP 
symptoms to women without POP or POP symptoms in a general population of women.32,33,36 
The other 5 studies were derived from the same expert in the field with different co-authors, 
of which one study included nulligravid volunteers 26 and 4 studies included women with 
symptoms of lower urinary tract and pelvic floor dysfunction.21,35,37,38 The use of a selected 
group of women and the lack of a control group with women without POP could have caused 
bias. Of the 2 studies which were selected to answer the question if levator hiatal area is 
associated with cystocele, both studies confirm that a larger hiatal area is associated with 
cystocele recurrence.24,28 
 
Conclusion 
Detecting levator ani defects and measuring hiatal biometry on translabial 3D ultrasound 
show moderate to good agreement when compared to findings on MR imaging, and is 
reproducible. Levator ani defects and a larger hiatal area are, in a selected population of 
patients with pelvic floor dysfunction, associated with POP and recurrent POP after surgery. 
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ABSTRACT 
 
Introduction and hypothesis 
This study aimed to determine the relationship of recurrent cystocele with avulsion of 
puborectalis muscle and other risk factors. 
 
Methods 
In this prospective observational cohort study, 245 women undergoing anterior colporrhaphy 
were invited for a 2 year follow‐up visit consisting of a questionnaire, physical examination 
and translabial 3D ultrasonography. Women with and without recurrent cystocele were 
compared to identify recurrence risk factors. 
 
Results 
Of the 245 women, 156 agreed to the follow‐up visit (63.7%). Objective recurrence rate was 
80 of 156 (51.3%). Seventeen of the 156 (10.9%) reported subjective recurrence. Risk factors 
for anatomical recurrence were complete avulsion of puborectalis muscle (OR 2.4, 95% CI 
1.3-4.7), advanced preoperative stage (OR 2.0, 95% CI 1.0-4.1), family history of prolapse 
(OR 2.4, 95% CI 1.2-4.9), and sacrospinous fixation (OR 6.5, 95% CI 2.0-21.2). 
 
Conclusions 
Risk factors for anatomical cystocele recurrence after anterior colporrhaphy were complete 
avulsion of puborectalis muscle, advanced preoperative stage, family history of prolapse and 
sacrospinous fixation. 
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INTRODUCTION 
 
The estimated lifetime risk of a woman for undergoing surgery for pelvic organ prolapse 
(POP) or urinary incontinence is 11.1%. These operations are known to have a high re‐
operation rate (30%) because of primary failure and secondary recurrence.1 The anterior 
compartment is most commonly affected in POP and is also the most prone for recurrence 
after surgery.2,3 
Little is known about the factors associated with failure of surgical correction. Probably, the 
factors that play a role in the occurrence of POP in the first place are also risk factors for 
recurrence of prolapse after surgery. Risk factors for POP that have been described in 
literature are aging 4,5, obesity 4,6, family history of prolapse 7,8 and collagen weakness.5 
Furthermore there is a strong relationship between vaginal child birth and POP.4,7,9 Vaginal 
birth gives a 4 to 11 fold increase in risk for developing POP among parous women compared 
to women without vaginal delivery in their history.10 It has been postulated that avulsions of 
the puborectalis muscle are the intermediary between vaginal deliveries and POP.11 
Studies with magnetic resonance imaging (MRI) and pelvic floor ultrasound have 
demonstrated the occurrence of trauma to the levator ani after vaginal birth. In 20‐23% of 
women who had delivered vaginally, trauma of the levator ani was identified.12,13 No defects 
were seen in nulliparous women. POP was seen in 83% of women with levator defects and 
in 44% women without levator defects. The association was strongest for cystocele and 
uterine prolapse. Furthermore, women with prolapse appeared to have more major levator 
defects than controls without prolapse (55% compared with 16%). Women with and without 
prolapse were equally likely to have minor defects.14 
The aim of the present study was to estimate the rates of anatomical and subjective recurrence 
after anterior colporrhaphy, to determine whether avulsion of the puborectalis muscle is a 
risk factor for recurrence of cystocele and to identify other risk factors associated with 
recurrence. 
Identifying patients at risk for recurrent POP after surgery offers the opportunity for 
individualizing counseling, and adapting treatment and prevention to the individual risk of 
recurrence. 
 
 
METHODS 
 
Between January 2006 and September 2008, 245 women undergoing an anterior 
colporrhaphy were enrolled in a multicentre randomized controlled trial comparing 
indwelling catheterization for 2 and 5 days following surgery respectively.15 Two years later 
these women were approached again and invited to participate in a follow‐ up study. The aim 
of this study was to estimate the rates of anatomical and subjective recurrence of cystocele 2 
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years after anterior colporrhaphy, to determine whether avulsion of the puborectalis muscle 
is a risk factor for recurrence of cystocele, and to identify other risk factors associated with 
this recurrence. 
Patients were localized by the address and telephone number that was registered in the 
hospitals. All patients received written information and were contacted by telephone to ask 
them for participation to this follow‐up study. Patients that agreed to participate were invited 
for a follow‐up visit at the outpatient clinic consisting of a validated questionnaire, a physical 
examination and translabial three-dimensional (3D) ultrasonography of the pelvic floor. 
Patients that did not agree with a follow‐up visit were invited to complete the questionnaire 
at home. 
The questionnaire that was used was a validated Dutch version of the Urinary Distress 
Inventory (UDI) 16,17 and the Defecation Distress Inventory (DDI).18 Questions concerning 
possible risk factors were added, including weight, length, parity, assisted deliveries, and 
family history of prolapse (defined as mother or sister with prolapse). 
Pelvic examination was performed with the patient in the lithotomy position. Clinical staging 
of POP according to the Pelvic Organ Prolapse Quantification (POPQ) classification system 
was performed.19 The examiner was blinded for the patients’ answers to the questionnaire 
and for the results of the ultrasound examination. 
A translabial ultrasonography of the pelvic floor was performed in supine position with hips 
flexed and slightly abducted and after voiding. A GE Voluson 730 expert system (GE Kretz 
Ultrasound, Zipf, Austria) was used with a 4.8 MHz curved abdominal transducer covered 
with gel and a condom. The transducer was placed against the perineum in the midsagittal 
plane with a maximum angle of 70 degrees for 2D imaging. If the (1) symphysis pubis, (2) 
urethra, (3) anal canal and (4) levator ani were visualized in one plane, an axial 4D volume 
was rendered with a maximum angle of 85 degrees to visualize the hiatus of minimal 
dimensions. In this plane a 4D volume cine was recorded containing a maximal pelvic muscle 
contraction to detect abnormal insertion of the puborectalis muscle on the inferior pubic 
ramus. (Figure 5.1) This method has been described by Dietz and has been shown to be 
reproducible.20,21 
The recorded data sets were analyzed off‐line using Voluson GE Kretz 4D‐view V 5.1 
software (GE Kretz Ultrasound, Zipf, Austria). The ultrasonographers were blinded for the 
outcome of the questionnaire and pelvic examination. With tomographic ultrasound imaging 
(TUI), a technique to show the levator ani muscle in multiple slices of 2.5 mm, levator 
damage was graded according to the scoring system described by Dietz et al.22 A complete 
avulsion was diagnosed on tomographic ultrasound if all three central slices, i.e. the plane of 
minimal dimensions plus slices 2.5 and 5 mm cranial to this plane, show an abnormal 
insertion of the puborectalis muscle on the inferior pubic ramus. Several authors have 
demonstrated the clinical relevance of a complete avulsion as compared to no or only a partial 
avulsion of the puborectalis muscle for the development of POP.14,22 
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Data collected during the follow‐up visits and from the returned questionnaires were entered 
into an existing database. Data on the patients’ history, the performed operation, and the 
surgical technique used had been collected prospectively during the original RCT in 2008 on 
indwelling catheterization. During that RCT the preoperative grade of prolapse was staged 
according to the Baden‐Walker classification as the POPQ classification was not generally 
introduced in daily practice yet. Stage I was a cystocele into the first half of the vagina, in 
stage II the prolapse protruded into the distal half of the vagina, in stage III the prolapsed 
tissue bulged out of the vagina, and stage IV was a total protrusion of the anterior wall of the 
vagina. 
Anatomical recurrence was defined as an anterior vaginal wall prolapse equal to or greater 
than stage II of the POPQ classification. Subjective recurrence was defined as (1) feeling 
and/or (2) seeing a vaginal bulge, with at least a judgment of one of these 2 symptoms as 
moderately bothersome, or both of these 2 symptoms as somewhat bothersome, according to 
the scoring system of the validated UDI questionnaire. 
 
 
Figure 5.1 3D ultrasonography of levator muscle  
 
 
On the right side the midsagittal plane, on the left side the rendered 3D volume of the levator ani muscle. Normal 
insertion of the puborectalis muscle, no avulsion. 1. bladder; 2. urethra; 3. central axis of symphysis; 4. anal canal; 
5.levator muscle; 6. urethra; 7. vagina; 8. anal canal; 9. levator sling. 
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The statistical analysis was performed using the statistical software package SPSS version 
16.0 for windows. Women with and without recurrent cystocele were compared to assess the 
association with age, body mass index (BMI), parity, cystocele stage III or IV before surgery 
(Baden‐Walker classification), assisted deliveries, family history of prolapse (defined as 
mother or sister with prolapse), constipation, number of compartments involved, combination 
with vaginal sacrospinous fixation, previous prolapse surgery and complete avulsions of 
puborectalis muscle. 
The independent sample t‐test was used to compare means of continuous responses. The chi‐
square test was used to compare categorical variables. Fisher’s exact test was performed 
when the assumptions of the Pearson chi‐square test were not reached, i.e. one or more cells 
contained <5 observations. Logistic regression models were employed to calculate odds 
ratios (OR) and 95% confidence intervals (CI). A p‐value <0.05 was considered statistically 
significant. 
The protocol was approved by the medical ethics committees of each individual participating 
hospital. All patients who agreed to participate gave written informed consent before 
enrolment. 
 
 
RESULTS 
 
Between November 2009 and April 2010, all 245 participants of a randomized controlled 
trial focusing on regimen of catheterization after anterior colporrhaphy, were asked to 
participate in a follow‐up study 2 years after the initial operation. From the total of 245 
women, 156 agreed to a follow‐up visit (63.7%), 222 women returned the questionnaire 
(90.6%), 23 women declined to participate (9.4%), among whom three women we were 
unable to localize (1.2%), two suffered from dementia (0.8%), and one had died at the time 
of the follow‐up study (0.4%). 
Patient characteristics are shown in Table 5.1. There were no significant differences between 
women who attended the follow‐up visit and women that did not participate with regard to 
BMI, parity, cystocele stage III or IV before surgery, assisted deliveries, family history of 
prolapse, constipation, previous prolapse surgery and concomitant surgery in combination 
with the anterior colporrhaphy. However, the mean age of women who did not attend the 
follow‐up visit was significantly higher than of those who did not attend. 
Table 5.2 shows the outcome measures of the results of the operation. The mean follow‐up 
interval was 31 months (range 14‐50). Eighty of 156 patients (51.3%) had an anatomical 
recurrence of the cystocele. Of these, 55 women (68.8%) had a stage II cystocele, 22 women 
(27.5%) had a stage III cystocele, and three women (3.8%) had stage IV cystocele. Seventeen 
of 156 women (10.9%) reported a subjective recurrence.  
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Table 5.1 Patient characteristics 
 
SD=Standard Deviation 
a Family history of prolapse and constipation were only known in patients who completed the questionnaire 
 
 
Table 5.2 Recurrence rates of cystocele 2 years after anterior colporraphy 
 
 Recurrence rates 
Patients with anatomical recurrence 80/156 (53.1%) 
Patients with subjective recurrence 
     - patients that attended the follow-up visit 
     - patients that only filled out the questionnaire 
     - total population 
 
17/156 (10.9%) 
6/52 (11.5%) 
23/208 (11.1%) 
Symptomatic patients with anatomical recurrence of cystocele 8/80 (10.0%) 
 
 
Of the 80 women with anatomical recurrence, eight (10.0%) were symptomatic compared to 
9 of 76 women (11.8%) without anatomical recurrence. Of the nine women with subjective 
recurrence but no anatomical recurrence, only three cases could be explained by a rectocele. 
The other six women had no objective anatomical prolapse of any compartment. There was 
 Participants 
that attended  
the follow-up 
visit 
N= 156  
Participants of 
questionnaire only 
(n=66) and 
refusers to join the 
study (n=23) 
N= 89 
 
 
p-value 
Mean age, years (±SD) 61.4 (10.1) 65.8 (11.0) <0.01 
Mean BMI, kg/m2 (±SD) 26.3 (3.7) 26.7 (4.1) 0.35 
Mean parity, n (±SD) 2.3 (1.1) 2.5 (1.0) 0.21 
Cystocele grade 3 or 4 before surgery, n (%) 76/154 (49.4%) 54/88 (61.4%) 0.07 
History of assisted deliveries, n (%) 21/156 (13.5%) 10/89 (11.2%) 0.66 
Family history of prolapsea, n (%) 63/156 (40.4%) 23/65 (35.4%) 0.49 
History of constipationa, n (%) 27/154 (17.5%) 7/52 (13.5%) 0.50 
History of previous prolapse surgery, n (%) 17/155 (11.0%) 9/89 (10.1%) 0.84 
Concomitant surgery, n (%) 
  Combination with hysterectomy  
  Combination with posterior repair 
  Combination with sacrospinal fixation 
 
85/156 (54.5%) 
75/156 (48.1%) 
22/156 (14.1%) 
 
50/89 (56.2%) 
45/89 (50.6%) 
16/89 (18.0%) 
 
0.80 
0.71 
0.42 
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no statistically significant correlation between anatomical and subjective recurrence 
(p=0.71). 
Of the 66 patients that only filled out the questionnaire, 52 women answered the questions 
concerning subjective recurrence. Of these 52 women, six women (11.5%) reported 
subjective recurrence. In total, of all 208 women who filled out the questions concerning 
subjective recurrence, the subjective recurrence rate was 11.1%. 
Table 5.3 shows the data on avulsions of the puborectalis muscle. In 152 patients it was 
possible to analyze the images of the ultrasound examination. In four of 156 (2.6%) patients 
the ultrasonographers had not been able to visualize all four reference points and therefore 
reading the ultrasound scan was not possible. Thirty of 152 women (20%) had no avulsion, 
59 women (39%) had a partial avulsion, and 63 women (41%) had a complete avulsion of 
the puborectalis muscle. Of the 77 women with an anatomical recurrence, 40 women (52%) 
had a complete avulsion of the puborectalis muscle as compared to 23 of 75 women (31%) 
without anatomical recurrence. Of the 17 women with a subjective recurrence, only eight 
women had an anatomical recurrent prolapse in the operated compartment. From these eight 
women there was not one person without an avulsion, four women had a partial avulsion and 
four women had a complete avulsion of the puborectalis muscle. In this small group of eight 
women symptomatic recurrent prolapse was not associated with complete avulsion.  
 
 
Table 5.3 Avulsion of puborectalis muscle 
 
 No anatomical recurrence Anatomical recurrence  Total 
No avulsion 21 (28%) 9 (12%) 30 
Partial avulsiona 31 (41%) 28 (36%) 59 
Complete avulsiona 23 (31%) 40 (52%) 63 
Total 75 (100%) 77 (100%) 152 
a Unilateral or bilateral avulsion 
 
 
Table 5.4 shows the univariable and multivariable logistic regression analysis of the possible 
risk factors for anatomical recurrence. Risk factors in univariable analysis for anatomical 
recurrence were cystocele stage III or IV before surgery, family history of prolapse, 
sacrospinous fixation, and complete avulsion of puborectalis muscle. These factors appeared 
to be independent as testing for interaction showed no significance. In multivariable logistic 
regression analysis all 4 variables turned out to be independently associated with anatomical 
recurrence: cystocele stage III or IV before surgery (OR 2.0, 95% CI 1.0-4.1), family history 
of prolapse (OR 2.4, 95% CI 1.2-4.9), sacrospinous fixation (OR 6.5, 95% CI 2.0-21.2), and 
complete avulsion of puborectalis muscle (OR 2.3, 95% CI 1.1-4.8). 
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Sacrospinous fixation was performed in 22 of the 156 patients attending the follow‐up visit 
(14.1%). Of these women, 18 patients had an anatomical recurrence of the cystocele, and of 
these 18 women, three women (16.7%) were symptomatic. 
Of the 156 women who attended the follow‐up visit, eight had a history of previous anterior 
colporrhaphy before the inclusion in the randomized controlled trial in 2008. Of these eight 
women, seven had again an anatomical recurrence in this follow‐up study. Surprisingly, three 
of four women with graft‐augmented anterior repair had an anatomical recurrence. 
 
 
Table 5.4 Risk factors for anatomical recurrence   
 
OR=Odds ratio, 95% CI= 95% Confidence Interval  
 
 
DISCUSSION 
 
After a mean follow‐up of 31 months following an anterior colporrhaphy, our study showed 
an anatomical recurrence rate of cystocele of 51.3%. Complete avulsion of puborectalis 
muscle was identified as risk factor for recurrence, along with cystocele stage III or IV before 
surgery, family history of prolapse, and sacrospinous fixation. 
The anatomical cystocele recurrence rate in our study is consistent with the rate of 
recurrences described in other studies.23,24 Of the women with anatomical cystocele 
  Univariate analysis Multivariate analysis 
Possible risk factors N OR 95% CI p-
value 
OR 95% CI p-
value 
Age (years) 156 1.0 1.0-1.0 0.83    
BMI (kg/m2) 156 1.0 0.9-1.1 0.56    
Parity 156 0.9 0.7-1.2 0.61    
Cystocele grade 3 or 4 before 
surgery 
76/154 2.2 1.1-4.1 0.02 2.0 1.0-4.1 0.05 
History of assisted deliveries 21/156 0.8 0.3-2.1 0.72    
Family history of prolapse 63/156 2.1 1.1-4.0 0.03 2.4 1.2-4.9 0.02 
History of constipation 27/154 1.0 0.4-2.3 0.99    
History of previous prolapse 
surgery 
17/155 1.4 0.5-4.0 0.49    
Number of compartments 
- 1 (reference) 
- 2  
- 3  
156  
 
1.1 
0.7 
 
 
0.5-2.5 
0.3-1.8 
 
 
0.84 
0.50 
   
Sacrospinous fixation 22/156 5.2 1.7-16.3 <0.01 6.5 2.0-21.2 <0.01 
Major levator defect 63/152 2.4 1.3-4.7 0.08 2.3 1.1-4.8 0.02 
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recurrence, only 10.9% had subjective recurrence. There was no statistically significant 
association between anatomical and subjective recurrence. This phenomenon has also been 
described by others.3,25 On the one hand, we know that a single POPQ exam may miss some 
women with prolapse because of the timing of the clinical examination on the day or the 
amount of activity performed by the woman. On the other hand, a considerable overlap exists 
between patients with and without symptoms in different stages of POP.26 The prevalence of 
bulge symptoms rises steadily with increasing extent of prolapse along a continuum. Ghetti 
et al. described how the frequency of bulge symptoms within stage II, varied from 57% at ‐1 
to 87% at +1. Within stage III and IV, up to 90% of women reported a bothering bulge. The 
turning point seems to be in stage II.26 In our study, 68.8% of women with anatomical 
recurrence had a POPQ stage II cystocele. This could possibly explain the low subjective 
recurrence rate in our study. 
In our study, complete levator avulsions were associated with anatomical recurrence of 
cystocele with an odds ratio of 2.3 (95% CI 1.1-4.8). In agreement with our study, others 
found levator defects to be a risk factor for recurrence too with an odds ratio of 7.0 (95% CI 
2.6-19.1).24 As other authors described before we did not find an association between partial 
avulsions of puborectalis muscle and anatomical recurrence.14,22 
In our study, only eight of the 17 women with a subjective recurrence had an anatomical 
recurrent prolapse in the operated compartment. In these eight women a symptomatic 
recurrent prolapse in the operated compartment was surprisingly not associated with a major 
levator defect. The amount of women with a subjective recurrence of prolapse was too small 
to generalize this finding, therefore larger studies are needed.  
Advanced prolapse grade before surgery was also identified as a risk factor for recurrent POP 
after surgery in other studies.25,27‐29 The association we identified between recurrence and 
family history of prolapse has not been found by others.25,27 In contrast to our study, several 
others found an association between recurrence and younger age.3,25,29 
There is only one study in the literature comparing cystocele recurrence rates after anterior 
colporrhaphy with and without sacrospinous fixation.30 In that study, cystocele recurrence 
rate was 11.7% versus 9.4% in patients undergoing anterior colporrhaphy with or without 
concomitant sacrospinous fixation, respectively. It was concluded that cystocele formation 
was not altered by performing a sacrospinous fixation. In our present study sacrospinous 
fixation is a risk factor for anatomical recurrence. We hypothesize that sacrospinous fixation 
creates an exaggerated posterior vaginal axis resulting in abnormal intra‐abdominal pressure 
on the anterior vaginal wall, resulting in an increased risk for recurrent cystocele formation. 
However, a sacrospinous fixation was performed in only 14.1% of participants in the follow‐
up study. Due to the small number of procedures, the OR has a wide 95% confidence interval 
(2.1-22.2), which makes this finding less accurate. Further research is indicated. 
A weakness of our study is that its accuracy might be challenged because not all women who 
underwent surgery attended the follow‐up visit. On the one hand, it is possible that women 
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with symptoms are more eager to join the study than women without symptoms. On the other 
hand, it is possible that women who had already been treated for a recurrence are less willing 
to visit a doctor afterwards. Considering the fact that there are no significant differences in 
patient characteristics except age, and that the percentages of patients with a subjective 
recurrence are comparable between the group of women that attended the follow‐up visit 
(10.9%) and the group of women that only filled out the questionnaire (11.5%), this potential 
bias may be limited. 
The mean age of women who did not attend the follow‐up visit was higher compared to the 
women who attended the follow‐up visit. In our study, age was not a significant risk factor 
for recurrence of cystocele. Therefore, we don’t expect this difference in age to influence our 
results importantly. If younger age is a risk factor for POP recurrence, as stated by others 
3,25,29, our recurrence rate might be an overestimate. 
Another limitation of our study was the heterogeneous mix of procedures. However, the 
performed concomitant procedures are common in normal clinical practice. Therefore, we 
can state that this study set‐up meets daily practice. Our population was predominantly 
Caucasian, limiting the generalizability of our findings to Caucasian women. 
In conclusion, anatomical recurrence of cystocele after anterior colporrhaphy is high, while 
subjective recurrences occur less frequently. No significant correlation was found between 
anatomical recurrence and subjective feeling of recurrence. Risk factors for anatomical 
recurrence are complete avulsion of puborectalis muscle, advanced stage cystocele 
preoperatively, family history of prolapse, and sacrospinous fixation. 
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ABSTRACT 
 
Introduction and hypothesis 
Levator defects are risk factors for pelvic organ prolapse (POP) and its recurrence. The most 
widely used scoring systems for severity of defects shown on magnetic resonance imaging 
(MRI) and perineal ultrasound are not identical. The aim of this study was to investigate the 
differences between these classification systems with regard to levator defects on ultrasound 
and their clinical relevance for recurrence after prolapse surgery. 
 
Methods 
Women with previous cystocele repair underwent transperineal 3D ultrasound. Levator 
defects were graded according to the scoring system described with regard to MRI (Delancey 
et al.) and perineal ultrasound (Dietz et al.). The results were compared using the weighted 
kappa and receiver operating characteristic (ROC) curves (SPSS version 20.0). 
 
Results 
We assessed 152 women. On ultrasound classification, more defects were categorized as 
highest grade compared with MRI classification [n=64 (42%) versus n=41 (28%), p<0.01]. 
The grades of levator defects on both scoring systems showed very good agreement with a 
weighted kappa of 0.82 [95% Confidence interval (CI), 0.75-0.88]. The predictive value of 
scoring systems for cystocele recurrence after prolapse surgery showed an area under the 
receiver operating curve (AUC) of 0.63 and 0.64, respectively.  
 
Conclusions 
Comparison of the two scoring systems showed good agreement, but was lowest for the 
highest grade defects. There was no difference in predictive value between scoring systems 
for cystocele recurrence after prolapse surgery. 
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INTRODUCTION 
 
Trauma to the levator ani muscle after vaginal delivery has shown to be a risk factor for 
pelvic organ prolapse (POP) 1 and its recurrence.2,3 Computer modeling based on magnetic 
resonance imaging (MRI) has shown that the most inferior and medial parts of the levator ani 
must increase in length by a factor of 3.5 during crowning of the fetal head during vaginal 
delivery.4 An ultrasound study concerning the degree of stretch of the levator hiatus in 
childbirth on 227 women showed great variations. The dimensions of the hiatal area at 
maximal Valsalva in some women appear to distend only 25 % but in others have to distend 
245 %.5 After vaginal delivery, detachment of these inferomedial aspects of the levator ani 
from its insertion on the pelvic sidewall may occur.6,7 In studies using MRI and ultrasound, 
levator trauma was identified in about 13–20% of women delivered vaginally.6,8 Shek et al. 
diagnosed 17% of women 6 months postpartum who delivered vaginally as having levator 
macrotrauma on ultrasound examination.9 Levator defects can be detected by digital vaginal 
palpation, MRI and pelvic floor ultrasound. A levator defect can be partial, with residual 
connection of the levator muscle to the pubic bone, or total, without connection and complete 
architectural distortion of the levator hiatus. 
Different classifications of levator ani muscle damage are used in studies using MRI and 
ultrasound as imaging methods. Delancey et al. classified levator damage as major, minor or 
none using MRI.10,11 This classification system showed good interrater reliability.12 Dietz et 
al. described a classification for three-dimensional (3D) transperineal ultrasound on which a 
levator defect is classified as complete, partial or no avulsion.13 This classification system 
has also shown good interrater reliability.14 The main difference between the two scoring 
systems is that Delancey et al. focus on the mean percentage of missing muscle, whereas 
Dietz et al. count the number of slices in a tomographic imaging technique showing a 
defect.8,11 Distinguishing major levator defects from minor or no levator defects is of clinical 
relevance because the development of POP was not associated with minor levator defects on 
MRI and ultrasound but only with a severe grade of levator defects.10,13  
There is little comparative research between MRI and 3D ultrasound imaging of the pelvic 
floor, especially to evaluate levator defects. Two studies showed that there is a good 
correlation between MRI and 3D transperineal ultrasound for levator hiatal dimensions 15,16, 
whereas another study found a moderate to poor correlation.17 These studies have not 
investigated levator defects. Zhuang et al. published a study comparing 3D ultrasound with 
MRI for detecting levator defects in 66 patients.18 The two imaging methods correlated well. 
With respect to the extent of the defect (i.e., complete or partial) the correlation showed a 
kappa of 0.65 (95% confidence interval (CI) 0.48-0.83). In this study ultrasound yielded a 
higher number of complete avulsions and 3D MRI identified a higher number of partial 
avulsions.  
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Direct comparison of studies using MRI with studies using ultrasound for diagnosing levator 
defects is limited due to different scoring and classification systems. It is not clear whether 
the cutoff between a minor and a severe grade levator defect on ultrasound is identical to the 
cutoff used in MRI. This hampers the comparison of studies using different imaging 
modalities and scoring systems. 
The aim of the study reported here was to compare MRI and ultrasound classifications of 
levator defects on pelvic floor ultrasound images. The prediction of cystocele recurrence after 
2 years was used to compare which scoring system related best to clinical outcome. 
 
 
MATERIALS AND METHODS 
 
Data on all women who underwent transperineal 3D ultrasonography because of their 
participation in a follow‐up study on risk factors for cystocele recurrence after anterior repair 
were assessed.3 Data on patient characteristics were available from the initial follow‐up 
study. Transperineal ultrasonography of the pelvic floor was performed with the women in 
the supine position after voiding. A GE Voluson 730 expert system (GE Kretz Ultrasound, 
Zipf, Austria) was used with an 8‐4 MHz curved‐array abdominal volume transducer. An 
axial four-dimensional (4D) volume was rendered at the level of the hiatus of minimal 
dimensions. In this plane, a 4D volume cine was recorded containing a maximal pelvic 
muscle contraction to detect abnormal insertion of the puborectalis muscle on the inferior 
ramus (Figure 6.1). This method has been described by Dietz et al. and is reproducible.14,19 
The recorded data sets were analyzed offline using Voluson GE Kretz 4D‐view V 5.1 
software (GE Kretz Ultrasound). Tomographic ultrasound imaging was used to assess the 
levator ani muscle in multiple slices of 2.5 mm for each side separately. In the three central 
slices (i.e., the plane of minimal dimensions plus slices 2.5 and 5 mm cranial to this plane), 
levator damage was graded according to the scoring system described in studies using MRI 
10,11 and in studies using ultrasound 13, and the levator urethral gap (LUG) was measured.13 
To measure the LUG, calipers were placed in the center of the hypoechogenic structure that 
indicates the urethral mucosa and smooth muscle and on the most medial aspect of the muscle 
insertion on the inferior pubic ramus.20 In the three central slices, insertion of the levator ani 
muscle on the pelvic sidewall was rated as normal or abnormal. In doubtful cases, the LUG 
was used. The insertion was regarded as abnormal when the LUG was >2.5 cm.13,20 A 
complete avulsion was diagnosed when all three slices showed an absent connection between 
the puborectalis muscle and inferior pubic ramus. Partial avulsion was diagnosed only when 
one or two slices showed absent connection. No avulsion was diagnosed when all three slices 
showed integrity. For the final score of each individual, assessments of the two sides were 
combined. If both sides showed no avulsion, it was defined as such. If at least one side was 
marked as complete avulsion, it was defined as such. In all other cases, a partial avulsion was 
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diagnosed. The three central slices were scored again by the scoring system described with 
regard to MRI. If no damage was visible, it was assigned a score of zero; if less than half of 
the muscle was missing, it was assigned a score of 1; if more than half of the muscle was 
missing, it received a score of 2; if the complete muscle bulk was lost, it was given a score 
of 3. The sum of the means of the left and right muscles was the total score, ranging from 
zero to 6. A total score of zero was defined as no levator defect, 1‐3 as minor levator defect, 
and 4‐6 or a unilateral score of 3 as major levator defect. Results of both scoring systems 
were used for comparison (Figure 6.2). The weighted kappa was used to compensate for the 
stepwise difference between no, minor and major levator defect. A kappa of <0.20 denotes 
poor agreement, 0.21‐0.40 fair, 0.41‐0.60 moderate, 0.61‐0.80 good and 0.81‐1.00 very good 
agreement.21 
 
 
Figure 6.1 Three-dimensional ultrasonography of levator ani muscle 
 
 
The right image shows the midsagittal plane, and the left image the rendered 3D volume of the levator ani muscle. 
Intact levator ani muscle, no levator defect. 
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Figure 6.2 Comparison of ultrasound and MRI scoring 
 
 
a Ultrasound score: all three slices normal = normal.  
   MRI score: no missing muscle on the right side (score 0) and the left side (score 0) = normal.  
b Ultrasound score: all three slices abnormal = complete avulsion.  
MRI score: mean amount of missing muscle 100 % on the right side (score 3) and the left side (score 3), total    
score 6 = major levator defect.  
c Ultrasound score: all three slices abnormal = complete avulsion.  
MRI score: mean amount of missing muscle <50 % on the right side (score 1) and >50 % missing on the left side 
(score 2), total score 3 = minor levator defect. 
 
 
To assess which classification system related best to clinical outcome, the receiver operating 
characteristic (ROC) curve and area under the curve (AUC) were compared for both scoring 
systems concerning the prediction of recurrence of cystocele after prolapse surgery. 
Statistical analysis was performed using statistical software package SPSS version 20.0 for 
Windows. The protocol was approved by the medical ethics committees of each participating 
hospital. All patients who agreed to participate gave written informed consent before 
enrolment. 
 
 
RESULTS 
 
Between November 2009 and April 2010, 152 participants in a follow‐up study 2 years 
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after anterior colporrhaphy underwent transperineal 3D ultrasonography.3 Patient 
characteristics of the initial follow‐up study are shown in Table 6.1. 
In Table 6.2, MRI and ultrasound scores are compared. Comparison showed very good 
agreement, with a weighted kappa of 0.82 (95% CI 0.75-0.88). In one of the 41 cases 
with a clinically relevant defect according to MRI classification (2%), no clinically 
relevant levator avulsion according to the ultrasound score was found. In 24 of the 64 
cases with a clinically relevant avulsion according to ultrasound classification (38%), 
no clinically relevant defect was found on MRI. This results in good agreement with a 
Cohen’s kappa of 0.65 (95% CI 0.53-0.77) with regard to severe grade of levator 
defect. 
 
 
Table 6.1 Patient characteristics 
 
Variable Mean (range) 
Age (years) 61.1 (41 – 89) 
Body mass index (kg/m2) 26.4 (19.8 – 38.1) 
Parity 2.3 (0 – 9) 
Anatomical recurrence 2 years after anterior colporrhaphy (%) 77/152 (51)a 
a Number/total number (%) 
 
 
Table 6.2 Levator defects according to ultrasound score compared to MRI score 
 
 
Ultrasound score Dietz et al. 13 
No avulsion 
Partial 
avulsion 
Complete 
avulsion 
 
MRI score Delancey et 
al.10,11 applied to 
ultrasound 
 
No defect 29 5 0 34 
Minor defect 0 53 24 77 
Major defect 0 1 40 41 
 29 59 64 152 
MRI = magnetic resonance imaging 
 
 
Figure 6.3 shows ROC curves of the two classification systems and of the highest grade 
defects in both scoring systems for predicting recurrent cystocele after prolapse 
surgery. In Table 6.3 AUC of the corresponding ROC curves are summarized. There is 
no difference in the predictive value between classification systems. However, the 
AUC of the ultrasound score diagnosing the highest grade defect shows the best absolute 
result. 
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Figure 6.3 Predictive value of different scoring systems for recurrent cyctocele 2 years 
after anterior repair 
 
 
 
Table 6.3 Area under the ROC curves concerning predictive value of levator defects on 
ultrasound for recurrent cystocele 2 years after anterior repair 
 
 AUC P value 95% CI 
Ultrasound score Dietz et al.13 
Normal/partial/complete avulsion 
 
0.64 
 
<0.01 
 
0.55 – 0.72 
Ultrasound score Dietz et al.13 
Normal/partial versus complete avulsion 
 
0.61 
 
0.02 
 
0.52 – 0.70 
MRI score Delancey et al.10,11 applied to ultrasound  
Normal/minor/major defect 
 
0.62 
 
0.01 
 
0.54 – 0.71 
MRI score Delancey et al.10,11 applied to ultrasound 
Normal/minor versus major defect 
 
0.58 
 
0.08 
 
0.49 – 0.67 
ROC = receiver operating characteristics; AUC = Area under the receiver operating characteristics curve;         
MRI = magnetic resonance imaging; p = p-value for level of significance; CI = Confidence interval 
 
Ultrasound score Dietz 
Ultrasound Dietz: 
normal/partial vs complete 
MRI score Delancey applied 
to ultrasound 
MRI score Delancey applied 
to ultrasound: no/minor vs 
major 
Reference line 
1 - Specificity 
S
en
si
ti
v
it
y
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DISCUSSION 
 
Our results showed that there was very good agreement between the classification systems 
used for MRI and ultrasound in diagnosing levator defects. The agreement between the scores 
in describing the extent of levator damage, by identifying cases with major levator defects 
(cases proven to be of clinical relevance) showed good agreement with a Cohen’s kappa of 
0.65. Using the ultrasound classification, more defects were categorized as complete avulsion 
compared with MRI classification. This study further shows similar predictive value of 
levator defect scoring systems with regard to cystocele recurrence after 2 years.  
Zhuang et al. published a study comparing ultrasound scans with 3D MRI in 66 patients.18 In 
that study, ultrasound and MRI findings correlated well with each other for diagnosing 
levator defects. Similar to the results in our study, the authors found that with ultrasound, 
more complete avulsions were diagnosed, whereas with the MRI, a higher number of partial 
avulsions was found. The authors’ explanation was that defects are best visualized on 
volumes obtained during a levator ani contraction, which was the case in ultrasound imaging 
and not in MRI. However, in our study, the same ultrasound volumes at Valsalva were used 
for both classification systems. Our study thus showed that this may not be the explanation 
for the differences between the ultrasound and MRI scores. The difference seems to result 
from the use of different scoring systems rather than from the imaging method itself. 
One criticisms of the classification system described by Delancey et al. was that it quantifies 
the amount of muscle bulk missing, but not the amount of muscle present.11 The reason was 
that there are wide variations in muscle bulk among unaffected women. Even in young, 
nulliparous women, there is great variance in biometry of normal pubovisceral muscle 
diameter.22 The amount of missing muscle is related to the normal diameter for that particular 
patient in view of the diameter of the contralateral muscle or the part of the muscle sling 
caudal from the anorectal junction. 
As there is no gold standard for diagnosing levator defects by which to validate the scoring 
systems, we have linked the two systems to clinical outcome. The predictive value of the 
scoring systems for cystocele recurrence after prolapse surgery was identical or similar. 
There are many risk factors for prolapse occurrence and recurrence: e.g., preoperative stage 
of prolapse, and family history of prolapse.3 As major levator defects are only one of the 
preoperative risk factors, the predictive value of major levator defects on ultrasound as a 
single risk factor for recurrent prolapse was limited. 
MRI had been the imaging method of choice due to its superior spatial resolution capabilities 
and its ability to identify different pelvic‐floor muscle groups.18,23 MRI shows the entire 
levator ani muscle in both 2D and 3D displays.24,25 Inter‐ and intraobserver reliability of 
pelvic‐floor assessment with MRI varies in the literature.15,26‐28 However, in several studies, 
MRI is considered the reference standard.16 Nonetheless, MRI has not been adopted in 
clinical practice, the main reason being cost and access issues.22 Translabial 3D/4D 
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ultrasound allows real‐time imaging of the levator ani muscle, and inter‐ and intraobserver 
reliability shows a strong correlation for the majority of measurements.14,20 Compared with 
MRI, 3D ultrasound imaging is non‐invasive, more patient friendly, and less expensive.10 
The ability to perform a real‐time (4D) assessment of pelvic‐floor structures makes 
ultrasound potentially superior to MRI.30 With real‐time imaging, it is possible to control for 
confounders such as inadequate levator contraction or concomitant levator activation during 
Valsalva maneuver. The technique to acquire and interpret ultrasound data can be readily 
learned by the clinician as opposed to MRI, which requires referral to a radiologist.15 As a 
diagnostic tool, ultrasound is more suitable for practical reasons. As a scientific tool, MRI 
has superior imaging qualities of detailed anatomy. 
Comparative studies between MRI and 3D ultrasound imaging, especially to evaluate 
levator defects, would enlarge our knowledge.  
Our study does not address the question of which imaging modality is best linked to clinical 
outcome; however, it shows that both scoring systems when used in ultrasound are equally 
linked to clinical outcome. It also shows that in a future comparative study, it will be possible 
to use the same scoring and classification system in MRI and ultrasound to make possible the 
direct comparison of outcome. 
In conclusion, the comparison of the classification systems described by Dietz et al. 13 for 
ultrasound and Delancey et al. 10 with regard to MRI showed good to very good agreement 
in diagnosing levator defects on ultrasound. The predictive value of levator defects for 
recurrence after surgery was equal for the two scoring systems. 
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ABSTRACT 
 
Objective 
To investigate whether increased levator hiatal area, measured preoperatively, was 
independently associated with anatomical cystocele recurrence 12 months after anterior 
colporrhaphy.  
 
Design 
Multicentre prospective cohort study. 
 
Setting 
Nine teaching hospitals in the Netherlands. 
 
Population 
Women planned for conventional anterior colporrhaphy without mesh. 
 
Methods 
Women underwent physical examination, translabial three-dimensional (3D) ultrasound and 
Magnetic Resonance Imaging (MRI) prior to surgery. At 12 months after surgery physical 
examination was repeated. 
 
Main Outcome Measures 
Women with and without anatomical cystocele recurrence were compared to assess the 
association with levator hiatal area on 3D ultrasound, levator hiatal area on MRI and potential 
confounders. Receiver Operating Characteristic (ROC) curve was created to quantify the 
discriminative ability of using levator hiatal area to predict anatomical cystocele recurrence. 
 
Results 
Of 139 included women, 76 (54.7%) had anatomical cystocele recurrence. Preoperative stage 
3 or 4 and increased levator hiatal area during Valsalva on ultrasound were significantly 
associated with cystocele recurrence with odds ratios of 3.47 (95% confidence interval (CI) 
1.66-7.28) and 1.06 (95% CI 1.01-1.11) respectively. The area under the ROC curve was 
0.60 (95% CI 0.51-0.70) for levator hiatal area during Valsalva on ultrasound and 0.65 (95% 
CI 0.55-0.71) for preoperative POP-Q stage.  
 
Conclusion 
Increased levator hiatal area during Valsalva on ultrasound prior to surgery and preoperative 
stage 3 or 4 were independent risk factors for anatomical cystocele recurrence after anterior 
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colporrhaphy. Increased levator hiatal area as sole factor to predict anatomical cystocele 
recurrence after surgery showed  poor test characteristics. 
 
 
INTRODUCTION 
 
Female pelvic organ prolapse (POP) is a common condition and its etiology is multifactorial.1 
Combinations of anatomical, physiological, genetic, lifestyle, and reproductive factors 
interact throughout a woman’s lifespan and contribute to pelvic floor dysfunction.2 
Symptoms of POP can have a great negative impact on women’s social, physical and 
psychological well-being.3 In case of symptomatic POP, options include expectant 
management, pessary treatment and surgery.4 POP is a prevalent condition with more than 
11% of women reporting POP symptoms in a general female population in the Netherlands.5 
The lifetime risk of surgery for POP in the general female population is 11-20%.6-9 POP 
surgery is known to have high reoperation rates.6 Identification of risk factors for POP and 
its recurrence is important with regard to preoperative counseling and individualized 
treatment.10  
The size of the levator ani hiatus seems to play a role in the etiology of POP.11 On pelvic 
floor imaging, the levator ani hiatus is defined as the area within the levator ani muscle, 
bordered by the levator ani muscle, the symphysis pubis and the inferior pubic ramus, through 
which the urethra, vagina and rectum pass.12 The size of the levator hiatal area varies with 
pubovisceral muscle activity. The levator hiatal area can be visualized by Magnetic 
Resonance Imaging (MRI) and translabial ultrasound. MRI has superior resolution 
capability, but until recently could not be used for dynamic scanning of the pelvic ﬂoor. 
Translabial three-dimensional (3D) ultrasound has the advantage of being more accessible, 
less expensive and can offer real-time imaging in different positions and during pubovisceral 
muscle activity like contractions or Valsalva manoeuvres.12 Studies using translabial 3D 
ultrasound have shown a significant association between an increased levator hiatal area, 
especially during Valsalva, and POP.11,13-18 A levator hiatal area of more than 25 cm2 during 
Valsalva has been defined as abnormal distensibility or ‘ballooning’ of the levator hiatus.14 
There are currently no prospective data available to investigate the association between 
levator hiatal area as measured by translabial 3D ultrasound or MRI preoperatively, and POP 
recurrence after surgery. The present study reports on a secondary analysis of the TRUDIL 
study, in which the diagnostic accuracy of translabial 3D ultrasound in the diagnosis of 
levator ani defects was assessed.19,20  
The aim of this study was to investigate whether an increased levator hiatal area, measured 
preoperatively, was independently associated with anatomical cystocele recurrence 12 
months after anterior colporrhaphy, and if so, to determine the ideal cut-off value of the 
levator hiatal area to predict cystocele recurrence. 
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MATERIALS AND METHODS 
 
A multicentre prospective cohort study was performed in 9 hospitals in the Netherlands. The 
primary aim of this study was to assess the diagnostic accuracy of translabial 3D ultrasound 
in the diagnosis of levator ani defects in women with POP, using MRI as reference test.19,20 
All patients who agreed to participate gave written informed consent before enrolment. 
Ethical approval for this study and local approval was obtained on the 22nd of February 2010, 
number 08-2-093, NTR2220 by the institutional review board of the Maastricht University 
Medical Centre. From March 2010 to July 2012, women who were planned for conventional 
anterior colporrhaphy (i.e. without the use of mesh-materials) because of a cystocele stage 2 
or more according to the Pelvic Organ Prolapse Quantification (POP-Q) classification 
system, where included.21 Anterior colporrhaphy was performed alone or in combination 
with other POP procedures. There was no standardised protocol for the anterior colporrhaphy. 
The surgeon and his trainee were free to perform the procedure as they were used to, 
reflecting daily clinical practice. The intention to use mesh, previous POP surgery, 
concomitant incontinence surgery, the inability to understand the Dutch language, and 
contra-indications for undergoing MRI (e.g. cardiac pacemaker, artificial valves, prosthesis, 
claustrophobia) were exclusion criteria. Patients who agreed to participate underwent 
physical examination and received translabial 3D ultrasound and MRI prior to surgery. At 6 
and 12 months after surgery physical examination was repeated. The Last-Observation-
Carried-Forward (LOCF) method was used in case of missing data.22,23 
Physical examination was performed by staging POP according to the POP-Q classification 
system. At the follow-up visit 12 months after surgery, the physical examination was 
performed by an independent examiner who was not the surgeon, and who was blinded for 
the results of the ultrasound and MRI examinations. Anatomical recurrence was defined as a 
cystocele POP-Q stage 2 or more. 
The translabial 3D ultrasound of the pelvic floor was performed in supine position with hips 
flexed and slightly abducted and after voiding. A GE Voluson E8 system (GE Kretz 
Ultrasound, Zipf, Austria) was used with a 4.8 MHz curved abdominal transducer covered 
with gel and a condom. The transducer was placed against the perineum. Imaging was 
performed at rest, on maximum pelvic floor muscle contraction and during Valsalva 
manoeuvre. Dimensions of the levator hiatus were determined in the axial plane. Levator 
hiatal area was measured as the area bordered by the levator ani muscle, the symphysis pubis 
and the inferior ramus pubis (figure 7.1). During contraction, the level of minimum hiatal 
dimensions, identified as the minimum distance between the posterior margin of the 
symphysis pubis to the anterior margin of the levator ani muscle, was determined. At rest, 
the levator hiatal area was measured in the neutral position of the levator ani muscle before 
a levator ani muscle contraction. During Valsalva, the maximum anteroposterior diameter in 
the midsagittal plane was used for analysis.24 Volumes were recorded 3 times during 
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contraction and during Valsalva, and the best images were chosen for analysis. For the 
assessment of levator ani defects the slices 2.5 and 5 mm cranial to the plane of minimum 
hiatal dimensions were also used. Levator ani defects were scored as described by Dietz et 
al.25 
 
 
Figure 7.1 Levator hiatal area measured on translabial 3D ultrasound in the axial plane 
 
 
3D = three-dimensional 
 
The recorded data sets were analysed offline using Voluson GE Kretz 4D-view V 5.1 
software (GE Kretz Ultrasound, Zipf, Austria). 
The MRI was performed with the patient in supine position with parallel and slightly flexed 
legs. Patients were requested to empty their bladder prior to the examination. No 
premedication was given. The urethra, bladder, vagina, and rectum were not opacified. MRI 
scans were acquired using either a 1.5 or 3 tesla MR scanner (Siemens/GE/Philips) and a 
surface coil. MRI scans of the pelvis were obtained in the sagittal plane using either a Half-
Fourier acquisition single-shot turbo spin-echo sequence (2000 ms/90 ms repetition 
time/echo time; 150° flip angle) or true fast imaging with steady state precession. The entire 
pelvis from symphysis to second or third lumbar vertebrae was scanned. Consequently axial 
and coronal T2-weighted turbo/fast spin echo sequence (>3500 ms, < 100ms repetition time/ 
echo time; 150° flip angle, slice thickness 3 mm and 0.5 x 0.5 in plane resolution) was 
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acquired covering the entire pelvis from symphysis to the fifth lumbar vertebrae. In addition 
a 3D T2-weighted turbo/fast spin echo sequence (< 1 x 1 x 1mm) was acquired. All images 
were assessed offline using a Dicom viewer (OsiriX, v3.8.1/v5.0.1, Geneva, Switzerland). 
Dimensions of the levator hiatus were determined at rest in the axial plane. The levator hiatus 
area was measured as the area bordered by the levator ani muscle, the symphysis pubis and 
the inferior ramus pubis. 
The ultrasound volumes were interpreted independently offline by 2 examiners from a pool 
of 5, who were blinded for the associated clinical data. There were no fixed couples. These 
observers were experienced in assessing these images (experience in years: 1-20 and number 
of pelvic floor exams assessed: 200-4000) and all participated in 2 training sessions before 
the study started. The MRI scans were interpreted independently offline by 2 examiners from 
a pool of 4, who were blinded for the associated clinical data. There were no fixed couples. 
These radiologists were experienced in assessing these images (experience in years: 1-20, 
number of pelvic floor images assessed: 200-4000). Furthermore all experts participated in 3 
training sessions before the study started, including a training given by an international 
expert, in which 50 images were discussed. 
The statistical analysis was performed using the statistical software package SPSS version 
19.0 (SPSS Inc., Chicago, IL). Intraclass Correlation Coefficients (ICC) were calculated to 
estimate the interobserver reliability between the assessments by two independent observers 
for levator hiatal area at rest on 3D ultrasound, levator hiatal area during contraction on 3D 
ultrasound, levator hiatal area during Valsalva on 3D ultrasound and levator hiatal area at 
rest on MRI. An ICC of <0.20 denotes poor agreement, 0.21-0.40 fair, 0.41-0.60 moderate, 
0.61-0.80 good and 0.81-1.00 very good agreement.26 Interobserver agreement in detecting 
major levator ani defects on 3D ultrasound and on MRI has been published elsewhere.20 
Women with and without anatomical cystocele recurrence 12 months after surgery were 
compared to assess the association with age, body mass index (BMI), parity, preoperative 
POP-Q stage, concomitant POP surgery, major levator ani defects on 3D ultrasound, major 
levator defects on MRI, levator hiatal area at rest on 3D ultrasound, levator hiatal area during 
contraction on 3D ultrasound, levator hiatal area during Valsalva on 3D ultrasound and 
levator hiatal area at rest on MRI. A p value of <0.05 was considered to be statistically 
significant. Multivariable logistic regression, including all factors with a p value of <0.10 in 
univariable analysis, was used to determine the association between potential risk factors and 
anatomical cystocele recurrence through odds ratios (OR) and 95% confidence intervals (CI). 
The discriminative ability of statistically significant associated factors (in combination and 
as separate factors) to predict anatomical cystocele recurrence was further quantified as the 
area under the Receiver Operating Characteristic (ROC) curve. An area of 1.0 represents a 
perfect test, while an area of 0.5 represents a worthless test.27 The difference between the 
areas under the curves was tested using the method of DeLong et al.28 In case appropriate, 
the ROC curve was also used to assess the trade-off between sensitivity and specificity and 
determine the ideal cut-off value of the levator hiatal area to predict cystocele recurrence. 
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Sensitivity expresses the proportion of women with cystocele recurrence correctly predicted 
by an increased levator hiatal area. Specificity expresses the proportion of women without 
cystocele recurrence correctly predicted by no increased levator hiatal area. The positive 
likelihood ratio indicates how much more likely an increased levator hiatal area is in women 
with cystocele recurrence compared to women without cystocele recurrence. The negative 
likelihood ratio indicates how much more likely a not increased levator hiatal area is in 
women without cystocele recurrence compared to women with cystocele recurrence. The 
positive predictive value is the proportion of women with an increased levator hiatal area 
who have cystocele recurrence. The negative predictive value is the proportion of women 
without cystocele recurrence who do not have an increased levator hiatal area.  
 
 
RESULTS 
 
From March 2010 to July 2012, 140 women were included in 9 hospitals. One patient 
withdrew from the study after surgery. For the remaining 139 patients, patient characteristics 
are shown in table 7.1. Twelve months postoperatively, 123 patients attended the follow-up 
visit. From the other 16 patients, POP-Q examination data were available from the follow-up 
visit 6 months earlier. By carrying the last observation forward, information on anatomic 
recurrence was available of all 139 patients. Of these 139 women, 76 (54.7%) had anatomical 
cystocele recurrence POP-Q stage 2 or more 12 months after surgery.  
Of the 139 datasets, 5 ultrasound datasets were excluded because of inadequately recorded 
volumes. The patient characteristics of these 5 women were similar to the total population. 
All 139 MRI datasets were recorded adequately for assessment.  
The measurements of the levator hiatal area on translabial 3D ultrasound at rest, during 
contraction and during Valsalva and on MRI at rest, in the total population, in women with 
cystocele recurrence and in women without cystocele recurrence are shown in table 7.2. 
Hundred sixteen women (86.6%) had levator hiatal area during Valsalva on 3D ultrasound 
of more than 25cm2. 
The interobserver reliability between the assessments by two independent observers for 
levator hiatal area was good, with an ICC of 0.78 (95% CI 0.69-0.85) at rest on 3D ultrasound, 
an ICC of 0.64 (95% CI 0.48-0.75) during contraction on 3D ultrasound, an ICC of 0.75 (95% 
CI 0.65-0.83) during Valsalva on 3D ultrasound and an ICC of 0.74 (95% CI 0.63-0.82) at 
rest on MRI.  
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Table 7.1 Characteristics of women prior to the anterior colporrhaphy 
 
BMI = Body Mass Index, POP-Q = Pelvic Organ Prolapse Quantification system 
a As measured on translabial three-dimensional ultrasound 
 
 
 Table 7.2 Measurements of levator hiatal area 
MRI = magnetic resonance imaging 
 
 
Univariable and multivariable analyses are depicted in table 7.3. Preoperative POP-Q stage 
3 or 4 and increased levator hiatal area during Valsalva on 3D ultrasound were significantly 
associated with cystocele recurrence in both univariable and multivariable analysis. 
Multivariable analysis showed that preoperative POP-Q stage 3 or 4 and increased levator 
hiatal area during Valsalva were independent risk factors for anatomical cystocele recurrence 
after surgery with an OR of 3.47 (95% CI 1.66-7.28) and 1.06 (95% CI 1.01-1.11) 
respectively.  
 
 
 
 
Variable N Outcome 
Age in years, mean (range) 139 57.4 (31-78) 
BMI in kg/m2, mean (range) 116 25.7 (17.5-41.9) 
Parity, mean (range) 128 2.3 (1-7) 
Preoperative POP-Q stage 3 or 4, n (%) 139 62 (44.6%) 
Concomitant surgery 
     Concomitant repair apical compartment, n (%)     
     Concomitant repair posterior compartment, n (%)  
 
139 
139 
 
69 (49.6%) 
55 (39.6%) 
Major levator ani defectsa, n (%) 135 66 (48.9%) 
 Overall population, 
n = 139 
Women with 
recurrence, n = 76 
Women without 
recurrence, n = 63 
Ultrasound at rest in cm2, 
mean (range) 
23.8 (13.7-54.1) 24.0 (15.3-54.1) 23.2 (13.7-42.3) 
Ultrasound during 
contraction in cm2, mean 
(range) 
19.3 (12.0-36.7) 19.6 (12.0-32.6) 19.0 (12.0-36.7) 
Ultrasound during Valsalva 
in cm2, mean (range) 
34.0 (16.8-67.4) 35.8 (18.9-67.4) 32.0 (16.8-47.6) 
MRI at rest in cm2, mean 
(range) 
26.1 (12.3-70.0) 26.3 (13.5-46.2) 26.0 (12.3-70.0) 
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Table 7.3 Risk factors for anatomical cystocele recurrence 
 
OR = Odds Ratio, 95% CI = 95% Confidence Interval, BMI = Body Mass Index, POP-Q = Pelvic Organ Prolapse 
Quantification system, MRI = magnetic resonance imaging 
 
 
In figure 7.2 the ROC curves are shown. The area under the ROC curve for levator hiatal area 
during Valsalva was 0.60 (95% CI 0.51-0.70), indicating poor discriminative ability of using 
levator hiatal area during Valsalva as sole risk factor for predicting anatomical cystocele 
recurrence. The area under the ROC curve for preoperative POP-Q stage was 0.65 (95% CI 
0.55-0.71). Using levator hiatal area during Valsalva combined with preoperative POP-Q 
stage 3 or 4 could discriminate significantly better between patients who were going to have 
anatomical cystocele recurrence than using only levator hiatal area during Valsalva (p = 0.02) 
or using only preoperative POP-Q stage (p = 0.05), with an area under the ROC curve of 0.70 
(95% CI 0.61-0.79).  
 
 
 
  Univariable analysis Multivariable analysis 
Potential risk factors N OR 95% CI p-
value 
OR 95% CI p-
value 
Age, years 139 1.00 0.97-1.03 0.99    
BMI, kg/m2 116 0.96 0.87-1.07 0.46    
Parity, number 128 1.10 0.73-1.65 0.65    
Preoperative POP-Q stage 3 
or 4 
139 3.02 1.49-6.10 <0.01 3.47 1.66-7.28 <0.01 
Concomitant surgery 137 0.80 0.38-1.68 0.56    
Major levator ani defect on 
ultrasound 
135 1.57 0.80-3.10 0.19    
Major levator ani defect on 
MRI 
139 1.41 0.68-2.92 0.36    
Levator hiatal area at rest on 
ultrasound, cm2 
134 1.02 0.97-1.09 0.44    
Levator hiatal area during 
contraction, cm2 
133 1.03 0.95-1.10 0.50    
Levator hiatal area during 
Valsalva, cm2 
134 1.06 1.01-1.10 0.01 1.06 1.01-1.11 0.02 
Levator hiatal area during 
Valsalva of >25cm2 
134 2.07 0.75-5.73 0.16    
Levator hiatal area at rest on 
MRI, cm2 
139 1.00 0.96-1.05 0.85    
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Figure 7.2 ROC curve for separate and combined risk factors for anatomical 
recurrence 
 
ROC = Receiver Operating Characteristics 
 
 
Test characteristics for the different cut-off values of levator hiatal area during Valsalva as a 
test to predict anatomical cystocele recurrence are depicted in table 7.4. The likelihood ratios 
of all cut-off values of the levator hiatal measurements during Valsalva were between 0.5 
and 1.7, except for the cut-off value of 20 cm2 showing a negative likelihood ratio of 0.1. 
 
 
DISCUSSION 
 
Main findings 
In this multicentre prospective cohort study we observed that an increased levator hiatal area 
during Valsalva, measured preoperatively with translabial 3D ultrasound, and preoperative 
POP-Q stage 3 or 4 were independent risk factors for anatomical cystocele recurrence 12 
months after anterior colporrhaphy.  
Hiatus Valsalva 
Preoperative stage 
Hiatus and preoperative stage 
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Table 7.4 Test characteristics for levator hiatal area during Valsalva as a predictor for 
anatomical cystocele recurrence 
 
 Sensitivity Specificity LR+ LR- PPV NPV 
Cut-off 20cm2 98.6% 9.8% 1.1 0.1 56.7% 85.7% 
Cut-off 25cm2 90.4% 18.0% 1.1 0.5 56.9% 61.1% 
Cut-off 30cm2 71.2% 42.6% 1.2 0.7 59.8% 55.3% 
Cut-off 35cm2 42.5% 60.7% 1.1 1.0 56.4% 46.8% 
Cut-off 40cm2 30.1% 82.0% 1.7 0.9 66.7% 49.5% 
LR+ = Positive Likelihood Ratio, LR- = Negative Likelihood Ratio, PPV = Positive Predictive Value, NPV = 
Negative Predictive Value, 95% CI = 95% Confidence Interval 
 
 
Strengths and limitations 
A limitation of our study was that cystocele recurrence was defined as anatomical recurrence. 
It is known that anatomical recurrence rate is higher than symptomatic recurrence rate.29 
Although subjective outcomes were available in the study population, the sample size in this 
study was too small to examine the association between levator hiatal area and symptomatic 
recurrence. 
The follow-up after surgery was 12 months. Anatomical recurrence rate was 54.7%, which 
is in accordance to other research.29-32  
 
Interpretation 
The observations in this study have been described before. Preoperative POP-Q stage 3 or 4 
was also an independent risk factor for POP recurrence after surgery in previous studies.10,29-
31 Age, BMI, parity and concomitant surgery were not significantly associated with POP 
recurrence, which confirms the findings by others as well.10,29 In this study, a major levator 
ani defect on 3D ultrasound and on MRI was not an independent risk factor for POP 
recurrence, which is in contrast with previous studies that have shown a significant 
correlation between levator ani defects and POP recurrence.29,33-36 All these studies were 
singlecentre compared to our multicentre study. The studies of Weemhoff et al (n = 156), 
Rodrigo et al (n = 334), Dietz et al (n = 83) and Model et al (n = 737) had a follow-up of 
more than 2 years.29,33-35 These studies differed from the present study in the fact that in these 
studies ultrasound was performed postoperatively while in the present study ultrasound was 
performed preoperatively. In one study of Morgan et al (n = 83) levator defects were assessed 
with MRI preoperatively.36 Their follow-up at six weeks after surgery showed that anterior 
vaginal wall support was not as optimal in women with major levator defects as in women 
without major levator defects. They did not include recurrence on longer follow-up. 
Increased levator hiatal area was only a significant risk factor for POP recurrence when it 
was measured during Valsalva and not when it was measured at rest or during contraction. 
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This implies that static MRI is not suitable for diagnosing levator hiatal area in the prediction 
of POP recurrence after surgery. Our research cannot explain why levator hiatal area during 
Valsalva was significantly associated with POP recurrence while levator hiatal area at rest or 
during contraction were not. We can hypothesize that distensibility and elasticity play a role 
in the development of POP, which are more visible during Valsalva. 
The interobserver reliability between the assessments by two independent observers for 
levator hiatal area was good. To our best knowledge, there are currently no other studies that 
have prospectively examined the correlation between levator hiatal area measured prior to 
surgery and recurrence of POP after surgery. Rodrigo et al have performed a retrospective 
cohort study in which the levator hiatal area during Valsalva was measured at the follow-up 
visit after surgery, which included polypropylene mesh augmentation in 74% of women.34 A 
significant correlation between levator hiatal area during Valsalva and recurrent POP after 
surgery was found, with an OR of 1.04 (95% CI 1.01-1.06). It is known that levator hiatal 
area during Valsalva is reduced after POP surgery.37 It is unknown whether levator hiatus 
measurements are influenced by mesh augmentation or by POP in itself. In other words, it is 
unknown whether the findings in the study by Rodrigo et al would have been the same if 
these measurements had been performed preoperatively.  
Dietz et al have suggested a cut-off value of 25 cm2 for increased levator hiatal area during 
Valsalva, based on an area under the ROC curve of 0.76 (95% CI 0.72-0.80), a sensitivity of 
0.52 and a specificity of 0.83 for detecting anatomical POP.14 In the present study, levator 
hiatal area during Valsalva on 3D ultrasound of more than 25cm2 versus less than 25cm2 was 
not a risk factor for POP recurrence. When analyzing increased levator hiatal area during 
Valsalva as a test for predicting anatomical cystocele recurrence after surgery, the test 
characteristics were poor, and this held true for all cut-off values considered. Likelihood 
ratios were close to 1.0, which indicates poor predictive value. An exception was the cut-off 
value of 20 cm2 showing a negative likelihood ratio of 0.1, which indicates that a levator 
hiatal area during Valsalva of less than 20 cm2 was strongly predictive of the absence of 
anatomical cystocele recurrence.38 The differences in results between our study and the study 
by Dietz et al may be attributed partly to a different study population. In our study, women 
with cystocele recurrence were compared to women with no cystocele recurrence after 
conventional anterior colporrhaphy, while in the study of Dietz women with POP were 
compared to women without POP.  
 
 
CONCLUSION 
 
In conclusion, this multicentre prospective cohort study demonstrated that an increased 
levator hiatal area during Valsalva prior to surgery and a preoperative POP-Q stage 3 or 4 
were independent risk factors for anatomical cystocele recurrence 12 months after anterior 
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colporrhaphy. Using increased levator hiatal area during Valsalva to predict anatomical 
cystocele recurrence after surgery does not have additional value due to poor test 
characteristics. However, a levator hiatal area during Valsalva of less than 20 cm2 was 
strongly predictive of the absence of anatomical cystocele recurrence. 
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ABSTRACT 
 
Objectives 
To compare translabial three-dimensional (3D) ultrasound with magnetic resonance imaging 
(MRI) for the measurement of levator hiatus biometry at rest in women with pelvic organ 
prolapse, and to determine the interobserver reliability between two independent observers 
for ultrasound and MRI measurements. 
 
Methods 
In a multicentre prospective cohort study, women planned for conventional anterior 
colporrhaphy underwent translabial 3D ultrasound and MRI prior to surgery. Intraclass 
Correlation Coefficients (ICC) were calculated to estimate the interobserver reliability 
between two independent observers and to calculate the agreement between ultrasound and 
MRI measurements. Bland-Altman plots were created to visualize the agreement between 
ultrasound and MRI measurements. 
 
Results 
One hundred thirty-nine women were included in 9 hospitals. The interobserver reliability 
between the assessments on ultrasound at rest, during Valsalva and during contraction and 
on MRI at rest by two independent observers was good. The agreement between ultrasound 
and MRI for the measurements of levator hiatus biometry at rest was moderate with an ICC 
of 0.52 (95% confidence interval (CI) 0.32-0.66) for levator hiatal area, an ICC of 0.44 (95% 
CI 0.21-0.60) for the anteroposterior diameter and an ICC of 0.44 (95% CI 0.22-0.60) for the 
transversal diameter. MRI measurements were statistically significantly larger than on 
translabial 3D ultrasound. 
 
Conclusions 
The agreement between translabial 3D ultrasound and MRI for the measurement of the 
levator hiatus biometry at rest in women with pelvic organ prolapse was only moderate. The 
results of translabial 3D ultrasound and MRI should therefore not be interchangeably used in 
daily practice or in clinical research.  
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INTRODUCTION 
 
Pelvic organ prolapse (POP) is a prevalent condition with more than 11% of women reporting 
POP symptoms in a general female population.1 The lifetime risk of surgery for POP or 
urinary incontinence is 11-20%.2-5 Surgery for POP is known to have a high recurrence and 
reoperation rate.2 The availability of ultrasound equipment and the development of translabial 
three/four-dimensional (3D/4D) ultrasound have renewed interest in using this technique to 
image the pelvic floor anatomy as a key to understand pelvic floor dysfunction. With the help 
of 3D/4D ultrasound it is possible to obtain information on the levator ani hiatus and 
morphological abnormalities of the levator ani muscle. The levator ani hiatus is the opening 
in the pubovisceral muscle, defined as the area bordered by the pubovisceral muscle, the 
symphysis pubis and the inferior pubic ramus, through which the urethra, vagina and rectum 
pass.6 Studies using translabial 3D ultrasound have shown a significant association between 
an increased levator hiatal area and POP, and between an increased levator hiatal area and 
POP recurrence after surgery.7-14  
Both translabial 3D ultrasound and magnetic resonance imaging (MRI) have shown to have 
very good inter- and intraobserver reliability for measuring levator hiatus biometry.7,12,15-21 
To allow comparison of studies using ultrasound with studies using MRI, it needs to be 
identified whether levator hiatal biometry is identical in both imaging modalities. There are 
three studies comparing translabial 3D ultrasound with MRI, all using healthy nulliparous 
volunteers for the purpose.6,22,23 Majida et al found a very good agreement between translabial 
3D ultrasound and MRI for the measurement of the levator hiatus biometry.6 Nardos et al 
found no difference between ultrasound and MRI for images in the axial plane.22 However, 
in the study by Kruger et al the measurements obtained with MRI were significantly larger 
than on translabial 3D ultrasound.23 
The aim of this study was to compare translabial 3D ultrasound with MRI for the 
measurement of levator hiatus biometry at rest in women who were going to have surgery 
for POP, and to estimate the interobserver reliability between two independent observers, in 
a multicenter design with multiple observers. 
 
 
METHODS 
 
The present study was realised with data obtained in the TRUDIL study, in which the 
validation and clinical relevance of translabial 3D ultrasound for diagnosing levator ani 
defects was investigated in women with POP.24,25 A multicentre prospective cohort study was 
performed in 9 hospitals in the Netherlands. All patients who agreed to participate gave 
written informed consent before enrolment. The study was approved by the institutional 
review board of the Maastricht University Medical Centre. Ethical approval for this study 
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and local approval was obtained on the 22nd of February 2010, number 08-2-093, NTR2220. 
From March 2010 to July 2012, women who were planned for conventional anterior 
colporrhaphy (i.e. without the use of mesh-materials) because of cystocele stage 2 or more 
according to the Pelvic Organ Prolapse Quantification (POP-Q) system, where included. The 
intention to use mesh, previous POP surgery, concomitant incontinence surgery, the inability 
to understand the Dutch language, and contra-indications for undergoing MRI (e.g. cardiac 
pacemaker, artificial valves, prosthesis, claustrophobia) were exclusion criteria. All patients 
who agreed to participate underwent translabial 3D ultrasound and MRI prior to surgery, 
which was in random order in time and often performed on the same day to prevent bias due 
to potential day by day variation in POP severity.  
The translabial 3D ultrasound of the pelvic floor was performed in supine position with hips 
flexed and slightly abducted and after voiding. A GE Voluson E8 system (GE Kretz 
Ultrasound, Zipf, Austria) was used with a 4.8 MHz curved abdominal transducer covered 
with gel and a condom. The transducer was placed against the perineum. Imaging was 
performed at rest, on maximum pelvic floor muscle contraction and during Valsalva 
manoeuvre.  
The recorded data sets were analysed offline using Voluson GE Kretz 4D-view V 5.1 
software (GE Kretz Ultrasound, Zipf, Austria). Dimensions of the levator hiatus (the levator 
hiatal area and the anteroposterior and transverse diameters) were determined at rest and 
during Valsalva in the axial plane at the level of minimum hiatal dimensions, identified as 
the minimum distance between the posterior margin of the symphysis pubis and the anterior 
margin of the puborectal muscle. (Figure 8.1)  
The MRI examination was performed with the patient in supine position with parallel and 
slightly flexed legs. Patients were requested to empty their bladder prior to the examination. 
No premedication was given. The urethra, bladder, vagina, and rectum were not opacified. 
MRI scans were acquired using either a 1.5 or 3 tesla MRI scanner (Siemens/GE/Philips) and 
a surface coil. MRI scans of the pelvis were obtained in the sagittal plane using either a Half-
Fourier acquisition single-shot turbo spin-echo sequence (2000 ms/90 ms repetition 
time/echo time; 150° flip angle) or true fast imaging with steady state precession. The entire 
pelvis from symphysis to second or third lumbar vertebrae was scanned. Consequently axial 
and coronal T2-weighted turbo/fast spin echo sequence (>3500 ms, < 100ms repetition time/ 
echo time; 150° flip angle, slice thickness 3 mm and 0.5 x 0.5 in plane resolution) was 
acquired covering the entire pelvis from symphysis to the fifth lumbar vertebrae. In addition 
a 3D T2-weighted turbo/fast spin echo sequence (< 1 x 1 x 1mm) was acquired. 
All images were assessed offline using a Dicom viewer (OsiriX, v3.8.1/v5.0.1, Geneva, 
Switzerland). The angled axial plane was used to determine the shortest distance between the 
posterior margin of the symphysis pubis and the anterior margin of the puborectal muscle. 
Dimensions of the levator hiatus (the levator hiatal area, the anteroposterior diameter and the 
transverse diameter) were determined at rest in this plane. (Figure 8.2) 
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Figure 8.1 Levator hiatal area measured on translabial 3D ultrasound in the mid-
sagittal and axial plane 
  
 
 
 
 
 
 
 
 
 
 
 
 3D = three-dimensional 
 
 
The ultrasound volumes were interpreted independently and offline by two randomly selected 
examiners from a pool of five, who were blinded to the associated clinical data. There were 
no fixed couples. These observers were experienced in assessing these images (experience in 
years: 1-20 and number of pelvic floor exams assessed: 200-4000). The MRI scans were 
interpreted independently and offline by two randomly selected examiners from a pool of 
four, who were blinded to the associated clinical data. There were no fixed couples. These 
radiologists were experienced in assessing these images (experience in years: 1-20, number 
of pelvic floor images assessed: 200-4000).  
The statistical analysis was performed using the statistical software package SPSS version 
19.0 (SPSS Inc., Chicago, IL). Intraclass Correlation Coefficients (ICC) were calculated to 
estimate the interobserver reliability between the assessments by two independent observers 
and to calculate the agreement between ultrasound and MRI measurements at rest. For the 
latter, only the measurements of the first observer were used. An ICC of <0.20 denotes poor 
agreement, 0.21-0.40 fair, 0.41-0.60 moderate, 0.61-0.80 good and 0.81-1.00 very good 
agreement.26 Bland-Altman plots were created to visualize the agreement between ultrasound 
and MRI measurements. 
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Figure 8.2 Levator hiatal area measured on MRI in the axial plane 
 
  
MRI = magnetic resonance imaging 
 
 
RESULTS 
 
For the primary study, 140 women were included in 9 hospitals. One patient withdrew from 
the study after surgery. For the remaining 139 patients, patient characteristics are shown in 
table 8.1.  
 
 
Table 8.1 Characteristics of women prior to the anterior colporrhaphy 
BMI = Body Mass Index, POP-Q = Pelvic Organ Prolapse Quantification system 
 
 
 
Variable N Outcome 
Age in years, mean (range) 139 57.4 (31-78) 
BMI in kg/m2, mean (range) 116 25.7 (17.5-41.9) 
Parity, mean (range) 128 2.3 (1-7) 
Preoperative POP-Q stage 3 or 4, n (%) 139 62 (44.6%) 
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Of the 139 datasets, 5 ultrasound datasets were excluded because of inadequately recorded 
volumes due to a technical error. The patient characteristics of these 5 women were similar 
to the total study population. All 139 MRI datasets were recorded adequately for assessment.  
The interobserver reliability between the assessments of the ultrasound scans at rest, during 
Valsalva and during contraction and of the MRI scans at rest by two independent observers 
is shown in table 8.2. Overall the agreement was good with ICC’s ranging from 0.55 to 0.81. 
 
 
Table 8.2 Interobserver reliability 
 
 N ICC (95% CI) 
Tanslabial 3D ultrasound at rest   
     Levator hiatal area 134 0.78 (0.69-0.85) 
     Anteroposterior diameter 134 0.65 (0.49-0.75) 
     Transversal diameter 134 0.59 (0.41-0.71) 
Translabial 3D ultrasound during Valsalva   
     Levator hiatal area 134 0.75 (0.65-0.83) 
     Anteroposterior diameter 118 0.81 (0.73-0.87) 
     Transversal diameter 118 0.63 (0.46-0.74) 
Translabial 3D ultrasound during contraction   
     Levator hiatal area 133 0.64 (0.48-0.75) 
     Anteroposterior diameter 127 0.66 (0.52-0.76) 
     Transversal diameter 127 0.55 (0.36-0.68 
MRI at rest   
     Levator hiatal area 139 0.74 (0.63-0.82) 
     Anteroposterior diameter 139 0.66 (0.52-0.76) 
     Transversal diameter 139 0.63 (0.47-0.74) 
ICC = Intraclass correlation coefficient, 95% CI = 95% confidence interval, 3D = three-dimensional, MRI = 
magnetic resonance imaging 
 
 
The measurements of levator hiatus biometry at rest on translabial 3D ultrasound and MRI 
are shown in table 8.3. On MRI, measurements were larger than on translabial 3D ultrasound, 
which was statistically significant. The agreement between ultrasound and MRI for the 
measurements of levator hiatus biometry at rest was moderate with an ICC of 0.52 (95% 
confidence interval (CI) 0.32-0.66) for levator hiatal area, an ICC of 0.44 (95% CI 0.21-0.60) 
for the measurement of the anteroposterior diameter and an ICC of 0.44 (95% CI 0.22-0.60) 
for the measurement of the transversal diameter. This is visualized in the Bland-Altman plots 
in respectively figure 8.3, figure 8.4 and figure 8.5.  
The mean difference lines were below zero (-2.14 for levator hiatal area, -0.50 for the 
anteroposterior diameter and -0.46 for the transversal diameter) indicating that MRI 
Chapter 8 
120 
 
measurements were systematically larger than ultrasound measurements. The 95% limits of 
agreement were relatively wide (-17.94 to 13.66 for levator hiatal area, -2.46 to 1.46 for the 
anteroposterior diameter and -2.64 to 1.67 for the transversal diameter), visualizing the 
moderate agreement between the ultrasound and MRI measurements. Table 8.3 shows that 
the bigger the levator hiatal area, the larger the difference between ultrasound and MRI 
measurements. 
 
 
Figure 8.3 Bland-Altman plot levator hiatal area measurement 
 
 
diffhiatus = difference in cm2 between levator hiatal area measurements with ultrasound and with magnetic 
resonance imaging 
meanhiatus = mean of levator hiatal area measurements in cm2 with ultrasound and magnetic resonance imaging 
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Figure 8.4 Bland-Altman plot anteroposterior diameter measurement 
 
 
diffAP = difference in cm between anteroposterior diameter measurements with ultrasound and with magnetic 
resonance imaging 
meanAP = mean of anteroposterior diameter measurements in cm with ultrasound and magnetic resonance imaging 
 
 
DISCUSSION 
 
In this multicentre prospective cohort study we found that the agreement between translabial 
3D ultrasound and MRI with regard to the measurement of the levator hiatus biometry in 
women with POP was only moderate. Measurements obtained with MRI were systematically 
significantly larger than with translabial 3D ultrasound. 
The interobserver reliability with regard to the measurement of levator hiatus biometry by 
two independent observers was good for both ultrasound and MRI, with ICC’s ranging from 
0.55 to 0.81. The ICC’s described in other studies were slightly higher, ranging from 0.61 to 
0.97, possibly due to the assessment by only two observers in a single centre, compared to 
five different observers in this multicentre study.7,15-21 
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Figure 8.5 Bland-Altman plot transversal diameter measurement 
 
 
diffTR = difference in cm between transversal diameter measurements with ultrasound and with magnetic resonance 
imaging 
meanTR = mean of transversal diameter measurements in cm with ultrasound and magnetic resonance imaging 
 
 
Table 8.3 Measurements of levator hiatus biometry at rest 
 
MRI = magnetic resonance imaging 
 
 
 Ultrasound,  
n = 134 
MRI,  
n = 139 
p-value 
Levator hiatal area in cm2, mean (range) 23.7 (13.7-54.1) 26.1 (12.3-70.0) <0.01 
Anteroposterior diameter in cm, mean (range) 6.3 (4.5-8.9) 6.9 (4.4-10.0) <0.01 
Transversal diameter in cm, mean (range) 4.9 (3.0-7.4) 5.4 (3.0-7.5) <0.01 
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The moderate agreement (ICC ranging from 0.44 to 0.52) between translabial 3D ultrasound 
and MRI for the measurement of the levator hiatus biometry is in contrast with previous 
findings of Majida et al in 2010, who have found a very good agreement (ICC ranging from 
0.80 to 0.97).6 In that study measurements of levator hiatus biometry using translabial 3D 
ultrasound were compared with measurements on MRI in 18 female volunteers. All datasets 
were assessed by a single investigator. These factors differ from our study in which the 
population consisted of women with POP and datasets were assessed by multiple 
investigators.  
In the present study, measurements obtained with MRI were systematically and statistically 
significantly larger than with translabial 3D ultrasound. This is visualized in the three Bland-
Altman plots (figure 8.3, figure 8.4 and figure 8.5), in which the mean difference line is below 
zero. This is in contrast with the findings by Nardos et al in 2014.22 In that study levator 
hiatus measurements obtained by translabial 3D ultrasound and by MRI were compared in 
39 asymptomatic nulliparous women. The anteroposterior diameter was measured in the 
sagittal plane, while the levator hiatal area, the anteroposterior diameter and the transverse 
diameter were measured in the axial plane. The authors found that only the mean 
anteroposterior diameter in the sagittal plane was significantly larger on MRI than on 
ultrasound, while in the axial plane the hiatal area, the anteroposterior diameter and 
transverse diameter were larger on ultrasound than on MRI. This difference between 
ultrasound and MRI was explained by the fact that on ultrasound the axial rendered volumes 
of a slice of 2 cm thickness were used, compared to one axial plane on MRI. In the present 
study ultrasound analysis was also performed in one axial plane at the level of minimum 
hiatal dimensions and not in the rendered volumes. This might explain opposite findings in 
the two studies.  
In a retrospective study, Kruger et al studied the difference between axial and coronal 
measurements on ultrasound and MRI.23 Levator hiatus biometry was measured on 
translabial 3D ultrasound and on MRI during Valsalva in 19 asymptomatic nulliparous 
women. The authors found that, owing to the warped nature of the hiatus during Valsalva, 
the measurements in the axial plane of minimal hiatal dimensions systematically 
overestimated the true coronal diameters of the hiatus as measured on MRI. They stated that 
using the rendered volumes on ultrasound would compensate for the fact that the true coronal 
minimal diameter was not located in the exact same plane as the minimal hiatal dimensions 
in the mid-sagittal or axial plane due to the warped plane of the hiatus.23  
Another possible explanation for the difference between the ultrasound and MRI findings, is 
that with translabial ultrasound the transducer is placed against the perineum, reducing the 
prolapse in patients with a stage 3 or 4 prolapse. Whether this would influence the 
measurement of the hiatus is not known. Because imaging was performed in lying position 
at rest, while POP-Q staging is performed during Valsalva, causing the hanging out of stage 
3 or 4, we think this phenomenon has only limited influence on the measurements of the 
hiatus. 
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A weakness of the present study is that we have only performed MRI at rest and not during 
Valsalva manoeuvre or contraction. It is unclear whether the differences between MRI and 
ultrasound would become even more apparent during Valsalva compared to rest.  
Strengths of the present study are the prospective multicentre design and the multiple 
observers to rule out ‘learning to see and define the same thing’ or ‘parroting in a close 
relationship between trainer and trainees’ in one centre.  
In some studies MRI is used as reference test to assess the diagnostic accuracy of translabial 
3D ultrasound. Because MRI is not a true gold standard, but the best available reference test, 
MRI may already be subject to unknown errors. That is why in the present study a comparison 
was made between translabial 3D ultrasound and MRI, instead of testing the diagnostic 
accuracy of translabial 3D ultrasound with MRI as a reference test.  
Ultrasound has several practical advances compared to MRI, such as shorter examination 
time, less exclusion criteria, relatively low cost, high patient compliance, easy accessability 
and it is easier to perform real-time assessment during dynamic manoeuvres such as Valsalva 
or pelvic ﬂoor muscle contraction. The good interobserver reliability and practical advances 
over MRI, make translabial 3D ultrasound the tool of choice for the measurement of the 
levator hiatal biometry in women with POP. 
Increased levator hiatal measurements have shown to be associated with POP and POP 
recurrence after surgery.7-14 Future research should focus on the clinical relevance of levator 
hiatus biometry and the consequence of finding an increased levator hiatus.  
In conclusion, the agreement between translabial 3D ultrasound and MRI for the 
measurement of the levator hiatus biometry in women with POP was only moderate. The 
results of translabial 3D ultrasound and MRI should therefore not be interchangeably used in 
daily practice or in clinical research. Interobserver reliability of MRI and translabial 3D 
ultrasound was good. 
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ABSTRACT 
 
Objective 
To develop a prediction model which estimates the risk of anatomical cystocele recurrence 
after surgery. 
 
Methods 
The databases of two multicenter prospective cohort studies were combined. Women 
undergoing an anterior colporrhaphy without mesh-materials and without previous pelvic 
organ prolapse (POP) surgery filled in a questionnaire, underwent translabial three-
dimensional (3D) ultrasound, and underwent staging of POP preoperatively and 
postoperatively. We developed a prediction model using multivariable logistic regression, 
and internally validated it using standard bootstrapping techniques. The performance of the 
prediction model was assessed by computing indices of overall performance, discriminative 
ability, and calibration, and its clinical utility by computing test characteristics. 
 
Results 
Of 287 included women, 149 (51.9%) had anatomical cystocele recurrence. Factors included 
in the prediction model were assisted delivery, preoperative cystocele stage, number of 
compartments involved, major levator ani muscle defects and levator hiatal area during 
Valsalva. Potential predictors that were excluded after backward elimination because of high 
p-values were age, body mass index, number of vaginal deliveries and family history of POP. 
The shrinkage factor resulting from the bootstrap procedure was 0.91. After correction for 
optimism, Nagelkerke’s R-squared and the Brier score were 0.15 and 0.22, respectively. This 
indicates satisfactory model fit. The area under the receiver operating characteristic curve 
(AUC) of the prediction model was 71.6% (95% confidence interval 65.7-77.5). After 
correction for optimism, the AUC was 69.7%. 
 
Conclusions 
This prediction model, including history of assisted delivery, preoperative stage, number of 
compartments, levator defects and levator hiatus, estimates the risk of anatomical cystocele 
recurrence. 
  
Anatomical cystocele recurrence: development and internal validation of a prediction model 
129 
 
INTRODUCTION 
 
Female pelvic organ prolapse (POP) is a common condition with a great negative impact on 
women’s social, physical and psychological well-being.1 The lifetime risk of surgery for POP 
in the general female population is 13-19%.2,3 POP surgery is known to have high reoperation 
rates, with anatomical recurrence rates after surgery described in literature from 31% up to 
59%.4,5 Cystocele is the most common affected compartment in POP and is the most prone 
for recurrence after surgery.6,7  
Little is known about the factors associated with surgical failure. Factors that play a role in 
the origin of POP may also be risk factors for POP recurrence after surgery. Frequently 
described risk factors for POP are aging, vaginal childbirth, obesity, family history of 
prolapse and collagen weakness.8,10 Levator ani muscle defects and increased levator ani 
hiatus also seem to be risk factors for POP.11-13 The levator hiatal area is defined as the area 
within the levator ani muscle, bordered by the levator ani muscle, the symphysis pubis and 
the inferior pubic ramus, through which the urethra, vagina and rectum pass. 14 For POP 
recurrence, preoperative stage seems to be an important risk factor.10,15 
Identifying patients at high risk of POP recurrence after surgery could be useful for 
individualized counselling. It may influence choice of treatment.   
The aim of this study was to develop a prediction model which estimates the risk of 
anatomical cystocele recurrence after native tissue repair, that can be used prior to surgery.  
 
 
MATERIALS AND METHODS 
 
The women included in this study had participated in one of two multicenter prospective 
cohort studies performed in nine teaching hospitals in the Netherlands. This was a secondary 
analysis of these data. In the first study, women were included between January 2006 and 
September 2008 for a randomized controlled trial comparing indwelling catheterization for 
2 with 5 days following surgery.16 The follow-up visits after two years, which included 
staging of POP and translabial 3D ultrasound, were performed between November 2009 and 
April 2010. The aim of that study was to determine whether levator defects were a risk factor 
for cystocele recurrence and to identify other risk factors associated with recurrence.15 In the 
second study, women were recruited from June 2010 until November 2012, with a follow-up 
of one year. The primary aim of this study was to assess the diagnostic accuracy of translabial 
3D ultrasound in the diagnosis of levator ani defects in women with POP, using magnetic 
resonance imaging as reference test.17,18 The protocols of both studies were approved by the 
medical ethics committees of each individual participating hospital. Data were recorded in a 
computer based registry by the authors and research nurses and all participants received a 
case number. 
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In both studies women had undergone an anterior colporrhaphy without the use of mesh-
materials and without previous POP surgery. Anterior colporrhaphy was performed alone or 
in combination with other POP procedures.  
All women filled in a validated questionnaire 19, with additional questions concerning 
possible risk factors. Staging of POP was performed preoperatively and postoperatively 
according to the Pelvic Organ Prolapse Quantification (POPQ) classification system.20 
Anatomical recurrence was defined as a cystocele POPQ stage 2 or more. 
The translabial 3D ultrasound was performed with a GE Voluson E8 system (GE Kretz 
Ultrasound, Zipf, Austria) with a 4.8 MHz curved abdominal transducer. Dimensions of the 
levator hiatus were determined in the axial plane at the level of minimum hiatal dimensions, 
identified as the minimum distance between the posterior margin of the symphysis pubis and 
the anterior margin of the puborectal muscle. In this plane, 4D volume cines were recorded 
during contraction and during Valsalva. The recorded data sets were analyzed offline using 
Voluson GE Kretz 4D-view V 5.1 software (GE Kretz Ultrasound, Zipf, Austria). The 
ultrasound volumes were interpreted independently offline by two experienced examiners 
who were blinded for the associated clinical data. In one study these two examiners were 
randomly selected from a pool of five.17,18 Tomographic ultrasound imaging was used to 
assess the levator ani muscle in multiple slices. In the three central slices (i.e., the plane of 
minimal dimensions plus slices 2.5 and 5 mm cranial to this plane), levator damage was 
graded according to the classification system developed by Dietz et al.21 A major levator 
defect was diagnosed if all three central slices showed an abnormal insertion of the 
puborectalis muscle on the inferior pubic ramus. Levator hiatal area during Valsalva was 
measured in square centimeter (cm2) as the area bordered by the levator ani muscle, the 
symphysis pubis and the inferior ramus pubis. 
Risk factors investigated to be included in the prediction model were age, body mass index 
(BMI), number of vaginal deliveries, having undergone an assisted delivery, preoperative 
cystocele stage 3 or 4, positive family history of POP, number of compartments involved, 
major levator ani muscle defects and levator hiatal area during Valsalva. In the first database 
the Baden-Walker classification was used for preoperative cystocele staging as the POPQ 
classification was not generally introduced in daily practice at the time of that study.22 
Positive family history of POP was defined as mother or sister with POP. Number of 
compartments involved was categorized as one, two or three, depending on the need for 
concomitant posterior colporrhaphy and/or surgery because of uterine or vaginal vault 
prolapse. Differences between the two databases in predictor variables were tested using the 
independent t-test for continuous variables and the Chi-squared statistic for categorical 
variables. 
Incomplete predictor variables were imputed using stochastic regression imputation, to avoid 
bias and loss of precision when only using complete cases.23 Predictive mean matching was 
used as the method to generate imputations. The maximum number of predictor variables 
included in the logistic regression model was set at 10-events-per-variable, which is a rule of 
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thumb, to prevent overfitting the model.24 As a sensitivity analysis, we compared results from 
the imputed dataset to the use of the complete cases only. 
We performed backward elimination using the Wald test to restrict the number of predictors, 
using a liberal alpha of 0.30 to prevent potentially important predictors from exclusion, 
according to prediction modeling guidelines.25 To assess potential non-linear association 
between levator hiatal area and the log odds of recurrence, we used visual inspection of 
restricted cubic spline transformation plots. 
The performance of the prediction model was assessed by computing indices of overall 
performance, discriminative ability and calibration. Nagelkerke’s R-squared and the Brier 
score were computed to quantify overall performance. Nagelkerke’s R-squared is a 
generalized form of the R-squared used in linear regression, and can be used to quantify the 
predictive strength of a model.25 The higher this R-squared measure is, the higher the 
predictive strength of the model. The Brier score is computed as the average squared distance 
between the observed value of the outcome and the prediction made by the prediction model. 
Conversely, the lower the Brier score is, the closer predictions are to the observed outcome, 
and this value should be close to 0. Discrimination refers to the models’ ability to discriminate 
between women who will and will not develop POP recurrence. It was quantified by 
computing the area under the receiver operating characteristic (ROC) curve (AUC).26 An 
AUC may range between 50% (in effect the flip of a coin) and 100% (perfect discrimination). 
Calibration measures compare the predicted probabilities to the actual probability of POP 
recurrence. To assess calibration of the prediction model, we visually inspected the 
calibration plot, and computed the calibration slope and intercept, and the Hosmer-
Lemeshow goodness-of-fit test. A low p-value in the latter statistics would indicate evidence 
of lack of fit.27 
Since translabial 3D ultrasound has not been widely incorporated in daily clinical practice, 
we determined its value in the prediction of POP recurrence. This was done by comparing 
the AUC’s of a prediction model with and one without ultrasonographic findings (i.e. major 
levator ani muscle defects and levator hiatal area during Valsalva) using the method of 
DeLong et al.28 
The initial prediction model was internally validated using standard bootstrapping 
techniques.25 The number of bootstraps was set to 1000. Results from the internal validation 
step were used to penalize the performance measures for optimism (i.e. the expected 
difference in performance between our cohort and future data) and shrink the regression 
coefficients towards 0 to prevent too extreme predictions for future patients.  
In addition, we computed sensitivity, specificity, positive and negative predictive values, and 
positive and negative likelihood ratios for a number of predicted risk thresholds. The latter 
can be used to calculate the probability of recurrence within groups if the prediction model 
result is dichotomized into positive/negative for clinical decision making. The probability of 
recurrence within a group can then be computed as posttest odds / (1 + posttest odds), where 
posttest odds = pretest odds * likelihood ratio, and the pretest odds = prevalence / (1 – 
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prevalence). If the prediction model result is not dichotomized, it can be interpreted as the 
posttest probability of recurrence for the individual it was computed for. 
We used the statistical software package SPSS version 22.0 (SPSS Inc., Chicago, IL) and R 
version 3.1.1, a language and environment for statistical computing for the statistical 
analyses.  
 
 
RESULTS 
 
The patient characteristics of the complete database (n=287) and the two separate databases 
(n=148 15,16 and n=139 17,18 respectively) are presented in table 9.1. The two databases 
differed in the duration of the follow-up (two years and one year respectively), in the amount 
of major levator defects (25.7% and 49.6% respectively) and in the performed concomitant 
surgeries (posterior colporrhaphy and repair of uterine or vaginal vault prolapse). Of all 
women, 149 (51.9%) had anatomical cystocele recurrence.  
Some potential predictor variables were incomplete. BMI had the most values missing, a total 
of 29 (10.1%). Family history of POP had 17 missing values (5.9%). Data on the number of 
vaginal deliveries and having undergone an assisted delivery was missing in 11 cases (3.8%). 
Of the ultrasonographic findings, there were 8 missing values for levator defects (2.8%) and 
14 missing values for levator hiatal area during Valsalva (4.9%). There were no missing 
values for age, preoperative cystocele stage and number of compartments involved. After 
imputation, data were complete for all women.  
We started with a full model that included all potential predictors. Table 9.2 shows the initial 
prediction model after backward elimination of potential predictors with high p-values. The 
prediction model consists of all regression coefficients, including the constant, and the odds 
ratios of the included predictor variables. The sensitivity analysis with respect to the 
imputation strategy we chose revealed no differences in the signs of regression coefficients, 
nor their relative contribution to the model. 
The shrinkage factor resulting from the bootstrap procedure was 0.91, which indicates only 
slight overfitting of the model (i.e. the regression coefficients we found in our cohort are 
likely reproducible and not based on spurious associations). This factor was subsequently 
used to penalize the regression coefficients from the initial model by multiplying all the 
coefficients by 0.91. This internally validated version of the prediction model is also shown 
in table 9.2. After penalization, future predictions will be less extreme, and fit future patients 
better compared to a model that was not internally validated. 
An individual’s risk of anatomical cystocele recurrence can be computed as follows:  
P(recurrence) = 1/(1+exp(-(Linear predictor)))  
Anatomical cystocele recurrence: development and internal validation of a prediction model 
133 
 
in which Linear predictor = -2.35 - 0.57*Assisted delivery (yes=1) + 0.82*Preoperative stage 
3 or 4 (yes=1) - 0.25*Number of compartments (1, 2 or 3) + 0.28*Major levator defect 
(yes=1) + 0.07*Levator hiatal area (in cm2). 
After correction for optimism, Nagelkerke’s R-squared and the Brier score were 0.15 and 
0.22, respectively. This indicates satisfactory model fit. The AUC of the prediction model 
was 71.6% (95% confidence interval (CI) 65.7-77.5), which means that the model 
discriminates sufficiently between those women who will develop POP recurrence, and those 
who will not. After correction for optimism, the AUC was 69.7%. This estimate represents 
the estimated discriminative ability of the model in future patients. The ROC curve of which 
the AUC was computed is shown in figure 9.1. 
Exclusion of the ultrasonographic findings (i.e. major levator ani muscle defects and levator 
hiatal area during Valsalva) from the prediction model presented an AUC of 63.2%, which 
was a statistically significantly poorer prediction than that of the initial model (p = 0.003). 
Figure 9.2 shows the calibration plot. Visual inspection of the plot shows that all risk-based 
deciles are very close to the 45-degree line representing perfect calibration. In addition, the 
calibration plot shows a wide range of predicted probabilities. This indicates excellent 
calibration, confirmed by a non-significant Hosmer–Lemeshow statistic (p = 0.98). 
Table 9.3 shows sensitivity, specificity, and positive and negative predictive values for a 
number of different possible risk thresholds that could be used in clinical practice. The higher 
the threshold used, the lower the sensitivity and negative predictive value and the higher the 
specificity and positive predictive value of the prediction model. The choice of the risk 
threshold is dependent on the goal of using the prediction model.  
 
 
DISCUSSION 
 
This prediction model estimates the risk of anatomical cystocele recurrence after anterior 
colporrhaphy. Factors included in the model are assisted delivery, preoperative stage, number 
of compartments, major levator defects and levator hiatal area during Valsalva. The AUC 
was 69.7%, after correction for optimism, which reflects a reliable estimation of the risk of 
recurrence. The model can be used in preoperative counseling and potentially when making 
treatment choices. 
The known risk factors for primary POP such as age, BMI, parity and family history, did not 
have additional value to predict anatomical cystocele recurrence. This is in line with previous 
findings.15 The differences between risk factors for primary POP and POP recurrence may 
be explained by the differences in population. In studies concerning risk factors for primary 
POP, women with POP and without POP are compared. In studies concerning recurrence, all 
women had primary POP (with higher prevalence of associated risk factors), and represent a 
selected group of women. 
  
 
Table 9.1 Patient characteristics 
 
Patient characteristics Total (n=287) Database Weemhoff 
(n=148) 15.16 
Database Notten  
(n=139) 17,18 
P-value 
Age in years, mean (range) (n) 58.0 (31-87) (n=287) 58.6 (39-87) (n=148) 57.4 (31-78) (n=139) 0.313 
BMI in kg/m2, mean (range) (n) 26.0 (17.5-41.9) (n=258) 26.3 (18.4-36.7) (n=142) 25.7 (17.5-41.9) (n=116) 0.435 
Vaginal delivery, mean (range) (n) 2.3 (0-9) (n=276) 2.3 (0-9) (n=148) 2.3 (1-7) (n=128) 0.645 
Vaginally assisted delivery, n/n (%) 32/276 (11.6%) 19/148 (12.8%) 13/128 (10.2%) 0.348 
Preoperative POPQ stage 3 or 4, n/n (%) 133/287 (46.3%) 71/148 (48.0%) 62/139 (44.6%) 0.567 
Mother or sister with POP n/n (%) 116/270 (43.0%) a 60/148 (40.5%) 56/122 (45.9%) b 0.376 
Number of compartments involved 
- Anterior colporrhaphy alone, n/n (%) 
- Surgery on 2 compartments, n/n (%) 
- Surgery on 3 compartments, n/n (%) 
 
71/287 (24.7%) 
128/287 (44.6%) 
88/287 (30.7%) 
 
29/148 (19.6%) 
65/148 (43.9%) 
54/148 (36.5%) 
 
42/139 (30.2%) 
63/139 (45.3%) 
34/139 (24.5%) 
0.035 
Posterior colporrhaphy, n/n (%) 128/287 (44.6%) 71/148 (48.0%) 57/139 (41.0%) 0.235 
Repair of uterus or vaginal vault, n/n (%) 
- Vaginal hysterectomy, n/n (%) 
- Sacrospinous fixation, n/n (%) 
- Manchester Fothergill, n/n (%) 
175/287 (61.0%) 
102/287 (35.5%) 
46/287 (16.0%) 
27/287 (9.4%) 
102/148 (68.9%) 
81/148 (54.7%) 
20/148 (13.5%) 
1/148 (0.7%) 
73/139 (52.5%) 
21/139 (15.1%) 
26/139 (18.7%) 
26/139 (18.7%) 
0.004 
Major levator defect, n/n (%) 104/279 (37.3%) 37/144 (25.7%) 67/135 (49.6%) <0.001 
Hiatal area in cm2, mean (range) (n) 33.3 (16.8-67.4) (n=273) 32.5 (18.4-56.4) (n=139) 34.0 (16.8-67.4) (n=134) 0.144 
Anatomical recurrence, n/n (%) 149/287 (51.9%) 73/148 (49.3%) 76/139 (54.7%) 0.364 
Subjective recurrence, n/n (%) 28/283 (9.9%) 16/148 (10.8%) 12/135 (8.9%) 0.589 
BMI = body mass index, POPQ = pelvic organ prolapse quantification system, POP = pelvic organ prolapse, a 27/270 (10.0%) unknown, b 27/122 (22.1%) unknown
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Table 9.2 Prediction model for POP recurrence 
 
Variable Initial model Internally validated model* 
 
 
Regression 
Coefficient 
 
OR (95% CI) 
Regression 
Coefficient 
 
OR (95% CI) 
Intercept -2.49 - -2.35 - 
Vaginally assisted 
delivery 
-0.63 0.53 (0.24-1.18) -0.57 0.57 (0.27-1.22) 
Preoperative POPQ stage 
3 or 4 
0.92 2.50 (1.51-4.14) 0.82 2.30 (1.45-3.92) 
Number of compartments 
(1-3) 
-0.27 0.76 (0.54-1.07) -0.25 0.78 (0.57-1.08) 
Major levator defect 0.31 1.37 (0.80-2.34) 0.28 1.32 (0.82-2.17) 
Hiatal area during 
Valsalva 
0.08 1.08 (1.04-1.12) 0.07 1.08 (1.04-1.10) 
OR = odds ratio, CI = confidence interval, POPQ = pelvic organ quantification system 
* Adjustment for overfitting by shrinkage (shrinkage factor = 0.91). The intercept was subsequently re-estimated. 
 
 
Figure 9.1 Receiver operating characteristic (ROC) curve for prediction of cystocele 
recurrence 
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Figure 9.2 Calibration plot of the prediction model 
 
 
 
 
In clinical practice, the prediction model can be used to identify patients with a low or high 
risk of anatomical recurrence, by choosing an individual risk threshold with the preferred test 
characteristics. The equation described in the results section should be used to calculate the 
risk of recurrence. For instance, in case the model is used to rule out POP recurrence, a risk 
threshold of 25% might be useful. Using this threshold, of all test-negative patients, 78.3% 
will not develop anatomical cystocele recurrence. Of all individuals that are test-positive, 
approximately 54.5% will develop anatomical cystocele recurrence. This example could be 
useful to a woman who is satisfied with pessary use, but would consider surgery in case of 
low risk of recurrence. In case the model is used in a woman who is considering multiple 
surgical options because her current POP symptoms have a major impact on her quality of 
life, a risk threshold of 75% can be useful. Using this threshold, of all test-negative patients 
approximately 51.8% will have anatomical cystocele recurrence. Of all test-positive patients 
approximately 89.4% will develop anatomical cystocele recurrence.  
  
 
 
Table 9.3 Test characteristics per threshold of recurrence rate 
 
Threshold  
(%)* 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
PPV  
(95% CI) 
NPV  
(95% CI) 
LR+ 
(95% CI) 
LR- 
(95% CI) 
15 100 (97.5-100) 2.9 (0.8-7.3) 52.7 (51.7-53.6) 100 (39.6-100) 1.03 (1.00-1.06) 0 (0.00-2.16) 
20 98.0 (94.2-99.6) 7.2 (3.5-12.9) 53.3 (52.0-54.6) 76.9 (48.4-92.2) 1.06 (1.00-1.11) 0.28 (0.08-0.99) 
25 96.6 (92.3-98.9) 13.0 (7.9-19.8) 54.5 (52.8-56.3) 78.3 (57.9-90.4) 1.11 (1.04-1.19) 0.26 (0.10-0.67) 
30 94.0 (88.8-97.2) 21.0 (14.5-28.8) 56.2 (53.9-58.6) 76.3 (61.3-86.8) 1.19 (1.08-1.31) 0.29 (0.14-0.59) 
35 90.6 (84.7-94.8) 34.8 (26.9-43.3) 60.0 (56.8-63.1) 77.4 (66.5-85.6) 1.39 (1.22-1.59) 0.27 (0.16-0.47) 
40 85.2 (78.5-90.5) 43.5 (35.1-52.2) 62.0 (58.1-65.7) 73.2 (63.9-80.7) 1.51 (1.28-1.77) 0.34 (0.22-0.52) 
45 74.5 (66.7-81.3) 53.6 (44.9-62.1) 63.4 (58.6-68.0) 66.1 (58.7-72.7) 1.61 (1.31-1.97) 0.48 (0.35-0.65) 
50 67.1 (59.0-74.6) 64.5 (55.9-72.4) 67.1 (61.3-72.4) 64.5 (58.3-70.2) 1.89 (1.47-2.43) 0.51 (0.39-0.66) 
55 63.1 (54.8-70.8) 71.0 (62.7-78.4) 70.1 (63.8-75.8) 64.1 (58.5-69.3) 2.18 (1.63-2.90) 0.52 (0.41-0.66) 
60 50.3 (42.0-58.6) 79.0 (71.2-85.4) 72.1 (64.3-78.8) 59.6 (55.1-63.9) 2.40 (1.67-3.44) 0.63 (0.52-0.76) 
65 40.3 (32.3-48.6) 84.8 (77.7-90.3) 74.1 (64.8-81.6) 56.8 (53.1-60.4) 2.65 (1.70-4.11) 0.70 (0.61-0.82) 
70 28.2 (21.1-36.1) 92.8 (87.1-96.5) 80.8 (68.7-88.9) 54.5 (51.7-57.2) 3.89 (2.03-7.45) 0.77 (0.69-0.87) 
75 18.1 (12.3-25.3) 94.9 (89.8-97.9) 79.4 (63.4-90.0) 51.8 (49.7-53.9) 3.57 (1.61-7.94) 0.86 (0.79-0.94) 
80 10.1 (5.7-16.1) 96.4 (91.7-98.8) 75.0 (52.8-88.9) 49.8 (48.2-51.4) 2.78 (1.04-7.44) 0.93 (0.88-0.99) 
85 5.4 (2.3-10.3) 100 (97.4-100) 100 (60.0-100) 49.5 (48.3-50.6) inf (0.86-inf) 0.95 (0.91-0.98) 
CI = confidence interval, PPV = positive predictive value, NPV = negative predictive value, LR+ = likelihood ratio of a positive test result, LR- = likelihood ratio of 
a negative test result, inf = infinite 
*Subjects were considered test-positive if their predicted risk was at or above this level 
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The choice of the risk threshold is dependent on the individual goal of using the prediction 
model (e.g. ruling in or ruling out POP recurrence), and the consequences of false negative 
and false positive findings. 
In addition to three factors that are collected in routine clinical practice (assisted delivery, 
preoperative cystocele stage, number of compartments involved), the prediction model 
contains two ultrasonographic findings (i.e. major levator ani muscle defects and levator 
hiatal area during Valsalva). Translabial 3D ultrasound has not been widely incorporated in 
daily clinical practice yet. Consistent with previous studies, our data show that there is 
additional value of translabial 3D ultrasound in predicting anatomical POP recurrence.  
As seen in the patient characteristics in table 8.1, the prevalence of major levator ani defects 
differed between the two databases, even though both studies used the same methodology of 
ultrasound and interpretation of the ultrasound images. We have no sufficient explanation for 
this. The only difference between the two studies was the timing of translabial 3D ultrasound, 
which was postoperatively in the first study 15,16 versus preoperatively in the second study.17,18 
On theoretical grounds, there is no reason to suspect that the morphology of the levator ani 
muscle is influenced by an anterior colporrhaphy.  
The two separate databases also differed in the duration of the follow-up and in the performed 
concomitant surgeries. Because anatomical cystocele recurrence rates in the two databases 
were comparable this will not have influenced the results of the prediction model. 
Weaknesses of the present study are the missing values and the definition of POP recurrence. 
POP recurrence was defined as anatomical cystocele recurrence after surgery, but not as 
recurrence of symptoms which would have been a more patient-centered outcome.29 Many 
women who may be categorized as ‘anatomic failures’ are satisfied with their postsurgical 
results.30 In our study population, only 28 women had subjective recurrence. This number 
was too small to analyze. Follow-up after surgery was one and two years. Because anatomical 
recurrence rates were in accordance to or even higher than in other research with equal or 
longer follow-up, we do not think that prolongation of the follow-up period would influence 
the results of this study.4,5,7 
Strengths of this study are the population size, the prospective multicenter design of both 
studies combined in the present database, the multiple observers of the ultrasonographic 
findings and the robust validation of the model. Despite our internal validation efforts, 
external validation is needed. 
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GENERAL DISCUSSION 
 
The aim of this thesis was to give an insight in the risk factors for pelvic organ prolapse 
(POP) recurrence after native tissue repair and to explore the role of findings on translabial 
three-dimensional (3D) ultrasound in predicting POP recurrence. In this chapter, the six 
research questions, as described in the introduction, are answered and the clinical 
implications are discussed. 
 
 
MAIN FINDINGS 
 
Risk factors for pelvic organ prolapse and pelvic organ prolapse recurrence 
This thesis offers an insight in the risk factors for POP recurrence after native tissue repair. 
The systematic review in chapter 2 showed that advanced preoperative stage is the only risk 
factor that has been confirmed to be associated with POP recurrence in at least two cohort or 
cross-sectional studies with multivariate analysis (i.e. that adjusted for confounders) in a 
western developed country. For primary POP, parity, vaginal delivery, age and body mass 
index (BMI) were significantly associated with development of POP in at least two articles. 
The differences between risk factors for primary POP and POP recurrence might be explained 
by the differences in population. In studies concerning POP recurrence, only women with a 
primary POP are included, so this is a selected group of women. 
The authors of the letter to the editor in chapter 3 which is a comment on this systematic 
review claimed that the conclusion of the systematic review is erroneous due to arbitrary 
inclusion criteria and by ignoring some studies all together. They have stated that there are 
multiple publications in the literature that have shown levator defects and an abnormal levator 
ani hiatus to be risk factors for both primary POP and POP recurrence. However, this 
statement is not supported by the articles with the strongest available evidence on this subject. 
Because of the enormous amount of articles published on risk factors for POP and POP 
recurrence, we were able to apply strict inclusion criteria in our systematic review, to select 
only the strongest available evidence to prevent bias. Because of this strategy, risk factors 
with a low prevalence that can only be examined in case–control studies, such as genetic 
mutations, have been missed in our systematic review. Nonetheless, pelvic floor factors such 
as levator ani muscle defects and the size of the levator ani hiatus, are not rare and can easily 
be investigated in cohort studies or cross-sectional studies. The studies the authors of the 
comment are referring to, did not fit the inclusion criteria, mainly because adjustment for 
confounders was lacking.  
In the prospective observational cohort study in chapter 5 complete levator ani muscle 
defects, advanced preoperative stage, family history of POP and sacrospinous fixation were 
significantly associated risk factors for anatomical cystocele recurrence after anterior 
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colporrhaphy. In chapter 7, increased levator hiatal area during Valsalva on ultrasound as 
measured prior to surgery and advanced preoperative stage were independent risk factors for 
anatomical cystocele recurrence after anterior colporrhaphy. The population in these two 
cohort studies were similar, i.e. women undergoing anterior colporrhaphy without the use of 
mesh. In both studies advanced preoperative stage was a risk factor for cystocele recurrence, 
which is in line with the results of the systematic review in chapter 2. Family history of POP 
and sacrospinous fixation were significant risk factors for cystocele recurrence in one of the 
cohort studies, while in the other cohort study these factors were not examined. The 
association between family history of POP and POP recurrence has not been found by others.1 
In the study of Diez-Itza et al. not only women with cystocele were included but also women 
with rectocele of uterine descent. Only 31.3% had anatomical recurrence after a follow-up of 
five years, which differed from our study in which 51.3% had anatomical recurrence after a 
follow-up of two years. In the study of Diez-Itza et al. only 27.6% of women reported positive 
family history of POP, while in our study 40.4% reported positive family history of POP. 
The relationship between sacrospinous fixation and cystocele recurrence has previously been 
investigated in one study.2 In a retrospective cohort study of Smilen et al. women undergoing 
anterior colporrhaphy with and without sacrospinous fixation were compared. Cystocele 
recurrence rate was 11.7% in women undergoing anterior colporrhaphy with concomitant 
sacrospinous fixation versus 9.4% in women undergoing anterior colporrhaphy without 
concomitant sacrospinous fixation, which was not significantly different. Noteworthy, in our 
study a sacrospinous fixation was performed in only 22 women (14.1%). Due to the small 
number of procedures, the odds ratio had a wide 95% confidence interval (2.1-22.2), which 
makes this finding less accurate. We hypothesize that sacrospinous fixation creates an 
exaggerated posterior vaginal axis resulting in abnormal intra‐abdominal pressure on the 
anterior vaginal wall, resulting in an increased risk for cystocele recurrence. Nonetheless, 
further research is indicated.  
The prediction model that was developed and internally validated in chapter 9, includes three 
factors that were collected in routine clinical practice (assisted delivery, preoperative 
cystocele stage, number of compartments involved) and two ultrasonographic findings 
(major levator ani muscle defects and levator hiatal area during Valsalva). Both assisted 
delivery and number of compartments involved were not risk factors for POP recurrence in 
the systematic review in chapter 2 and the prospective cohort study in chapter 5, in which a 
significant association was defined as a p-value <0.05. In the prediction model, according to 
prediction modeling guidelines, a p-value of <0.30 was used to prevent potentially important 
predictors from exclusion. This explains why assisted delivery and number of compartments 
involved were not significant risk factors for POP recurrence, but were nevertheless included 
in the prediction model. 
Another prediction model concerning POP was published previously, created by Slieker-ten 
Hove et al.3 This prediction model differs greatly from our prediction model, because of 
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another goal and a different population. In that cross-sectional study in a general population 
of women between 45 and 85 years of age the prevalence of clinically relevant POP was 
estimated and a prediction model was developed and internally validated for the risk of 
having clinically relevant POP. Factors included in the prediction model of Slieker-ten Hove 
et al. were seeing or feeling a bulge, age, parity, smoking, previous anti-incontinence surgery, 
current heavy work, the presence of POP symptoms during pregnancy and a mother with 
POP. The differences between the prediction model of Slieker-ten Hove et al. and the 
prediction model in this thesis can be explained by the difference in population when 
investigating prediction of primary POP compared to prediction of POP recurrence. For the 
development of the prediction model of Slieker-ten Hove et al., women in a general 
population who were not seeking medical care were examined, while in the prediction model 
in this thesis, all women were undergoing surgery because of a cystocele Pelvic Organ 
Prolapse Quantification system (POPQ) stage 2 of higher. 
 
The role of findings on translabial three-dimensional ultrasound in predicting POP 
recurrence 
The systematic review in chapter 4 demonstrated that findings on translabial 3D ultrasound, 
i.e. detecting levator ani muscle defects and measuring levator hiatal biometry showed 
moderate to good agreement when compared to findings on magnetic resonance imaging 
(MRI), and the reproducibility was good. In multiple studies in the systematic review in 
chapter 4 levator ani muscle defects and the levator hiatal area were associated with POP and 
POP recurrence after surgery. Most of these studies originated from the same research group. 
In the prospective observational cohort studies in chapter 5, 7 and 9 of this thesis, these 
findings were confirmed, except for the non-significant association between major levator 
defects and anatomical cystocele recurrence in chapter 7, which is in contrast with previous 
findings. Increased levator hiatal area was only a significant risk factor for anatomical 
cystocele recurrence in case it was measured during Valsalva and not when it was measured 
at rest or during contraction. Although levator defects and levator hiatal area were not suitable 
as sole factors to predict anatomical cystocele recurrence after surgery, they had a substantial 
additional value in the prediction model presented in chapter 9 (area under the receiver 
operating characteristic curve (AUC) of 71.6% when ultrasonographic findings were 
included compared to an AUC of 63.2% when ultrasonographic findings were not included, 
p = 0.003). 
In the systematic review in chapter 4, translabial 3D ultrasound in a single center setting 
seemed to be reproducible. Noteworthy, concerning the reproducibility of detecting levator 
ani defects six out of eight studies, and concerning the reproducibility of measuring the 
levator hiatal area six out of ten studies, were published by the same research group in which 
reproducibility was tested between two observers (trainer and trainee) in 20 women or less. 
In the prospective multicenter cohort study in chapter 8 of this thesis, the interobserver 
reliability for measuring levator hiatus biometry on ultrasound and on MRI by two 
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independent observers was good, confirming the findings of the systematic review in chapter 
4. Nonetheless, the agreement between ultrasound and MRI for the measurements of levator 
hiatus biometry was moderate. This is in contrast with previous findings.4 This dissimilarity 
might be due to a difference in study population, i.e. a study with 18 female volunteers and 
one single investigator, compared to 139 women with POP and multiple investigators in the 
study in this thesis. 
In chapter 6 of this thesis, two classification systems of levator defects were compared using 
translabial 3D ultrasound. Overall comparison of the two scoring systems showed very good 
agreement. The agreement between the scores in describing the extent of levator damage, by 
identifying cases with major levator defects (cases proven to be of clinical relevance) showed 
good agreement. When diagnosing levator defects on translabial 3D ultrasound in further 
research or in daily clinical practice, it seems logical to use the classification system 
developed by Dietz et al. 5, because it was created for diagnosing levator defects on translabial 
3D ultrasound, while the classification system developed by DeLancey et al. was created to 
diagnose levator defects on MRI.6,7 In studies comparing ultrasound with MRI, one 
classification system can be chosen to classify both modalities. 
Translabial 3D ultrasound has not been widely incorporated in daily clinical practice. 
Nonetheless, it is a tool that has a short examination time, relatively low costs, easy 
accessibility and it can offer real-time imaging in different positions, with good interobserver 
reliability, which can be learned in a short period of time.4,8,9 As shown in this thesis, levator 
defects and levator hiatal area measured on translabial 3D ultrasound have a substantial 
additional value in predicting anatomical cystocele recurrence after surgery.  
 
 
CLINICAL IMPLICATIONS 
 
Preoperative counseling 
Anatomical cystocele recurrence after native tissue repair is common: in this thesis 
anatomical cystocele recurrence was present in 51.3% of women in the population described 
in chapter 5 and in 54.7% of women in the population described in chapter 7. Because of the 
high recurrence rates, preoperative counseling is very important, to meet patients’ 
expectations and to individualize treatment.10 Treatment options include expectant 
management, pessary treatment and surgery.11 Because POP is a non-emergent non-lethal 
condition with a great negative impact on women’s social, physical and psychological well-
being 12, health care should be adjusted to patients’ preferences, needs and values, i.e. patient-
centered care. In current obstetrics and gynecology shared decision making seems to become 
more common practice.13,14 Shared decision making is a process in which patients are 
involved as active partners with the clinician, in sharing all relevant risk and benefit 
information on all treatment alternatives and in choosing a preferred course of clinical care.15 
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The prediction model presented in chapter 9 can be used as an aid in counseling patients with 
POP. Women who are in doubt on continuation of pessary use or POP surgery, may choose 
to continue pessary use if they have a high risk of cystocele recurrence according to the 
prediction model, while women having a low risk of recurrence will opt for surgery. The 
prediction model provides evidence based information to assist the decision making process. 
 
Preventing pelvic organ prolapse recurrence 
Little is known about prevention of POP or POP recurrence. In the systematic review in 
chapter 2 parity, vaginal delivery, age and BMI were found to be risk factor for primary POP. 
Of these factors, BMI is the only modifiable risk factor. Theoretically, parity and vaginal 
delivery are also modifiable, but in obstetric care future POP seldom plays a role in 
considerations. A planned caesarean section for the prevention of POP is considered 
controversial.16 Pelvic floor muscle training has been investigated as an intervention to 
prevent POP, but the effect was disappointing.17,18 Estrogen therapy has also been proposed 
as an intervention to prevent POP, but current evidence is limited.19 
There are many studies that compare different interventions with regard to the risk of POP 
recurrence after surgery. In a large multicenter randomized controlled trial, perioperative 
pelvic floor muscle training did not decrease the risk of POP recurrence two years after 
surgery.20 A systematic review to determine the effects of different surgical techniques to 
manage POP concluded that the current data from randomized trials were insufficient to 
guide practice.21 The high recurrence rates after POP surgery have encouraged surgeons to 
use mesh-materials instead of native tissue to repair POP. Several randomized controlled 
trials have shown that the use of mesh resulted in a statistically significant better anatomical 
outcome compared with anterior colporrhaphy, however, except for studies on polypropylene 
mesh, subjective outcome and quality of life was similar between groups.21-23 Because of 
severe complications such as erosions and exposure, the use of mesh in primary POP surgery 
has become controversial.24 
This thesis has shown that advanced preoperative stage is an important risk factor for 
anatomical cystocele recurrence after surgery. This raises the question whether it would be 
favorable to perform POP surgery in an earlier stage, i.e. POPQ stage 2, rather than to wait 
until the POP is advanced to POPQ stage 3 or 4. It might be possible that women who develop 
a cystocele POPQ stage 3 or 4 are a subpopulation of women with POP with different baseline 
characteristics who already have a higher risk of POP recurrence compared to women with a 
cystocele POPQ stage 2. Our thesis has no answer to this question. Further research might be 
useful. 
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STRENGTHS AND LIMITATIONS 
 
Strengths 
Strengths of this thesis were the two prospective multicenter cohort studies with a large study 
population and multiple observers of the ultrasonographic findings, and the two systematic 
reviews. In both systematic reviews, the search was thorough and systematic, and two 
reviewers independently did the study selection and data extraction to minimize errors. 
 
Limitations 
Before implementing the results of this thesis in daily clinical practice, some limitations in 
generalizability should be addressed.  
The population of the prospective multicenter cohort studies in chapters 5 to 9, was 
predominantly Caucasian. Therefore the findings may not be generalizable to other 
ethnicities.25,26 Only women with a cystocele undergoing anterior colporrhaphy were 
included, and thus the findings are not generalizable to women with a rectocele or uterine or 
vaginal vault prolapse without a cystocele, or to women undergoing another intervention for 
cystocele than anterior colporrhaphy. The findings are however applicable to women who 
had concomitant surgery in addition to anterior colporrhaphy. In the prospective multicenter 
cohort studies in this thesis, a heterogeneous mix of concomitant procedures was performed 
in addition to anterior colporrhaphy, reflecting daily clinical practice. 
POP recurrence was defined as anatomical recurrence after surgery. This does not equate to 
recurrence or persistence of symptoms which would have been a more patient-centered 
outcome.27 Many women who were categorized as having cystocele recurrence were satisfied 
with their postsurgical results.28 Subjective outcomes were available in our studies but the 
sample sizes were too small to analyse. Although patient-reported outcomes of symptom 
relief is the most important and fundamental goal of surgery 29, uniformly accepted criteria 
for the definition of a successful POP operation are still lacking.30 
The follow-up after surgery was two years in chapters 5 and 6 and one year in chapters 7 and 
8. Anatomical recurrence rate were 51.3% and 54.7% respectively, which is in accordance to 
other research with follow-up between one and five years.1,22,31 Whether these recurrence 
rates remain constant with longer follow-up is not known. 
Due to the designs of the studies, i.e. observational cohort studies and a systematic review in 
which only cohort studies and cross-sectional studies are included, potential risk factors with 
a low prevalence that can only be examined in case-control studies, such as polymorphisms 
in the collagen and matrix metalloproteinase genes, have been missed. 
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GENERAL CONCLUSION 
 
• Advanced preoperative stage is the only risk factor that was associated with POP 
recurrence in at least two cohort or cross-sectional studies with multivariate analysis 
in a western developed country.  
• In the systematic review on the use of translabial 3D ultrasound for the diagnosis of 
levator defects and measuring levator ani biometry, detecting levator ani defects and 
measuring hiatal biometry on translabial 3D ultrasound showed moderate to good 
agreement when compared to findings on MRI, and the reproducibility was good.  
• In the prospective multicenter cohort studies in this thesis findings on translabial 3D 
ultrasound, i.e. levator ani muscle defects and the levator hiatal area, were associated 
with cystocele recurrence after native tissue repair. 
• The interobserver reliability for measuring levator hiatus biometry on ultrasound 
and on MRI by two independent observers was good, while the agreement between 
ultrasound and MRI for the measurements of levator hiatus biometry at rest was 
moderate. 
• Two classification systems of levator defects showed good agreement on translabial 
3D ultrasound. 
• A prediction model was developed and internally validated, including three factors 
that were collected in routine clinical practice (assisted delivery, preoperative 
cystocele stage, number of compartments involved) and two ultrasonographic 
findings (major levator ani muscle defects and levator hiatal area during Valsalva). 
The model provides a reliable estimation of the risk of anatomical cystocele 
recurrence after native tissue repair and can be used in preoperative counseling and 
when making treatment choices. 
 
 
FUTURE RESEARCH 
 
The developed and internally validated prediction model in chapter 9 needs to be externally 
validated. In case the external validation is satisfactory, implementation of the prediction 
model in clinical practice should be considered and evaluated. In order to successfully 
implement the prediction model, translabial 3D ultrasound would need to be incorporated in 
daily clinical practice. Barriers and facilitators of this process could be studied. 
The prediction model has been developed for the prediction of anatomical cystocele 
recurrence. It may be more patient-centered to develop a prediction model for the prediction 
of subjective cystocele recurrence. A prediction model for other compartments, e.g. rectocele 
or uterine descent, may also be valuable. For these research questions a larger population is 
needed.  
General discussion 
149 
 
Besides that, since this thesis has shown that advanced preoperative stage is an important risk 
factor for anatomical cystocele recurrence after surgery, it might be useful to investigate 
whether it would be favorable to perform POP surgery in an earlier stage, i.e. POPQ stage 2, 
rather than to wait until the POP is advanced to POPQ stage 3 or 4.  
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SUMMARY 
 
Female pelvic organ prolapse (POP) is a common condition and its etiology is multifactorial. 
The identification of risk factors for POP development and its recurrence are important to 
allow preoperative counseling and individualized treatment. 
 
Chapter 2 provides an overview of literature on risk factors for POP and POP recurrence 
after native tissue repair. A thorough and systematic search was performed until the 4th of 
August 2014. Cohort or cross-sectional studies situated in western developed countries 
containing multivariate analyses and with a definition of POP based on anatomical references 
were included. POP recurrence had to be defined as anatomical recurrence after native tissue 
repair without mesh, with follow-up after surgery of at least one year. For primary POP, ten 
studies with a total of 41,501 women were included, in which 30 risk factors were 
investigated. Parity, vaginal delivery, age and body mass index (BMI) were the most 
important risk factors. For POP recurrence, five studies including a total of 954 women and 
investigating 29 risk factors were selected. Only preoperative stage was a confirmed risk 
factor.  
 
Chapter 3 contains a letter to the editor concerning the article in chapter 2, and a response 
to this comment. The authors of the comment claim that the conclusion of the systematic 
review is erroneous due to arbitrary inclusion criteria and by ignoring some studies all 
together. It is stated that there are multiple publications in the literature that have shown 
levator defects and an abnormal levator ani hiatus to be risk factors for both primary POP 
and POP recurrence. However, this statement is not supported by the articles with the 
strongest available evidence on this subject, which is debated in the response to the comment 
in the letter to the editor. 
 
There have been a number of studies investigating levator ani muscle defects and the size of 
the levator ani hiatus as risk factors for the development of POP and POP recurrence. 
Chapter 4 offers a systematic review of studies on the use of translabial three-dimensional 
(3D) ultrasound for the diagnosis of levator defects and measuring the levator ani biometry. 
Detecting levator ani defects and measuring hiatal biometry on translabial 3D ultrasound 
showed moderate to good agreement when compared to findings on magnetic resonance 
imaging (MRI), and the reproducibility was good. Noteworthy, concerning the 
reproducibility six of the eight included studies on detecting levator ani muscle defects and 
six of the ten included studies on measuring hiatal biometry were derived from the same 
research group in which reproducibility was tested between two observers. Studies on 
external validation and reproducibility between multiple observers in a multicenter setting 
are scarce. Levator ani defects and a larger hiatal area were, in a selected population of 
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patients with pelvic floor dysfunction, associated with POP and POP recurrence after surgery. 
Many articles were published by the same research group.  
 
Chapter 5 contains a prospective observational cohort study with 245 women who 
underwent an anterior colporrhaphy. The aim of the study was to determine the relationship 
between cystocele recurrence after anterior colporrhaphy and levator defects and other risk 
factors. Two years after surgery, women were invited for a follow‐up visit consisting of a 
questionnaire, physical examination and translabial 3D ultrasound. Of 245 women, 156 came 
to the follow‐up visit (63.7%). Anatomical cystocele recurrence rate was 80 of 156 (51.3%), 
defined as Pelvic Organ Prolapse Quantification system (POPQ) stage 2 of higher. Risk 
factors for anatomical cystocele recurrence after anterior colporrhaphy were a levator ani 
defect (odds ratio (OR) 2.4, 95% confidence interval (CI) 1.3-4.7), advanced preoperative 
stage (OR 2.0, 95% CI 1.0-4.1), family history of POP (OR 2.4, 95% CI 1.2-4.9), and 
sacrospinous fixation (OR 6.5, 95% CI 2.0-21.2). 
 
Different classification systems of levator ani defects are used in studies using MRI and 
studies using ultrasound. DeLancey et al. classified levator damage as major, minor, or none 
using MRI. Dietz et al. described a classification system for translabial 3D ultrasound on 
which a levator defect was classified as complete, partial, or no avulsion. In chapter 6 these 
two classifications of levator defects were compared using translabial 3D ultrasound in 152 
women. Overall comparison of the two scoring systems showed very good agreement, with 
a weighted kappa of 0.82 (95% CI 0.75-0.88). The agreement between the scores in 
describing the extent of levator damage, by identifying cases with major levator defects 
(cases proven to be of clinical relevance) showed good agreement with a Cohen’s kappa of 
0.65 (95% CI 0.53-0.77). Using the ultrasound classification, more defects were categorized 
as complete avulsion compared with MRI classification. There was no difference in 
predictive value between scoring systems for cystocele recurrence after POP surgery (area 
under the receiver operating characteristic (ROC) curves (AUC) between 0.58 and 0.64). 
 
In chapter 7 the association between levator hiatal area and anatomical cystocele recurrence 
after surgery was investigated in a multicenter prospective cohort study with 139 women 
undergoing surgery for POP. Women planned for conventional anterior colporrhaphy without 
mesh underwent physical examination, translabial 3D ultrasound and MRI prior to surgery. 
At 12 months after surgery physical examination was repeated. Women with and without 
anatomical cystocele recurrence were compared to assess the association with levator hiatal 
area on 3D ultrasound, levator hiatal area on MRI and potential confounders. Of 139 included 
women, 76 (54.7%) had anatomical cystocele recurrence. Increased levator hiatal area during 
Valsalva on ultrasound prior to surgery and preoperative POPQ stage 3 or 4 were independent 
risk factors for anatomical cystocele recurrence after anterior colporrhaphy (OR of 1.06 (95% 
Chapter 11 
156 
 
CI 1.01-1.11) and 3.47 (95% CI 1.66-7.28) respectively). Increased levator hiatal area as sole 
factor to predict anatomical cystocele recurrence after surgery showed poor test 
characteristics, with an AUC of 0.60 (95% CI 0.51-0.70). 
 
Chapter 8 compared translabial 3D ultrasound with MRI for measuring levator hiatus 
biometry at rest in 139 women with POP. Intraclass Correlation Coefficients (ICC) were 
calculated to estimate the interobserver reliability between two independent observers and to 
calculate the agreement between ultrasound and MRI measurements. The interobserver 
reliability between the assessments on ultrasound at rest, during Valsalva and during 
contraction and on MRI at rest by two independent observers was good. The agreement 
between ultrasound and MRI for the measurements of levator hiatus biometry at rest was 
moderate with an ICC of 0.52 (95% CI 0.32-0.66) for levator hiatal area, an ICC of 0.44 
(95% CI 0.21-0.60) for the anteroposterior diameter and an ICC of 0.44 (95% CI 0.22-0.60) 
for the transversal diameter. MRI measurements were statistically significantly larger than 
on translabial 3D ultrasound. 
 
In chapter 9 the development of a prediction model for anatomical cystocele recurrence after 
surgery is presented, including an internal validation. The database used for this study was 
composed of two multicenter prospective cohort studies, both including women undergoing 
an anterior colporrhaphy without the use of mesh and without previous POP surgery. All 
women completed a questionnaire, received translabial 3D ultrasound, and underwent 
staging of POP. Of 287 included women, 149 (51.9%) had anatomical cystocele recurrence. 
Factors included in the prediction model were assisted delivery, preoperative stage, number 
of compartments involved, major levator ani muscle defects and levator hiatal area during 
Valsalva. The AUC of the prediction model was 69.7%, after correction for optimism. In 
clinical practice, the prediction model can be used in preoperative counseling, to identify 
patients that have a low or high risk of anatomical recurrence, by choosing a risk threshold 
with the preferred test characteristics. 
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SAMENVATTING 
 
Een verzakking van de inwendige vrouwelijke geslachtsorganen (prolaps) is een frequent 
voorkomende aandoening en de etiologie is multifactorieel. Het identificeren van 
risicofactoren op een prolaps en een recidief prolaps is belangrijk ten aanzien van de 
preoperatieve counseling van de patiënt en het opstellen van een individueel behandelplan. 
 
Hoofdstuk 2 geeft een overzicht van de literatuur over risicofactoren op prolaps en recidief 
prolaps na conservatieve chirurgie. Er werd een volledige en systematische zoekstrategie 
uitgevoerd tot 4 augustus 2014. Cohort en cross-sectionele studies in Westers ontwikkelde 
landen, die een multivariate analyse omvatten en die een definitie van prolaps gebruikten 
gebaseerd op anatomische referentiepunten, werden geïncludeerd. Recidief prolaps moest 
gedefinieerd zijn als anatomisch recidief na conservatieve chirurgie zonder het gebruik van 
mesh, met een follow-up na chirurgie van minstens één jaar. Ten aanzien van een eerste 
prolaps, werden er tien studies met in totaal 41,501 vrouwen geïncludeerd, waarin 30 
risicofactoren werden onderzocht. Pariteit, vaginale baring, leeftijd en body mass index 
(BMI) waren de belangrijkste risicofactoren. Voor recidief prolaps, werden vijf studies met 
totaal 954 vrouwen geïncludeerd waarin 29 risicofactoren werden onderzocht. Alleen 
preoperatief stadium was een bevestigde risicofactor.  
 
Hoofdstuk 3 bevat een brief aan de redacteur betreffende het artikel in hoofdstuk 2, en een 
reactie op dit commentaar. De auteurs van dit commentaar stellen dat de conclusie van het 
systematische review foutief is ten gevolge van arbitraire inclusiecriteria en het negeren van 
sommige studies. Zij voeren aan dat er meerdere publicaties zijn waarin getoond wordt dat 
schade aan de levator ani spier en een abnormale levator ani hiatus risicofactoren zijn op 
zowel een eerste prolaps als recidief prolaps. Echter, dit wordt niet bevestigd door artikelen 
met het meest sterke wetenschappelijk bewijs over dit onderwerp. Dit wordt bediscussieerd 
in de reactie op het commentaar in de brief aan de redacteur. 
 
Er zijn verschillende studies die schade aan de levator ani spier en de grootte van de levator 
ani hiatus hebben onderzocht als risicofactoren op prolaps en recidief prolaps. Hoofdstuk 4 
biedt een systematische review van studies over het gebruik van translabiale drie-
dimensionele (3D) echografie voor het diagnosticeren van levatorschade en het meten van 
levator ani biometrie. Het diagnosticeren van levatorschade en het meten van levator ani 
biometrie middels translabiale 3D echografie laat een gemiddelde tot goede 
overeenstemming zien in vergelijking met de bevindingen op magnetic resonance imaging 
(MRI), en de reproduceerbaarheid was goed. Noemenswaardig, wat betreft de 
reproduceerbaarheid zijn zes van de acht geïncludeerde artikelen over het diagnosticeren van 
levatorschade en zes van de tien geïncludeerde artikelen over het meten van levator ani 
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biometrie afkomstig van dezelfde onderzoeksgroep waarin reproduceerbaarheid werd getest 
tussen twee beoordelaars. Studies ten aanzien van externe validatie en reproduceerbaarheid 
tussen meerdere observeerders in een multicenter omgeving zijn zeldzaam. Levatorschade 
en een grote levator ani hiatus waren, in een geselecteerde groep vrouwen met 
bekkenbodemklachten, geassocieerd met prolaps en recidief prolaps. Veel artikelen werden 
gepubliceerd door dezelfde onderzoeksgroep. 
 
Hoofdstuk 5 betreft een prospectieve observationele cohort studie met 245 vrouwen die een 
voorwandplastiek kregen. Het doel van de studie was het bepalen van de relatie tussen 
recidief cystocele na voorwandplastiek en levatorschade en andere potentiële risicofactoren. 
Twee jaar na de operatie werden de vrouwen uitgenodigd voor een controle die bestond uit 
een vragenlijst, lichamelijk onderzoek en translabiale 3D echografie. Van de 245 vrouwen, 
kwamen 156 vrouwen (63.7%) op controle. Anatomisch recidief werd gezien bij 80 van de 
156 vrouwen (51.3%) gedefinieerd als Pelvic Organ Prolapse Quantification system (POPQ) 
stadium 2 of hoger. Risicofactoren op anatomisch recidief na voorwandplastiek waren 
levatorschade (odds ratio (OR) 2.4, 95% betrouwbaarheidsinterval (BI) 1.3-4.7), hoger 
preoperatief stadium (OR 2.0, 95% BI 1.0-4.1), familieanamnese van prolaps (OR 2.4, 95% 
BI 1.2-4.9), en sacrospinale fixatie (OR 6.5, 95% BI 2.0-21.2). 
 
Er worden verschillende classificatiesystemen gebruikt voor levatorschade in studies die 
MRI gebruiken en studies die echografie gebruiken. DeLancey et al. definieert levatorschade 
als major, minor of niet aanwezig bij het gebruik van MRI. Dietz et al. beschrijft een 
classificatiesysteem voor translabiale 3D echografie waarbij levatorschade gedefinieerd 
wordt als een complete, partiële of geen avulsie. In hoofdstuk 6 werden deze twee 
classificatiesystemen met elkaar vergeleken waarbij gebruik werd gemaakt van translabiale 
3D echografie bij 152 vrouwen. De gehele vergelijking tussen de twee classificatiesystemen 
geeft een zeer goede overeenkomst, met een gewogen kappa van 0.82 (95% BI 0.75-0.88). 
De overeenkomst tussen de classificatiesystemen in het beschrijven van de mate van 
levatorschade, door de gevallen van major levatorschade (de gevallen die bewezen klinisch 
relevant zijn) te identificeren, geeft een goede overeenkomst met een Cohen’s kappa van 0.65 
(95% BI 0.53-0.77). Met het gebruik van het classificatiesysteem dat is beschreven voor 
translabiale 3D echografie werden meer defecten gedefinieerd als complete avulsies 
vergeleken met de MRI classificatie. Er was geen verschil in voorspellende waarde tussen de 
classificatiesystemen voor het voorspellen van een recidief prolaps na operatieve ingreep 
(area under the receiver operating characteristic (ROC) curves (AUC) tussen 0.58 en 0.64). 
 
In hoofdstuk 7 werd de associatie tussen levator hiatus oppervlakte en anatomisch recidief 
cystocele na operatieve ingreep onderzocht in een multicenter prospectieve cohort studie met 
139 vrouwen die een operatie ondergaan vanwege prolaps. Vrouwen die gepland werden 
voor een voorwandplastiek zonder mesh ondergingen lichamelijk onderzoek, translabiale 3D 
Chapter 12 
160 
 
echografie en MRI voorafgaand aan de operatie. Twaalf maanden na de operatie werd het 
lichamelijk onderzoek herhaald. Vrouwen met en zonder anatomisch recidief werden 
vergeleken om de associatie met levator hiatus oppervlakte op translabiale 3D echografie, 
levator hiatus oppervlakte op MRI en potentiële confounders vast te stellen. Van de 139 
geïncludeerde vrouwen, hadden 76 vrouwen (54.7%) een anatomisch recidief. Een grotere 
levator hiatus oppervlakte tijdens Valsalva op echo voorafgaand aan de operatieve ingreep 
en preoperatief POPQ stadium 3 of 4 waren onafhankelijke risicofactoren voor anatomisch 
recidief na voorwandplastiek (OR 1.06 (95% BI 1.01-1.11) en 3.47 (95% BI 1.66-7.28) 
respectievelijk). Een grotere levator hiatus oppervlakte als enige factor om een anatomisch 
recidief na operatieve ingreep te voorspellen liet slechte testkarakteristieken zien, met een 
AUC van 0.60 (95% BI 0.51-0.70). 
 
Hoofdstuk 8 vergelijkt translabiale 3D echografie met MRI voor het meten van levator hiatus 
biometrie in rust bij 139 vrouwen met een prolaps. Er werden Intraclass Correlatie 
Coëfficiënten (ICC) berekend om de interobserver betrouwbaarheid tussen twee 
onafhankelijke onderzoekers en de overeenkomst tussen echo- en MRI-metingen te bepalen. 
De interobserver betrouwbaarheid tussen de beoordelingen van echografie in rust, tijdens 
Valsalva en tijdens contractie en van MRI in rust door twee onafhankelijke onderzoekers was 
goed. De overeenkomst tussen echografie en MRI voor het meten van levator hiatus 
biometrie in rust was matig met een ICC van 0.52 (95% BI 0.32-0.66) voor de levator hiatus 
oppervlakte, een ICC van 0.44 (95% BI 0.21-0.60) voor de anteroposterieure diameter en een 
ICC van 0.44 (95% BI 0.22-0.60) voor de transversale diameter. MRI-metingen waren 
statistisch significant groter dan de metingen met translabiale 3D echografie.  
 
In hoofdstuk 9 wordt de ontwikkeling en interne validatie van een predictiemodel voor 
anatomisch recidief cystocele na operatieve ingreep gepresenteerd. De database die voor deze 
studie is gebruikt bestaat uit twee multicenter prospectieve cohort studies, met in beide 
databases vrouwen die een voorwandplastiek zonder mesh ondergingen, en zonder 
prolapsoperatie in het verleden. Alle vrouwen vulden een vragenlijst in, kregen translabiale 
3D echografie en ondergingen lichamelijk onderzoek met stadiëring van de prolaps. Van de 
287 geïncludeerde vrouwen hadden 149 vrouwen (51.9%) een anatomisch recidief cystocele. 
Factoren die geïncludeerd werden in het predictiemodel waren kunstverlossing, preoperatief 
stadium, aantal betrokken compartimenten, major levatorschade en levator hiatus 
oppervlakte tijdens Valsalva. De AUC van het predictiemodel was 69.7%, na correctie voor 
optimisme. In de klinische praktijk kan het predictiemodel gebruikt worden bij preoperatieve 
counseling van de patiënt, door patiënten te identificeren die een laag of hoog risico hebben 
op een anatomisch recidief, afhankelijk van het gekozen afkappunt op basis van de 
testkarakteristieken.   
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